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ABSTRACT
The foliage of thirteen genetic clones of the nitrogen-fixing trees Erythrina berteroana, 
E. poeppigiana and E. cos tarricens is growing under similar environmental conditions in 
the Latin American Nitrogen Fixing Tree Arboretum, CATEE, Turrialba, Costa Rica, 
was evaluated by gas chromatography/mass spectrometry for toxic alkaloid content. 
The major alkaloid identified was B-erythroidine, a naturally derived drug used in the 
1950s and 1960s as a neuromuscular blocking agent in surgery and electroshock 
treatments. Other alkaloids identified were a-erythroidine, erybidine, erythraline, 
erysodine, oxo-B-erythroidine and several previously undescribed compounds. There 
was a difference of more than two orders of magnitude in the B-erythroidine 
concentration between the clones with the highest and the lowest content. Although all 
clones tested contained some amount of B-erythroidine, at least one clone of each species 
was notably low in this drug. The results indicate that the expression of Erythrina 
alkaloids is at least partially under genetic control. A feeding study was performed 
utilizing goats on three experimental diets: control, 40% E. berteroana foliage and 40% 
E. poeppigiana foliage. The B-erythroidine present in the foliage of Erythrina species 
was hydrogenated in the rumen and B-erythroidine, dihydroerythroidines and 
tetrahydroerythroidines were detected it. the milk of goats in the Erythrina foliage 
treatment groups, however, these compounds were not detected in the milk the control 
group. Synthetic experiments demonstrated that the dihydroerythroidine isomers 
present in the milk and rumen samples were not the same isomers produced by catalytic 
hydrogenation. During catalytic hydrogenation, the conjugated diene in B-erythroidine 
is reduced to a single double bond at the 1-6 position. Mass spectral data indicate that 
the conjugated diene is conserved during hydrogenation of B-erythroidine in the rumen
and that the double bond in the lactone ring may be hydrogenated. Synthetically derived 
dihydroerythroidine is ten times more potent than the parent drug, B-erythroidine, 
therefore there is a possibility that the presence of biologically hydrogenated 
dihydroerythroidines in the milk of goats which consume Erythrina foliage may pose a 
health hazard to individuals consuming the contaminated milk. Further studies designed 
to investigate the toxicology of biologically hydrogenated dihydroerythroidines are 
recommended.
CHAPTER ONE: 
INTRODUCTION AND OBJECTIVES
1
21.1 Introduction
Costa Rica is a small country in Central America about the size of West Virginia. In 
spite of its small size, Costa Rica has received world wide scientific attention due to the 
immense biological diversity encountered in twelve distinct biological life zones 
(Standley, 1937). However, like many Latin American countries and tropical areas in 
general, Costa Rica is suffering from an accelerated rate of deforestation and land 
degradation. In part, the forests are being cleared for their valuable tropical wood, but 
the many of the reasons behind the deforestation are political and social.
The rate of deforestation exceeds 60, 000 acres per year. The main purpose of 
deforestation is the clearing of land for grazing cattle. Once the forest is cleared the soil 
fertility decreases rapidly until the land reaches very low levels of productivity. To 
complicate matters, much of Central America is mountainous and the pressure on land 
with over a 40% slope for cattle grazing is threatening land and water resources for the 
future.
In Costa Rica the majority of the farms are ten hectares or less in size and are usually 
farmed by a family (Ministerio de Agricultura, San Jos6, Costa Rica, personal 
communication). Although the majority of the farms are small, there are large 
landowners that possess vast areas of the jest land. Therefore, many small farmers are 
forced to farm marginal lands of poor soils and steep slopes. In general, the government 
gives title to farmers if they can show that they have improved and developed the land. 
Improvement means clearing the land and keeping it clear. The easiest way to 
accomplish this is to clear cut, bum the plant residue and introduce cattle. Ecologically, 
this is disastrous. Due to the fragility of the soils and the high precipitation, all the 
topsoil is eroded within a few years and the farmer and his family are obliged to move on 
and continue the process somewhere else. Already in Costa Rica these degradated areas 
are infamous and are particularly visible in the high population centers such as the
3Central Valley and Puriscal, Unfortunately, alternatives to these practices, although 
available, have not been effectively transferred to the farmers and they continue to ruin 
the land in a new area where they become established.
Tropical ecosystems and temperate ecosystems are very different. The majority of the 
available nutrients and organic matter in tropical ecosystems are found in live organisms 
and not in the soil. Nutrient cycles are very rapid. Due to the high humidity and warm 
temperatures, organisms decompose quickly and the nutrients that are liberated are taken 
up and used again almost immediately. Therefore, systems which maintain a permanent 
soil cover are the only systems that offer a reasonable solution to the problem of erosion. 
Sustainable systems which include partial clearing of the land and the incorporation of 
permanent crops or trees will have a better chance of success in the long term than 
clearcutting. For this reason, many farmers as well as researchers are turning to 
agroforestry systems to provide alternatives to the current clearcutting tradition.
Agroforestry is a relatively new concept which involves the cultivation of trees in 
association with crops, pasture and/or animals in a sustainable agricultural production 
system. Nitrogen fixing species of trees offer the most flexibility and therefore the 
greatest number of potential uses within these agroforestry systems. As well as 
producing wood and maintaining cover over the soil, they also add nitrogen to the soil 
and are, in general, easy to propagate. Nitrogen fixing trees usually have a high crude 
protein content and can be used as a high protein supplement for many ruminants 
(National Science Foundation, 1979).
The Centro Agrondmico Tropical para Investigacfon y Ensefianza (CATIE), an 
international agricultural research institution located in Turrialba, Costa Rica is actively 
involved with the promotion of agroforestry. Agroforestry systems which combine 
pasture with trees and which integrate animals have been developed at CATIE. The best 
results in terms of forage and biomass production have come from those systems which
4utilize nitrogen fixing trees in association with pasture such as the king grass 
(Pennisetum purpureum x typhoides) and Por6 {Erythrina spp.) system (Benavides, 
1983). The development of a high protein forage is necessary for the tropics where 
nitrogen fixing grasses are unable to compete with the natural vegetation. This need is 
especially felt in the dryer areas where pasture is essentially unavailable or of very poor 
quality during the dry season. Again, nitrogen fixing trees offer a possible solution 
because they can be managed to provide green forage all year round. The high crude 
protein content of these arboreal species can serve as a concentrated source of protein in 
the diet of the ruminant and increase its production potential.
Several models of agroforestry systems for forage production have been developed 
and their incorporation into traditional agricultural practices may be relatively easy. Use 
of the foliage bom nitrogen fixing trees already established on farms as live fences or 
shade foT permanent crops would be an alternative technology easier to transfer to the 
farmer than other more unfamiliar technologies. Nevertheless, the development of a 
protein bank where nitrogen fixing trees are cultivated in pure stands or in association 
with pasture for cut and carry systems, non-traditional systems in Central America, 
would be ideal from a purely technical standpoint.
In the past two decades, world wide tropical research has concentrated on the small 
fanner. Due to restrictions such as slope, extremely high rainfall and lack of capital, the 
majority of the tropical farmers use low input techniques on their farms. The typical 
small farm is a subsistence, risk minimizing, low investment, low production and low 
return operation. Emphasis is placed on spreading the risk and investment of land and 
labor over a variety of crops. Small ruminants integrated into these systems offer the 
opportunity to convert crop residues, weeds and otherwise unusable materials, such as 
nitrogen fixing tree foliage, into useful products for family user and cash income. For 
these reasons it has been postulated that integrating goats into agroforestry systems
offers a more practical solution than using cattle as a source of protein (meat and milk) 
for the small farmers. This is very important is rural areas where the scarcity of animal 
protein is severe. Goats are smaller and, when kept in confinement, cause no destruction 
to fragile tropical soils. They are easier to handle and therefore are more adaptable to 
family managed production systems, where female or older members of the family are 
frequently in charge of the small animal production. In addition, it is known that goats 
can be fed for short periods of time up to 100% of their diet in the form of nitrogen 
fixing tree foliage and maintain adequate milk production and weight gain with no ill 
effects (Benavides, 1983; Samur, 1984). The main objective of the Nitrogen Fixing 
Tree Project at CATIE is to introduce technology which provides a source of animal 
protein in the form of milk, meat and cheese to the small farmer and his family.
1.2 The Genus Erythrina and its Traditional Uses
The genus Erythrina of the family Papiionaceae contains about 110 species and is 
widely distributed in the tropical areas of both hemispheres. Several Erythrina species, 
locally known as por6, are naturalized in Costa Rica. One species, E. poeppigiana, was 
introduced into the Central Valley of Costa Rica approximately 80 years ago. Since that 
time it has spread to most of Costa Rica. It has played a very important role in the 
development of the coffee industry where it is used as a nurse or shade crop species 
along with E. fusca. Farmers have adopted E. berteroana and E. costarricensis as live 
fence posts and guides for climbing crops. Normally the trees are pruned once or twice a 
year and the foliage is left on the ground to decompose thus adding nitrogen and organic 
matter to the soil. At a planting rate of 230 trees/ha in a coffee plantation, 140 kg/ha of 
nitrogen can be added to the system per year, or the equivalent of 700 kg/ha of 
ammonium sulfate per year (Lessard, 1982). Experiments completed at CATIE 
comparing the utilization of Erythrina as shade with a similar non-nitrogen fixing species
6have shown that the coffee yields increased when grown under the por6 when compared 
with other tree species when no commercial fertilizers were used (Lessard, 1982).
1.3 Erythrina as Forage
Erythrina is usually vegetatively propagated by large cuttings of stakes approximately 
two meters in height and four to six inches in diameter. Because of its versatility, wide 
distribution and ease of propagation, alternative uses of of the genus have been 
investigated. Of special interest is the use of the foliage of Erythrina as a high protein 
forage for ruminant animals. E. poeppigiana contains 27-34% crude protein on a dry 
weight basis. The total digestible nitrogen is 70% and its potential overall digestibility is 
74% (Nitrogen Fixing Tree Project, 1986). One tree of E. poeppigiana can produce 10 
kilograms of dry foliage per year. The digestibility of the biomass can be affected by 
varying the pruning frequency. A higher pruning frequency produces more tender stems 
and leaves which have a higher crude protein content and digestibility than older 
counterparts (Benavides, 1986).
Studies done by the Animal Production Department at CATIE have shown that E. 
berteroana is more effective as a goat feed than E. poeppigiana, or at least that it is more 
attractive to goats when offered a choice. In an experiment where goat kids were offered 
the foliage of the two Erythrina spp. and that of banana leaves, E. berteroana was 
significantly superior to the other treatments in terms of weight gain (Benavides, 1986). 
Benavides (1983) also demonstrated that the performance of goats on a Erythrina spp. 
diet could be improved when an adequate source of energy was provided, such as mature 
or green bananas. It seems that the animals need a starch source to efficiently utilize the 
protein available in the Erythrina leaves.
71.4 Antiqualitative Agents in Erythrina
Given all of the above advantages of Erythrina, it is unfortunate that the seeds and 
foliage of the genus are known to contain toxic alkaloids. If the alternative use of 
Erythrina as a forage for animals is to be developed, the alkaloid profile of each species 
and specific genetic clones selected for development must be determined and the fate of 
the alkaloids investigated. If low alkaloid content clones can be identified, then these 
clones could be promoted over those clones with higher concentrations of alkaloids and 
eventually, the alkaloid content of selected low alkaloid content clones may be reduced 
further by genetic engineering and plant breeding.
1.5 Objectives and Overview
The following pages describe the preliminary investigations undertaken to answer two 
major questions. 1) Are there differences in the alkaloid content of genetic clones and 
can low alkaloid containing clones be identified? 2) If toxic alkaloids are present in the 
foliage of Erythrina species, are these alkaloids or possibly toxic metabolites present in 
the milk of dairy goats fed Erythrina foliage? Following this introductory Chapter, 
Chapter two summarizes what is known about Erythrina alkaloids in the form of a 
review of the scientific literature. Chapter three describes the Erythrina plant material, 
clonal selection and sample collection process in Costa Rica and presents a statistical 
analysis of the biomass data of each clone and the results of liquid chromatographic 
techniques applied to Erythrina alkaloid separation. Chapter four details the alkaloid 
profile of each clone analyzed by gas chromatography and mass spectrometry and 
compares the profiles of the thirteen gen^.ic clones. Finally, Chapter five discusses a 
feeding study performed at CATTE using goats and identifies the possible metabolic fate 
of the major Erythrina alkaloid present in the foliage of the selected Erythrina clones. A 
data base of parameters necessary for the the identification and characterization of a wide
8variety of Erythrina alkaloids compiled from the scientific literature is presented as 
Appendix A. The gas chromatographic and mass spectral data of selected Erythrina 
alkaloids that were generated from the investigations described in the following chapters 
are presented in condensed form as Appendix B. Lists of tables, figures and 
abbreviations follow the table of contents for more convenient cross reference.
CHAPTER TWO: 
REVIEW OF LITERATURE
9
10
This chapter consists of a review of the scientific literature on the discovery, use and 
structure eluciadation of Erythrina alkaloids,
2.1 Erythrina Alkaloids: Occurrence, Isolation and Identification
Figures 2.1, 2.2 and 2.3 display the chemical structures of many of the Erythrina 
alkaloids to be discussed subsequently. Figure 2.1 shows the structures of B- (1) and 
a-erythroidine (3) along with 8-oxo-erythroidine (2), erysodienone (4) and crybidine 
(5). Figure 2.2 depicts the aromatic diene Erythrina alkaloids (6-21) whereas Figure
2.3 depicts the alkenoid type of Erythrina alkaloid (22-30).
2.1.1 Folkers, Unna, Majors and Koniuszy
As early as the 1880s, it was observed that Erythrina seed extracts possessed curare­
like properties (Altamirano, 1888). Curare selectively paralyzes neurotransmission of 
the motor nerve endings of striated muscles. In 1937, Folkers and Majors of Merck and 
Co, Inc. isolated a pure crystaline material from the seeds of E. americana that they 
named erythroidine (1), the same name Altamirano used for his crude extracts. The 
compound was active when given orally whereas true curare is active only when injected 
intraveneously. Folkers and Unna (1938 , 1939) began surveying the genus and they 
found that extracts of at least half of the species were biologically active. Folkers and 
Koniuszy (1939a) isolated erythramine (22) from E. sandwicensis and E. subumbrans 
and further studies were done to identify the structure of the alkaloid (1939b). In the 
following decade additional Erythrina alkaloids were isolated from a variety of species 
and structure determination studies ensued (Folkers and Koniuszy, 1940a, 1940b, 
1940c; Folkers, Shavel and Koniuszy, 1941; Folkers and Shavel, 1942a; Koniuszy, 
Wiley and Folkers, 1949).
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(1) X=H2 B-eryihroidine 
(2) X=0 8-oxo-B-erylhroidine
O
(3) a-erythroidine
OH
HO
O
<4) erysodienonc
N — CH
OCH
(5) erybidine
Figure 2.1 Some Erythrina Alkaloids.
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NAME R l R2 R3 R4
(6) erysotrine CH3 CH3 CH3 H
(7) erythaline —CH2— CH3 H
(8) 11-Methoxyerythaline —CH2— CH3 OCH3
(9) eryihristtmine CH3 CH3 CH3 OCH3
(10) erythrascine CH3 CH3 CH3 OOOCH3
(11) erysodine H CH3 CH3 H
(12) erysovine CH3 H CH3 H
(13) erythravine CH3 CH3 H H
(14) erythrinine —CH2— c h 3 OH
(15) erysopinc H H CH3 H
(16) erysonine H CH3 H H
(17) erysoline CH3 H H H
(18) 11-oxoerysodine H CH3 CH3 =0
(19) 11 -hydroxy erysodine H CH3 CH3 OH
(20) 11-tnethoxy erysodine H CH3 CH3 OCH3
(21) 11-oxoerythraline —CH2— CH3 ==0
Figure 2.2 The Dienoid Type Erythrina Alkaloids.
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NAME R l  R 2 R3
(22) erythramine —CH2— H
(23) crythratidinc CH3 CH3 OH
(24) crythratinc —CH2— OH
(25) erysotine H CH3 OH
(26) crysosalvine CH3 H OH
(27) erysopitine H H OH
(28) erythratidinone CH3 CH3 =0
(29) erythratinone —CH2— **0
(30) erysotinone H CH3 =0
Figure 2.3 The Alkenoid Type of Erythrina Alkaloids.
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Folkers and co-workers divided the Erythrina alkloids into three classes. The "free" 
alkaloids were ex tractable by immiscible solvents from clean, fat-free plant extracts 
which had been rendered alkaline. They were given the prefix ERYTHR- and some 
examples are erythraline (7), erythramine (22) and erythratine (24). The "liberated" 
alkaloids were only extractable after acid hydrolysis. They have the prefix ERYSO- and 
erysodine (11), erysopine (15) and erysovine (12) are examples. The "combined" 
alkaloids were not extractable by ordinary methods, contained sulfur and were sources 
of the "liberated" alkaloids. Later, it was determined that the "combined” alkaloids were 
sulfoacetic acid derivatives of the "liberated" alkaloids. They were given the prefix 
ERYSOTHIO-.
The first basic structure for the aromatic Erythrina alkaloids based on UV data and 
degradation studies was suggested by Folkers, Koniuszy and Shavel (1942). A 
structure was suggested for B-erythroidine (1) by Koniuszy and Folkers in 1950. In 
1944, Folkers, Koniuszy and Shavel began investigating and isolating some of the 
combined alkaloids which were determined to be sulfoacetic acid esters of the 
corresponding liberated alkaloids. Colorimetric assay of B-erythroidine was devised in 
1946 (Dietz and Folkers, 1946; Folkers and Shavel, 1946). Several U.S. patents were 
issued in conjunction with Folkers and coworkers' work with Erythrina alkaloids 
(Folkers and Major 1945a, 1945b; Folkers and Koniuszy, 1946; Major and Folkers, 
1947).
2.1.2 Deulofeu
At nearly the same time that Folkers and coworkers at Merck were investigating 
Erythrina species for alkaloids, Deulofeu was looking at Latin American species in 
Argentina (Deulofeu, Hug and Mazzocco, 1939). Following Folkers work, Deulofeu et 
al. isolated erythratine (24) and erysodine (II)  from E. crista-galli (1947). Deulofeu
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proposed an alternative structure for the aromatic Erythrina alkaloids (Labriola, Deulofeu 
and Berinzaghi, 1951; Deulofeu, 1952).
2.1.3 Boekelheide
Boekelheide while at the University of Rochester began a series of studies aimed at 
elucidating the structure of B-erythroidine and identifying the structural features required 
for biological activity (Sauvage and Boekelheide, 1950). Merck and Co., Inc. provided 
the B-erythroidine required for the studies. Several B-erythroidine derivatives and 
decomposition products where found to be biologically active (Boekelheide and 
Agnello, 1951). In 1953, Boekelheide et al. published a structure of B-erythroidine that 
is now accepted as the true structure of B-erythroidine, based on UV, IR, degradation 
studies and comparison studies of the apo-derivative with lysergic acid. Studies on the 
degradation and structure of apo-erythroidine (Grundon and Boekelheide, 1953; 
Grundon, Sauvage and Boekelheide, 1953), the hydrogenation of desmethoxy-B- 
erythroidine (Boekelheide, Anderson and Sauvage, 1953) and the structure a- 
erythroidine (3) were also completed (Boekelheide and Grundon, 1953; Godfrey, 
Tarbell and Boekelheide, 1955). Boekelheide summarized his results and those of 
others in a review written with Prclog in 1955 and in Manske in 1960.
After the structures of a  and B-erythroidine were elucidated, experiments focused on 
determining the absolute configuration of a  and B-erythroidine (Wenzinger and 
Boekelheide, 1963) and the other Erythrina alkaloids (Boekelheide and Wenzinger, 
1964).
2.1.4 Other Studies on Structure Elucidation.
Lapifre and Robinson (1951) were also involved in determining the structure of B- 
erythroidine. Lapi6re developed a specific test for the determination of B-erythroidine
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upon degradation based on a reaction with ferric chloride. Hill and Schearer (1962) 
proposed the absolute configuraion of a-erythroidine at C-12. And finally in 1963, 
Hanson determined the crystal structure of dihydro-B-erythroidine hydro bromide and the 
absolute configuration at the spiro atom became known. Barton et al. (1970) published 
the crystal structure of a new Erythrina alkaloid named erythristemine (9) isolated from 
E. lysistemon.
Following the publication of the crystal structure, other modem spectroscopic 
analyses were performed on the Erythrina alkaloids. Mass spectrometry was first 
performed on Erythrina alkaloids by Boar and Widdowson in 1970. The aromatic diene 
alkaloids exhibited a novel fragmentation and rearrangement reaction with a loss of 58 
amu. Peaks attributible to a retro-Diels-Alker reaction in ring D were seen in the mass 
spectra of a  and B-erythroidine. Mass spectral studies of synthesized erythrinane 
derivatives were done by Migron and Bergmann in 1977. In all cases the molecular ion 
peaks were relatively intense when electron impact ionization was used. Nuclear 
magnetic resonance (NMR) studies performed on Erythrina alkaloids were reviewed by 
Crabb in 1975. Decoupling and INDOR techniques proved helpful in the assignment of 
the NMR peaks (Barton et al., 1970; Ju-ichi et al., 1977 and 1978).
2.1.5. Occurance of Erythrina Alkaloids
While some researchers concentrated on the elucidation of the chemical structure of 
Erythrina alkaloids, others were working on the isolation and characterization of new 
alkaloids or the investigation of unstudied Erythrina species. A new alkaloid, 
erysotrine (6) was isolated from E. suberosa by Singh and Chawla (1969). The 
discovery of erysotrine was important because it had been synthesized in the laboratory 
from other Erythrina alkaloids but had never before been found in nature. Ito et al.
(1970) isolated erythrinine (14) from E. indica, which was novel in that ring C was
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oxygenated at C-l 1 and this structural variation had not been seen before. This paper 
was also important in that the alkaloid was isolated from the leaves. All previous studies 
had focused on the seeds of Erythrina species although it was known that other plant 
parts possessed biological activity (Folkers and Unna, 1938).
Ghosal, Ghosh and Dutta (1970) also began investigating other plant parts for 
Erythrina alkaloids in India. Their work followed reports of medicinal uses of various 
Erythrina plant pans. The highest alkaloidal content was found in the bark of E. 
variegata. In the bark and leaves, erysotrine was the major alkaloid whereas in the seed, 
hypaphorine was the major alkaloid. Erysodine, erythraline (7) and erysopine (15) 
where also identified. A similar pattern was seen when E. lithosperma was investigated 
(Ghosh and Majumdar, 1972). Ghosal, Chakraborti and Srivastava (1972) identified an 
O-acetylated alkaloid at C-l 1 called erythrascine (10) from the seeds of E. arborescens. 
In this species the highest alkaloid content was found in the seeds. Ghosal and 
Srivastava (1974) also isolated a quaternary indole alkaloid derivative of ersyovine from 
the seeds of £. arborescens.
Singh and Chawla (1969) were also working in India on the identification of various 
Erythrina alkaloids in Indian species of Erythrina. They isolated erysodine and 
erysotrine from E. suberosa and erythraline and erysovine from £. variegata (Singh and 
Chawla, 1970a, 1970b and 1970c). They noted that different collections of £. suberosa 
seeds varied in their alkaloidal constitution. They did not isolate any Erythrina alkaloids 
from the leaves of £. suberosa, however they did isolate several Erythrina alkaloids 
from the bark of £. variegata. Miana et al. (1972) isolated erysotrine from the leaves of 
£. suberosa.
A new structural variation was discovered by Letcher (1971). Methylation of the C- 
ring at carbon-11 was discovered in the leaves of £. lysistemson and the new alkaloid 
named 11-methoxyerythraline was identified. By this time the use of B-erythroidine and
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the more potent dihydro-B-erythroidine in clinical practice had trailed off due to 
replacement by synthetic drugs, but interest in Erythrina alkaloids continued.
Hargreaves et al. (1974) reviewed the occurrence of Erythrina alkaloids in twenty- 
two American species of Erythrina. They reported that the largest alkaloidal fraction in 
the seeds of the American species was the liberated alkaloid fraction (the eryso- 
alkaloids) which constituted about 0.1% of the dry seed weight. Only in exceptional 
cases did the percent alkaloids exceed 1% of the seed dry weight. They identified six 
new Erythrina alkaloids: erythravine, erysoline (17), erysosalvine, erysosalvinonc and 
erysoflorinone. Games et al. (1974) reviewed the occurrence of Erythrina alkaloids in 
the seeds of eighteen African, Asian, Polynesian and Australian species. The analysis 
was done by field desorption GC/MS. Games reported that erysodine and erysovine 
were the most abundant alkaloids found in the eastern species of Erythrina and they 
occured in every sample analyzed. The Hargreaves et al. (1974) and Games et al. (1974) 
papers were part of a special issue of Lloydia concerning the taxonomy of the genus 
Erythrina. In that same issue, Romeo and Bell (1974) measured the amino acid 
concentration and alkaloids in 78 species of Erythrina with representative from each of 
the 26 taxonomical sections. Amino acid concentration was usually low when alkaloid 
content was high and only common amino acids were found in the genus. No Erythrina 
alkaloids were detected in E. edules, an Erythrina species eaten by natives in Colombia. 
They found that a and B-erythroidine only occured in the sections of Micropteryx, 
Erythrina and Chirocalyx and their presence may be taxonomically important. When a 
and B-erythroidine occured they were often the major alkaloids. Romeo and Bell did 
not evaluate the alkaloidal variation between clones of Erythrina.
Ito and co-workers continued to investigate Erythrina species found in Japan, New 
alkaloids, erythrinine and erybidine (5) were isolated and characterized from E. 
bidwillii. (Ito, Furukawa and Tanaka, 1973) and E. crysta-galli (Ito et al.,1973) as well
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as other previously identified alkaloids. They isolated the new alkaloids 11- 
hydroxy cry so trine, erythrabine and cry so tra mi dine from E. arborescens (Ito, Furukawa 
and Haruna, 1974a and 1974b) and crystamidine (10,11 dehydro-8-oxo-erythraline) 
from £. crysta-galli (Ito et al., 1976).
In the late 1970s, Erythrina type alkaloids were isolated from genera other than 
Erythrina. Dihydroerysovine was isolated from Cocculus trilobus (Ju-ichi et al., 1977) 
and was completely characterized by NOE and INDOR NMR and MS techniques. Ju- 
ichi used these techniques to determine the substitution pattern on the aromatic Erythrina 
alkaloids synthesized in that laboratory (Ju-ichi et al, 1978) and those isolated from 
Cocculus (Ju-ichi, Fujitani and Furukawa, 1985).
Erythrina alkaloids have also been isolated from the flowers of Erythrina species. 
The flowers are sometimes used to make tea for medicinal purposes. El-Olemy et al. 
(1978) investigated the Erythrina alkaloids in the flowers and seeds of E. variegata in 
EygpL Erysotrine was the major alkaloid in the flowers while erysodine was the major 
alkaloid in the seeds. Aguilar, Giral and Espejo (1981) found that a  and B-erythroidine 
comprised 0.11 % by weight of the dried flowers of E. americana. Dagne and Steglich 
(1984) discovered 8-oxoerythrinine in the flowers o f f .  brucei, a tree found only in the 
highlands of Ethiopia and used for medicinal purposes. Other previously identified 
alkaloids were also isolated. A unique Erythrina alkaloid was isolated from the seed of 
E. melancantha (Dagne and Steglich, 1983). Erymelanthine (31) (Figure 2.4) contains 
a second nitrogen atom in the tetracyclic Erythrina skeleton.
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Figure 2.4 Erymelanthine from E. melancantha.
2.1.6 Jackson, Chawla and Coworkers.
Most recently another group at the University of Cardiff in Great Britain has begun to 
isolate and characterize the Erythrina alkaloids. Some of their work has been in 
collaboration with Chawla in India. Initial studies focused on the seeds of Erythrina 
species (Barakat et al., 1977, Abdullah et al., 1979). Further studies examined the 
leaves of E. poeppigiana, E. berteroana, E. macrophylla, and E. salviiflora (Jackson 
and Chawla, 1982) using the field ionizadon GC/MS method developed by Games et al. 
(1973). The alkaloids a and B-erythroidine were isolated from the leaves of the former 
species, but not from E. macrophylla. 8-oxoerythroidine (2) was detected in E. 
berteroana but not in E. poeppigiana. The seeds of various collections of other 
Erythrina species were examined for Erythrina alkaloids by GC/MS (Redha, 1983) and 
quantitative differences were found between samples which they attributed to different 
growing conditions (Jackson et al., 1982). Further studies were done on the synthetic 
interconversion of 11-oxygenated Erythrina alkaloids (Abdullah et al., 1982), on the 
NMR of Erythrina alkaloids (Chawla, Chunchatprasert and Jackson, 1983; 
Chunchatprasert, 1982) and on semi-preparative normal phase HPLC of Erythrina
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alkaloids (Chawla, Jackson and Ludgate, 1982; Chunchatprasert, 1982; Chawla, Redha 
and Jackson, 1985). In the normal phase HPLC studies, a  and B-erythroidine 
constituted more than 90% of the alkaloids in the seeds and more than 95% of the 
alkaloids in the leaves of E. berteroana. Mantle, Laws and Widdowson (1984) 
developed a reversed-phase HPLC method for the purification of 8-oxo-erythraline and 
crystamidine from the leaves of E. crista-galli using methanol and water as the mobile 
phase.
Studies continued with Indian Erythrina species using GC/MS. E. blakei bark was 
investigated (Singh et al., 1981). Several common Erythrina alkaloids and a few new 
Erythrina alkaloids, which were N-oxides, were identified in E. crista-galli flowers 
(Chawla, Gupta and Jackson, 1987). A previous study had shown that the N-oxides 
were not artifacts but were real natural products (Sarragiotto, Filho and Marsaioli, 
1985). The bark of E. variegata also contained mostly free alkaloids and few liberated 
alkaloids (Chawla et al., 1988).
Much of the work by Chawla and Jackson is summarized in the reviews on Erythrina 
alkaloids in Natural Product Reports aim the Chemistry and Biology o f Isoquinoline 
Alkaloids (Chawla and Jackson, 1984, Jackson, 1985, Chawla and Jackson, 1986). 
Reviews on the use of alkaloids in the chemotaxonomy of Erythrina and other 
leguminosae can be found in Smolenski et al. (1972), Kinghom and Smolenski (1978), 
and Mears and Mabry (1971).
2.2 Erythrina Alkaloids: Biosynthesis.
2.2.1 Early Studies
Leete and Ahmad (1966) isolated radioactive a and B-erythroidine from E. berteroana 
plants which were fed radiolabled ^C-tyrosine (32), The radioactivity was equally
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divided between the C-8 and C-10 positions suggesting that a symmetrical biosynthetic 
intermediate was involved in the biosynthetic pathway, Radiolabed phenylalanine was 
not incorporated. Leete suggested that dopamine (33) and 3,4 dihydroxy- 
phenylacetaldehyde (34), both derived from tyrosine, condensed to yield a Schiff base 
which is reduced to a symmetrical amine. Several workers had been successful in 
synthesizing the aromatic Erythrina ring system from the in vitro oxidation of the amine 
through the erysodienone (40) (Mondon and Ehrhardt, 1966; Gervag et al., 1966).
2.2.2 Barton and Coworkers.
Barton et al. (1966) worked on the later stages of the biogenesis and suggested that 
erythratine (24) was the biogenically favored intermediate after ersyodienone. Later 
this group isolated erythratine as a new natural product from E. crysta-galli. Barton et 
al. (1968a and 1968b) also refined the early steps in Erythrina alkaloids biogenesis by 
demonstrating that the previously proposed symmetric amine precursor, synthesized in 
their lab in the radioactive and inactive forms, was not incorporated into the Erythrina 
alkaloids. N-norprotosinomenine (35) was incorporated, specifically and exclusively 
(Barton et al. 1974) and it was postulated as the new biogenetic pecursor making 
Erythrina  alkaloids in reality benzylisoquinoline alkaloids. Later a few 
benzylisoquinoline alkaloids were isolated along with Erythrina alkaloids from several 
Erythrina species (Ghosal et al., 1971; Barton et al., 1973).
Even though a symmetrical amine was thought to be a precursor of 
norprotosinomenine for a few years (Barton et al., 1970a and 1970b), it was ultimately 
discarded as a precursor of Erythrina alkaloids and a new symmetrical intermediate (38) 
formed from the benzylisoquinoline structure was suggested. A new biogenetic scheme 
was postulated and is presented in a modified form as Figures 2.5 and 2.6. Two moles 
of tyrosine condense to form the shiffs base as earlier postulated but the symmetrical
amine intermediate is not formed, instead a dibenzazonine symmetrical intermediate 
(38) is formed from norprotosinomenine by para-para phenolic oxidative coupling and 
ring opening followed by reduction of the inline (37) to the dibenzazonine (Barton et 
al., 1974a). Subsequent attack by the lone pair of electrons on the nitrogen on the 
conjugated double bond of the diquinone (39) leads to erysodienone (40). The 
dienone is converted to erysoenone (41) which is reduced to thcErythrina alkaloid 
erysotrine (6). Erysotrine, an alkenoid type of Erythrina alkaloid, is converted through 
loss of water to the common alkaloid erysodine (11), a diene type alkaloid, or to 
erythratine (24) through the formation of the bisoxymethylene bridge. The order of 
bisoxymethylene formation is not important. Methylation of the hydroxy groups or 
demethylation of the methoxy groups yields the other common aromatic Erythrina 
alkaloids such as erysopine and erysovine.
The lactonic Erythrina alkaloids, a and B-erythroidine, are thought to arise from the 
degradation of an aromatic precursor as shown in Figure 2.7 (Barton et al., 1974b; 
Grethe, 1981). It is still unknown if the biosynthetic sequence to the lactonic alkaloids 
occurs via intradiol cleavage (Figure 2.7a) or extradiol (Figure 2.7b) cleaveage. 
Extradiol cleavage of an aromatic ring in a natural product has been demonstrated in the 
betalains (Impellizzeri and Piattelli, 1972). In either case, cyclization would produce a- 
erythroidine and then B-erythroidine after isomerization. A plausible biogenetic route 
has been proposed for the formation of the double nitrogen containing erymelanthine 
(31) through extradiol cleavage of the aromatic ring of erysovine (Dagne and Steglich, 
1983) providing additional evidence that the aromatic ring cleavage of Erythrina 
alkaloids may occur through extradiol cleavage. Good reviews of the biosynthesis and 
biogenesis of Erythrina alkaloids can be found in Mondon (1970) and Dyke and Quessy 
(1981). A recent review on the biosynthesis of benzylisoquinoline alkaloids in cell 
culture, including certain Erythrina alkaloids, can be found in Zenk (1989).
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2.3 Erythrina Alkaloids: Synthesis
Much of the work on the synthesis of Erythrina alkaloids which occurred in the 1950 
and 1960s by Boekelheide and Mondon focused on discerning probable biosysthetic 
routes. Belleau (1953) first published a synthesis of the erythrinane skeleton in a 12% 
overall yield from 2-carbethoxycyclohexanone in five steps. Unfortunately, no natural 
products resulted from this research for many years (Boekelheide, 1955). However, 
interconversions of various natural products were performed, for example 
hydroxylations or methylations or the isomerization of a and 8-erythroidines 
(Boekelheide and Morrison, 1958).
Mondon and Ehrhardt published the total synthesis of dihydroerysodines in 1966, 
even though the natural product erysodine was not synthesized, however the paper was 
one of the first to present NMR spectal data on Erythrina derivatives. Erysodienone was 
produced during the synthesis. This compound was a proposed natural precusor in the 
biosynthetic process of Erythrina alkaloid formation. Erysodienone was isolated from 
E. lithosperma as a natural product in 1971 (Ghosal et al., 1971). Erysotrine was 
synthesized by Mondon and Nestler (1964) from the erythrinan skeleton, however this 
compound was not isolated as a natural product until later.
There was some work done on the synthesis of Erythrina alkaloids or their 
biosynthetic intermediates from benzylisoquinoline derivatives (Franck andTeetz, 1971; 
Kupchan, Kim and Lynn, 1976). A B-erythroidine derivative was synthesized from the 
erythrinane skeleton in 1974 (Kitahara and Matsui, 1974). A new approach to 
erythrinane skeleton using an diphenyl amide was suggested by Ito et al. (1976). Ito's 
group also prepared erybidine (5) photochemically (Ito and Tanaka, 1974).
Further work focused on preparing Erythrina alkaloids from the basic erythrinane 
skeleton (Haruna and Ito, 1976; Mondon and Nestler, 1964). Most recently, new 
methods of erythrinane skeleton formation have appeared (Ahmed- Scholfield and
Mariano, 1985 and 1987; Westling, Smith and Livinghousc, 1986). Variations on the 
above methods have also appeared and are too numerous to list here, Chawla and 
Jackson (1989) have recently reviewed Erythrina alkaloid synthesis and readers 
interested in Erythrina alkaloid synthesis are referred to their paper
2.4 Erythrina Alkaloids: Pharmacology and Toxicology
As mentioned in the introduction, interest in Erythrina began because of its use by 
South American Indians as an arrow poison. Various plant parts have been used in folk 
medicine for purgative, diuretic, sudorific or hypnotic effects (Unna et al.t 1944a and 
1944b). In the 1880s, extracts of E. americana were shown to have curare-like activity 
in frogs (Altamirano and Dominquez, 1888). Lehman (1936) followed up on this work 
and reported preliminary pharmacological data using a crude ethanolic extract of E. 
americana. The crude drug was fatal to mice, rats, rabbits and pigeons in a range of 5 to 
600 mg/kg depending on the route of administration and species. Intravenous injection 
was the most effective route of administration followed by intramuscular injection and 
then intraperitoneal injection. Lehman observed complete sciatic nerve paralysis at 
sublethal doses that lasted anywhere from 20 minutes to eight hours depending on route 
of administration and species. He found that phrenic nerve paralysis was peripheral and 
if artificial respiration was maintained, nanral respiration resumed even if 10 to 15 times 
the effective dose was given. Intravenous administration of the crude drug completely 
inhibited the typical convulsions which occur after strychnine poisoning. Lehman 
recommended pursuing the pharmacological activity of this drug as a possible 
anticonvulsant. A year later, Folkers and Major (1937) from Merck and Co., Inc. 
isolated B-erythroidine in its crystal form and members of that organization continued to 
evaluate compounds from Erythrina as possible commercial drugs.
2.4.1 Research at Merck
Folkers and Major (1937) determined the LD50 of erythroidine hydrochloride in 
white mice to be 120 mg/kg when given perorally and 13 mg/kg when given 
subcutaneously (SC). 0.10-0.15 mg per frog caused complete motor paralysis when 
injected into the lymph sac (intralymphatic injection, IL). In order to ascertain whether 
the curare like activity was present in all the Erythrina species, a collaborative effort with 
the New York Botanical Gardens was undertaken (Folkers and Unna, 1938, 1939) All 
fifty-one species surveyed demonstrated curare like action in frogs to varying degrees. 
The frogs injected with a threshold dose recovered within three hours. Those injected 
with ten times the threshold dose recovered the next day. No deaths were reported.
When the first aromatic Erythrina alkaloid, erythramine, was isolated, it was 
determined to have a threshold dose of 7 mg/kg as the hydrobromide in the frog 
(Folkers and Koniuszy, 1939). The threshold dose for erythraline hydrobromide and 
erythraline hydrobromide was 8 mg/kg and 75 mg/kg frog respectively by 
intralymphatic injection (Folkers and Koniuszy, 1940). The threshold dose for 
erysonine was 100 mg/kg frog (IL) (Folkers, Shavel and Koniuszy, 1941). The 
sulfoacetic acid derivatives proved to be more potent than the liberated alkaloids.
A more detailed pharmacological study of B-erythroidine and its derivatives was 
performed by Unna, Kniazuk and Greslin (1944a and 1944b). Dihydro-B-erythroidine 
(43) (Figure 2.8.) was found to be the most potent drug with an LD50 *n cats of 2-3 
mg/kg when given orally or subcutaneously. Cats were the most sensitive species 
tested, whereas rats were the most resistant. The alkaloids were rapidly absorbed from 
the gastrointestinal tract and elicited a response with the same time frame independent of 
route of administration. The animals died of nsphyxia. In chronic studies, rats were fed 
40% of the LD50 of B-erythroidine for two months. No acute toxicological symptoms 
were seen, however, after two months the animals began to lose weight and died. Cats
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fed 50% of the LD50 for three months displayed no toxic effects. Dihydro-C- 
erythroidine was also the most effective and longest lasting alkaloid in paralysis studies 
completed with frogs with an effective dose (ED) of 0.5 mg/kg. Administration of these 
alkaloids depressed blood pressure at doses below those that caused paralysis. Skeletal 
muscle was affected before the diaphragm. The margin of safety was small, but larger 
than that of curare itself. The major mode of action of Erythrina alkaloids was 
determined to be myo-neural transmission blockage of nerve impulses to the skeletal 
muscles. Smooth muscle and cholinesterase activity was not affected by B-erythroidine. 
This was confirmed by other researchers (Pichard and Luco, 1944a and 1944b). 
Prostigmine was an erythroidine antagonist. In a similar study of the the aromatic 
Erythrina alkaloids, the liberated alkaloids were less effective than the combined 
alkaloids and dehydrogenation diminished the curarized effect of the alkaloids. (Unna 
and Greslin, 1944a and 1944b).
O O
(42) dihydro-B-erythroidine (43) B-tetrahydro-B-erythroidine
Figure 2.8 The Structures of Dihydro- and B-Tetrahydro-B- 
erythroidine.
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In later studies, it was determined that B-erythroidine had less of an effect on the 
central nervous system than curare and other curare-like compounds (Pick and Unna, 
1945) and that B-erythroidine was synergistic with narcotics such as pentobarbital (Pick 
and Richards, 1947). Both drugs together could be administered in smaller amounts 
than either drug separately to obtain the same effects.
2.4.2 Clinical Studies.
The most frequent use of B-erythroidine was in controlling seizures and convulsions 
in medical treatment for schizophrenia and other mental diseases (Lehman, 1936). 
Cottington (1941) describes the use of B-erythroidine in mctrazol treatment of children 
with schizophrenia to reduce the severity and duration of the induced seizures and to 
alleviate the dread felt by the patients associated with the treatment. Previously the 
treatment almost always resulted in compression fractures of the thoracic vertebrae. The 
administration of 100 mg of B-erythroidine intraveneously resulted in complete muscle 
relaxation and subsequent administration of metrozol produced mild or no seizures. 
This treatment was given three times a week. B-Erythroidine was used in the same 
capacity in electroshock treatments (Robbins and Lundy, 1947a).
Curare and curare like compounds were used in surgery to produce a degree of 
anesthesia impossible to obtain with nitrous oxide or ethylene anesthesia (Robbins and 
Lundy, 1947b). B-Erythroidine was atractive for this purpose because it could be 
administered orally as well as intraveneously whereas curare had to be administered 
intraveneously. It also had a greater margin of safety than did curare (Berger and 
Schwartz, 1949), nevertheless, B-erythroidine’s margin of safety was small by today's 
standards. The LD50 was twice the paralyzing dose in mice (Berger and Schwartz, 
1949; Savage, Berger and Boekelheide, 1949). In the 1940s and 1950s, curare was 
widely used in American operating rooms. The use of B-erythroidine and investigation
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of its mode of action were inhibited by the lack of knowledge of the structure of fi­
ery throidine at that time and possibly by the induction of hypotension and bradycardia in 
some patients.
Megirian, Leary and Slater (1955) surveyed a wide variety of B-erythroidine 
derivatives pharmacologically. Dihydro- (42) and fi-tetrahydro (43) derivatives 
remained the most potent drugs tested. The desmethoxy and apo derivatives had greatly 
reduced potency. The toxicological data available in the literature on Erythrina alkaloids 
is summarized in Table 2.1.
2.4.3 Other Pharmacological Studies.
Dhar et al. (1968) discovered that Erythrina extracts had anticancer activity and 
although homoerythrina alkaloids isolated from Cephalotaxius harringtonia were 
pursued for this activity (Achenbach, 1977), the alkaloids isolated from Erythrina 
species never passed athe initial screening. The biological activity of Erythrina extracts 
has been frequently mentioned in folk medicine literature (Ghosal et al., 1970a and 
1970b; Bartos and Bhattacharya, 1970; Bhattacharya et al., 1971; Gayum et al., 1971; 
Ghosal et al., 1972)
One conclusion drawn from the review of Mondon's synthetic studies (1964 and 
1966) was that the cisttrans configuration at the double bonds in the A and B rings was 
not important for pharmacological activity as all four optical isomers showed similar 
activities in biological assays (Snieckus, 1973). However, the position of the double 
bond in the D ring may be important. Unfortunately, there is no toxicological data 
available on the relative potencies of a and B-erythroidine or other Erythrina alkaloid 
derivatives that vary in the position of the double bond in the lactonic ring.
Table 2.1 Summary of Toxicological Data on Erythrina Alkaloids.a
SPECIES
Chemical F rogs^ MiceE Ratsc Catsc H um ans Ref.
B-erythroidine (O) 120 
1-Dioo(0) 140 
(SC) 45 
LDioo(SC) 50
d
TD3 (0)75 510 
(SC) 48 1260
24 
ED50 14
(IP) 30 ED50 0.4
30-40 
20-25 
ED 1.5
ED 15-17 
ED 25
e
f
methiodide 200
DihydrO'B-erythroidine 0.5 (O) 7.5 320 
(SC) 9.3 230 
(IP) 4.5 ED30 08
2-3
2-3
e
f
B-ietrahydro-8 0.5 (SC) 9.5 e
ery throidine (IP) 10.6 ED50 .12 f
erythramine 7 (SC) 104 e
HBr 10
methiodide 40
dihydroerythamine 300
erythraline 8 (SC) 72 
(0)80
hydrobromide 10
methiodide 50
erythratine 75
methiodide 300
dihydioerythratine 100
erysonine HQ 100
erysopine HQ 4 (SC) 15
(0)18
dihydroerysopine HBr 40
erysovine HC1 3
tetrahydroerysovine HBr 1
erysodine HQ 10 (SC) 100
(O) 155
tetrahydnwysodine HBr >300
aAll values in mg/kg. ^Threshold value for paralysis by intralymphatic injection. 
cED5o (dose required to kill 50% of test animals) unless otherwise noted. ^Folkers and 
Major, 1937. eUnna et al., 1944. ^Cited in Robbins and Lundy, 1947b.
2.5 Summary
It has been known for many decades that Erythrina alkaloids were present in the 
seeds of a number of Erythrina species. Even though other plant parts were known to 
be biologically active, the leaves and bark of Erythrina species were not investigated 
for alkaloid content until the late 1970s and 1980s and only then in a restricted number 
of species. No studies were performed on the differences in alkaloid content between 
genetic clones of Erythrina.
In studies on the taxonomic sections of Erythrina of the eastern hemisphere, the 
aromatic Erythrina alkaloids erysodine and erysovine seemed to be present in the highest 
concentrations. On the other hand, the lactonic Erythrina alkaloids, a  and B-erythroidine 
seemed to dominate in the Erythrina species of the western hemisphere.
Biosynthetically, Erythrina alkaloids are derived from two molecules of tyrosine 
which condense to form a benzylisoquinoline intermediate, A symmetrical intermediate 
is involved in a later biosynthetic step. The lactonic alkaloids are derived from aromatic 
ring cleavage of the aromatic Erythrina alkaloids.
The principal biological action of Erythrina alkaloids is muscle paralysis. The 
lethality of each alkaloid depends on its structure, route of administration and the animal 
species. All Erythrina alkaloids possess some degree of biological activity. The 
dihydroderivatives of the lactonic alkaloids are more potent than the parent compounds, 
whereas the dihydrodcrivatives of the aromatic Erythrina alkaloids are usually less 
potent that the parent compounds. Pharmacokinetic and metabolic fate studies have 
never been performed on these drugs.
CHAPTER THREE:
SAMPLE COLLECTION, STATISTICAL ANALYSIS 
AND LIQUID CHROMATOGRAPHIC TECHNIQUES
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3.1 Introduction
The use of nitrogen fixing trees in agroforestry systems in general, and as feed for 
animals in particular, is attractive because the incorporation of nitrogen fixing trees to an 
agricultural system will help control erosion and add nitrogen to the system. Cassia, 
Leucaena and Gliricidia are a few species in addition to Erythrina that have been 
suggested for use in agroforestry systems. Leucaena is problably the best studied genus 
because of its ease of propagation, tolerance to a range of soil conditions and its 
palatibility to animals. It can contain up to 30% by weight crude protein and twice the 
carotene content of alfalfa. Unfortunately, it is also toxic to some animals due to its high 
mimosine content. Toxic symptoms include haemorrhagic cystitis and death in some 
animals. It was discovered, however, that certain rumen bacteria in some animals in 
specific geographical locations could degrade mimosine to non-toxic compounds 
(Molyneux et al., 1979). Therefore, Leucaena serves as a case study in forage 
assessment of nitrogen fixing trees. Crude protein content, biomass production and 
digestibility are important forage assessment parameters, but the presence of 
antiqualitadve compounds such as mimosine, tannins or alkaloids is also important.
The presence of Erythrina alkaloids in the seeds of various Erythrina species was 
known in the 1930s, however, their presence in other Erythrina plant parts was not 
investigated until 1974 (Barton et al., 1974b). Most of the isolations of Erythrina 
alkaloids were performed using large amounts of seeds which were high in alkaloid 
content, approximately 1% by weight. The concentration in the leaves is known to be 
smaller, approximately 0.1% or less. Early work utilized traditional column 
chromatography over silica or alumina and preparative TLC. Gas chromatographic 
techniques using packed columns was first used in the 1970s by Boar and Widdowson
(1971), who in addition to describing GC conditions used to separate several alkaloids, 
developed a theory of fragmentation of the diene and alkenoid type alkaloids, which has
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been very important the the classification of newly discovered Erythrina alkaloids. More 
information on the mass spectra of Erythrina alkaloids will be discussed in Chapter 4 
and 5.
In addition to the use of OV 17 type packed columns for gas chromatographic 
Erythrina alkaloid analysis, several researchers began using normal phase HPLC to 
separate and isolate Erythrina alkaloids because several Erythrina alkaloids could be 
analyzed using the GC method. Reversed phase liquid chromatographic techniques up 
until the present have only been used for sample purification after column separation, 
not for Erythrina alkaloid analysis. This chapter describes the clonal selection of thirteen 
Erythrina clones from the Nitrogen Fixing Tree Arboretum at CAT1E, the subsequent 
plant collection and sample preparation and the development of TLC and reversed-phase 
HPLC techniques for the separation of Erythrina alkaloids. Ultimately, liquid 
chromatography was not used in the analysis of the Erythrina alkaloids. Gas 
chromatography/mass spectrometry proved to be the more sensitive method. However, 
the reversed phase HPLC technique could be used when GC/MS is not available.
3.2 Experimental
3.2.1 Clonal Selection
Erythrina clones were selected on the basis of genetic quality, nutritional quality, and 
biomass availability after consultation with animal nutritionists, forest geneticists and 
other scientists at CAUL, Turn alba, Costa Rica. Clones were originally included in the 
arboretum on the basis of phenology, biomass production and suggestions from 
farmers. A summary of this data for each of the thirteen clones selected is presented in 
Table 3.1.
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Table 3.1. Selected Erythrina Clones and Important Characteristics.
CLONE# PROVIDENCE NUTRITIVE PHENOLOGY^.* BIOMASS 
SPECIE 1 (ORIGIN) VALUE2-3 PRODUCTION^
E. berteroanaf*
2674 Sarapiqui med/low superior very high
2652 Naranjo high average high
2670 Iroquois high superior high
2667 La Suiza high superior high
2689 Santa Marfa high superior med/low
2668 Paso Canoas high average med/low
2691 Quebrada low superior med/low
2703 Palo Verde high average low
E. poeppigiana 
2661 Tejar high
2708 Alajuela high
2687 StMarfa Dota high
2700 San Pablo high
superior
superior
superior
average
med/high
med/high
med/high
medium
E. costarricensis6 
2750 Paso Canoas high average n/a?
1 Latin American Seed Bank Number, CATIE. 2perez, 1990. 3 Determined in 
consultation with Marfa Kass, Animal Nutritionist, Animal Production Dept.,
CATIE. 4D e t e r m i n e d  in consultation with Edgar Viqudz, Forestry Geneticist, 
NFTP, CATIE, and tree register information. 5Nitrogen Fixing Tree Project
(NFTP) evaluation, ^Clone Numbers 2668, 2691 and 2703 were originally 
classified as E. costarr teens is. 7 Not available.
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Five E. berteroanas, four E. costaricensis and four E. poeppigianas were selected in 
order to have a variety of clones from eacr. species. The thirteen clones selected were of 
priority interest to the Nitrogen Fixing Tree (NFT) Project at CATIE. They were 
growing under similar environmental and soil conditions in the Latin American Nitrogen 
Fixing Tree Orchard, San Juan Sur, CATIE, Turriabla, Costa Rica. Three of the E. 
costarricensis were reclassified as E. berteroana by the NFT project in June, 1991.
3.2.2 Sample Collection and Preparation
Twelve individual trees represented each Erythrina clone. The twelve trees were 
separated into three groups of four at random providing three replicates for each clone. 
Leaves where detached from the second or third branch of the tree, collected and 
weighed. Immediately upon arrival at the laboratory, the leaf blades were clipped from 
the petiole and weighed. Two 100 g samples from each replicate were immediately 
frozen; one fresh frozen sample was extracted as fresh material and the other was 
lyophilized (Eyela Tokyo Tatakikai Freeze Dryer LFD1) for two to three days until dry. 
The remaining leaf blades were placed in aerated paper bags and dried at 60°C for 72 
hours and then milled with a Thomas Wiley Model 4 Lab mill to a powder. All samples 
were collected in June or July of 1989 and transported to LSU after preparation.
3.2.3 Extraction of Fresh and Frozen Material
Typical alkaloid extraction procedures were used. One hundred grams of the fresh- 
frozen material was extracted with 400 mL 50% aqueous ethanol macerated in a Servall 
Omni Mixer (Sorvall Inc., Norwalk, Conn.). The macerate was filtered through cheese 
cloth and rinsed with 50% aqueous ethanol. The filtrate was left overnight with 100 mL 
of hexane to extract the lipids. The hexane was removed and the filtrate adjusted to pH 
10 with 25% NH4OH and extracted with 6 x 100 mL ethyl acetate. The ethyl acetate
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extract was extracted with 5 x 100 mL 2% aqueous H2SO4 which was cleaned up by a 
5 x 100 mL extraction with ethyl acetate. The aqueous mixture was adjusted to pH 10 
with NaHC03 and 25% NH4OH and reextracted with 5 x 100 mL ethyl acetate which 
was concentrated to a small volume and dissolved in dichloromethane (DCM) for TLC 
experiments.
The DCM solutions were extracted with 4 x 1  mL of 1 % HC1 for the HPLC 
experiments. The extraction was monitored using Mayer's reagent. Mayer’s reagent 
was made by dissolving 1.36 g HgCl2 in 60 mL of water and 5 g KI in 10 mL of water. 
The solutions were combined and diluted to 100 mL with water.
3.2.4 Total Nitrogen Determination
Total nitrogen was determined using a modified microKjedahl method (Association 
of Official Agricultural Chemists, 1960). A sample of dried leaves (0.10-0.12 g) was 
weighed using copying paper and placed in a kjeldahl flask. Two mL of H2SO4 was 
added with the catalytic mixture (a few drops of a solution of 25 g K2SO4, 25 mL 
CUSO4 saturated water mixed with 2.5 g sodium selenate in 1 liter of concentrated 
H2SO4). After 10 minutes the flask was placed in the support apparatus and digested 
for 1 hour or until clear. The flask was cooled and then rinsed down the sides with 
water until the kjeldahl tube was 1/2 full. Boric acid (25 mL) which contained an 
indicator was added. The boric acid solution consisted of 7 mL of a solution of 0.450 g 
methyl red and 0.250 g methyl blue in 250 mL ethanol which was added to 1 L of H2O 
that contained 20 g of boric acid. The flask was placed in the distillation aparatus and 4 
mL of 50% NaOH was added The solution was distilled until the distillate collected was 
30 mL and green in color. The distillate was titrated with H2SO4 (0.0863N) until a 
grey blue. The percent nitrogen and cru3>; protein was calculated as follows; % total
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nitrogen = [(mL H2S04-bIank)(0.0863 x 0.014 x 100)]/(weight of sample); % crude 
protein » [(mL H2SC>4-blank)(0.0863 x 0.014 x 6.25 x 100)]//(weight of sample).
3.2.5 Dry Weight Determinations
Dry weights were determined at 60° and 100°. After the leaf blades were dried in the 
oven, the milled material was weighed. This value was taken as the dry weight. Three 
gram samples were taken from the 60° dried samples and further dried in crucibles at 
100° for 24 hours and reweighed.
3.2.6 Blade to Leaf Ratios
The total leaf weight was measured in the field and the leaf blade weight was 
determined after separation from the petiole in the laboratory. This ratio was on a fresh 
weight basis.
3.2.7 Statistical Analysis
A NOVA and correlation statistical analysis was accomplished using STATVIEW 
512+ software (Abacus Concepts).
3.2.8 Thin Layer Chromatography
Aliquots of 10 to 25 ^L were spotted using a Hamilton syringe on Keisgelguhr 254 
TLC glass plates (Merck). These were developed in 95% chloroform/5% methanol and 
sprayed with Draggendorfs reagent or Ehrlich's reagent. Draggendorfs reagent was 
made by dissolving 8.0 g B i(N 03)3-5H 20 in 20 mL HNO3 (density 1.18 or 
concentration 30%) and dissolving 27.2 g KI in 50 mL of H2O. The two solutions 
were mixed and left for 24 hours. The solution was decanted and diluted to 100 mL 
with H2O. This reagent was used with acidic solutions.
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3.2.9 Reversed Phase HPLC
Two buffers were used in the reversed phase HPLC development: 33 mM phosphate 
buffer at pH 7.4 and 30 mM carbonate buffer at pH 10.4. The carbonate buffer was 
made by dissolving 1,045 g NaHC03 and 1.32 g Na2C0 3  in 450 mL of water, mixing 
and then diluting to 500 mL in a volumetric flask. No pH adjustment was attempted. 
All buffers as well as solvents were filtered and degassed before use.
Two different types of HPLC columns were evaluated: 1) a 15 cm Lichrospher C-18 
column (Merck, dp = 5 pm, Vm = 1.18 mL) and 2) a 15 cm polystyrene divinyl 
benzene column (Phenomenex PLRP-S, dp = 5 (im, Vm = 1.85 mL). The void 
volumes were measured using acetone in 100% acetonitrile. The instrument system 
consisted of three Rannin Rabbit HPLC pumps with mixer and a ISCO variable 
wavelength detector set at 254 nm. The flow rate was 1.0 mL/min. The system was 
controlled and the data acquired using a Dynamax software package.
3.2.10 HPLC/MS Studies
The HPLC/MS studies were performed at the Institute for Environmental Studies, 
LSU. The liquid chromatograph consisted of two Waters model 510 pumps, a Waters 
model U6K Universal Liquid Chromatograph Injector, a Waters Lambda-Max model 
481 LC spectrophometer and a Hewlett Packard 3390A integrator. Only filtered and 
degassed methanol and water were used ai solvents. The column was a 25 cm polymer 
coated polybutadiene column (Alcobond Unisphere, pore size = 60 A, dp = 10 pm, Vm 
= 3.16 mL), a 15 cm Lichrospher C-18 column (Merck, dp = 5 pm, Vm = 1.23 mL) or 
a 15 cm polystyrene divinyl benzene column (Phenomenex PLRP-S, dp = 5 pm, Vm = 
2.29 mL). The void volumes were measured using acetone in 100% methanol. An 
Extrel ThermaBcam interface was interfaced to an Extrel ELQ400 triple quadrupole mass 
spectrometer. Optimization was accomplished by spiking caffeine or B-erythroidine in a
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small amount of mobile phase to produce 100 ppm or 532 ppm solutions, respectively, 
and varying the liquid chromatographic and mass spectral parameters until a combination 
of adequate separation on the liquid chromatograph and maximum ion intensity on the 
mass spec was obtained. Optimum interface conditions were a flow rate of 0.8 mL/min 
with a capillary i.d. of 0.10 mm or a flow rate of 0.4 mlVmin with a 50 pm i.d. 
capillary. The vaporizer control temperature was 176° and the helium nebulization gas 
was set at 36 units. The stage one pressure of the interface was 6.8 torr and the second 
stage pressure was 0.3 tore. The mass spectrometer was tuned by Dr. Roberto Wong of 
the Institute of Environmental Studies. Electon impact at 70 eV was used as the 
ionization method. The methanol concentration in the mobile phase varied from 60% to 
100%.
3.3 Results
3.3.1 Statistical Analysis
Table 3.2 list the results of the statistical analysis of the Erythrina clones on a dry 
matter and total nitrogen basis. The blade to leaf ratio proved to be too variable to be 
useful in distinquishing clones, but there was significant differences between the species 
in relation to blade to leaf ratio. £. berteroana had a significantly higher proportion of its 
weight as leaf blade than did E. poeppigiana. There were statistically significant 
differences between clones of the same species and between species in dry matter and 
total nitrogen content. For example, E. berteroana clones 2652 and 2670 were 
statistically different from each other in both parameters with clone 2652 being lower in 
dry matter and nitrogen content than clone 2670. £. berteroana as a species was lower 
in nitrogen content than £. peoppigiana, but £. berteroana was generally higher in dry 
matter content. The reclassified clones 2668, 2691 and 2703 along with clone 2689
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were significantly higher in dry matter content than the remaining E. berteroana clones. 
They were also generally lower and very similar in total nitrogen content There was no 
correlation between dry matter content and nitrogen content
3.3.2 Reversed Phase HPLC
The major alkaloid in clone 2652 was B-erythroidinc (see Chapter 4). B-Erythroidine 
was isolated in 98% purity from the oven dried material of clone 2652 and this was used 
in the development of reversed phase HPLC. Boekclheide (1952) determined the pKa 
of B-erythroidine to be 6.8. Since it is generally desirable to separate compounds in 
reversed phase HPLC in their neutral form, the mobile phase must be buffered at a pH 
well above the pKa. Unfortunately, silica based reversed phase columns are limited to a 
pH range of 2 to 8, therefore a buffer of pH 7.4 was used when traditional silica based 
columns, such as the C-18 column, were used. At an optimized acetonitrile content of 
25%, B-erythroidine was satisfactorily separated from early eluting compounds (Figure 
3.1) with a k‘ of 1.54, however the asymmetry factor (a) of 3.7 and the resulting plate 
count (N) of 902 were unsatisfactory. The addition of 1.4 mM triethylamine changed 
the pH slightly to pH 7.6 and did improve the symmetry of the B-erythroidine peak (a « 
3.3) and the plate count (N=1127), but the asymmetry of the peak was still 
unsatisfactory (Figure 3.2).
Since it was desirable to run the HPLC separation well above the pKa of the B- 
erythroidine, a polymeric column which could be used up to a pH of 12 was 
investigated (Phenomenex PLRP-S). This column utilizing a carbonate buffer at pH 10 
was much more efficient than the Merck column at the same organic modifier 
concentration (25% acetonitrile) (Figure 3.3). The plate count increased to 1535 and the 
asymmetry factor decreased to 2.3. B-Erythroidine was also retained longer with a k' of
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1.98. However, even though the efficiency and asymmetry were better than on the 
silica based column, they were still poor.
Using the latter system, B-erythroidine could be analyzed in 5 minutes by HPLC. It 
may be possible to use a scale up of this method to collect and isolate Erythrina alkaloids 
by HPLC. The drawback to this method, however, it that standards are required to 
identify the alkaloids because UV absorption at one wavelength, although appropriate 
for quantification is insufficient for identification. At this point only B-erythroidine as 
isolated by the author from clone 2652 was available as a standard and an alternative 
technique that would be able to give more information about the compounds of interest 
for identification purposes was desired.
3.3.3 HPLC/MS
HPLC/MS studies were successful in separating and identifying two Erythrina 
alkaloids, but only at high concentrations. The best results were obtained using the 
polymeric column due to its high retentive ness. Ionization efficiency at the 
ThermaBeam interface dropped off precipitously when the methanol concentration 
dropped below 75%. At water concentrations above 25%, it was difficult to produce an 
adequate spray in the expansion chamber. Mobile phases with high water 
concentrations also tended to condense in the interface requiring a time consuming 
cleanup between runs. Using a high percentage of methanol in the mobile phase to 
avoid the condensation problem meant that the column had to retain the compounds 
adequately since the solvent strength was increased.
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Tabic 3.2 Percent Dry Matter and Total Nitrogen Content of Erythrina Clones
CLONE__________________DRY MATTER______________TOTAL NITROGEN
(%) (%)
E. berteroana
2652 14.1 al 4.3 a
2667 17.6 b 4.9 abdef
2670 17.8 bed 5.0 b
2674 16.9 d 4.8 d
2689 20.4 c 4.4 ac
2668* 20.7 c 4.4 ac
2691* 21.9 c 4,4 ac
2703* 17.9 b 4.5 c
X 18.4 4.6
E. costarricensis
2750 16.4 d 4.5 c
E. poeppigiana
2661 16.3 de 5.4 e
2608 14.4 a 5.9 g
2700 16.7 de 5.1 f
2708 15.3 e 4.7 d
X 15.7 5.3
l Differing letters between clones indicates significant difference between the average 
values at die 95% confidence level using Fisher ANOVA analysis.
Optimized HPLC conditions as descibed in the previous secdon were 75% (vol/vol) 
carbonate buffer at pH 10.4 and 25% acetonitrile. These conditions could not be used in 
the HPLC experiments because no ions were detected under these conditions. In 
addition, a slower flow rate was required in order to completely vaporize the mobile 
phase at the interface. Depending on the i.d. of the capillary in the interface, a flow rate 
of 0.4 mL/min to 0.8 mL/min could be used.
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Figure 3,1 HLPC Trace of B-Erythroidine on Merck Lichrospher Column, 
Conditions: 25% ACN/75% 33 mM phosphate buffer at pH 7.4. Vm=1.18, 
F=1.0 mL/min.
5 0
0
Figure 3.2 HLPC Trace of B-Erythroidine on Merck Lichrospher Column with 1.4 
mM trie thy lamine. Conditions: 25% ACN/75% 33 mM phosphate buffer at pH 
7.6. Vm= 1.18, F= 1.0 mL/min.
3
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Figure 3.3 HLPC Trace of B-Erythroidine on Polymeric Phenomenex PLRP-S 
Column. Conditions: 25% ACN/75% 50 mM carbonate buffer at pH 10.4. 
Vm=1.85, F=1.0 mL/min.
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Despite the aforementioned problems, mass spectra were obtained. The total ion 
chromatogram of one standard sample is presented in Figure 3.4. Ox o-B-crythroidinc 
was detected at 2.88 minutes and B-erythroidine was detected at 3.11 minutes. The run 
was 7 minutes and 631 scans were collected. The mass spectra obtained of B- 
erythroidine is presented in Figure 3.5. The total ion chromatogram of an extract of a 
clone (2674) is depicted in Figure 3.6. Only mass spectra of B-erythroidine and oxo-B- 
erythroidine were obtained from this run. The other peaks could not be identified from 
their mass spectra due to the large amount of noise.
3.4 Discussion and Conclusions
Statistical analysis of total nitrogen content and dry weight of the clones revealed that 
there are differences between clones of the same species with respect to these two 
parameters. As a species, E. poeppigiana in general was higher than either E. 
cosiarricensis and E. berteroana in nitrogen content, whereas E. berteroana was higher 
albeit more variable in dry matter content than E. poeppigiana. These differences 
suggest that Erythrina clones may vary in certain parameter due to genetic differences.
Several investigators have used normal phase chromatography for Erythrina alkaloids 
analysis usually on a semi-preparative scale. Chawla et al. (1982) used silica columns 
with a 96/4/0.1 chloroform/ethanol/concentrated ammonia solution as the eluant in the 
alkaloid analysis of E. berteroana seeds and leaves. Redha (1983) used silica as the 
stationary phase and chloroform as a me bile phase in his analysis. Although normal 
phase chromatography offers the advantage of easy sample isolation because the mobile 
phases are volatile, it is much more difficult to obtain reproducible separations. In 
normal phase LC, the water content of the mobile phases must be scrupulously 
controlled. In order to develop a useful analytical method, reversed phase 
chromatography was employed because of its good reproducibility.
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Figure 3.4 Total Ion Chromatogram from the HPLC/MS Analysis of a 500 PPM 
Solution of Oxo-B-erythroidine and B-Erythroidine. Conditions: Phenomenex 
column, 100% MeOH, F= 0.8 mL/min, inj. volume = 60 )iL, analysis time = 7 
minutes.
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Figure 3.5 Mass Spectra of B-Erythroidine by HPLC/MS Analysis. Conditions 
same as in Figure 3.4. Retention time at scan 280 is 3.11 minutes.
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Figure 3.6 Total Ion Chromatogram from the HPLC/MS Analysis of a 7000 PPM 
Solution of an Extract from Clone 2674. Conditions: Phenomenex column, 
100% MeOH, F= 0.8 mLVmin, inj. volume = 20 jiL, analysis time = 25 
minutes.
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Mantle et al. (1984) did use reversed phase HPLC as a means of purification of 
Erythrina alkaloids from the leaves of E. crista-galli. After extraction and preparative 
TLC, one fraction from the TLC plate was further resolved on a semipreparative 
octyldecylsilyl column with a methanol/water mobile phase (4/1). They were able to 
separate crystamidine and oxoerythraline. Cryst ami dine is similar to oxoerythaline 
except for an additional double bond at the 10-11 position.
Our studies have also shown that reversed phase HPLC can be useful in the analysis 
of Erythrina alkaloids. However, if trace amounts of alkaloids are present and need to 
be identified, there are other methods which are more sensitive (Chapter 4). 0- 
Erythroidine eluted within 5 minutes in our system; peak asymmetry was minimized by 
using a polymeric column and a mobile phase of relatively high pH. If the compounds 
of interest are known and standards are available, then reversed phase HPLC can be 
very useful. Unfortunately, this is frequently not the case.
In an effort to develop a technique in which the alkaloids could be identified without 
the use of standards, LC/MS was investigated. Mass spectra of oxo-B-erythroidine and 
3-erythroidine were obtained but only when large injection volumes and high 
concentrations of alkaloids were used. Optimal HPLC conditions could not be used 
because of the drop in efficiency at the ThermaBeam interface. Buffers could not be 
used in this system because of the high background which would have increased with 
the use of buffer Highly aqueous mobile phases developed during the optimization 
stage of this research could not be used because of condensation at the interface and the 
high pressures generated at relatively low flow rates (0.8 mL/min). Nevertheless, if 
samples are highly concentrated this method can be used to give preliminary 
identification via mass spectra of the compounds of interest. This is the first time 
LC/MS has been used to investigate Erythrina alkaloids.
CHAPTER FOUR:
CLONAL EVALUATION OF ERYTH RINA  ALKALOIDS BY 
GAS CHROMATOGRAPHY AND MASS SPECTROMETRY
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4.1 Introduction
Erythrina is an important tree species distributed worldwide at low to mid elevations. 
It is important in Latin America, Africa, Australia and Asia. Erythrina is one of many 
leguminous trees which are used in agroforestry systems, especially in Central and 
South America, as living fences, shade for cash crops such as coffee or cocoa, 
windbreaks, support for climbing crops, and more. The widely distributed Erythrina 
genus has been used in agricultural systems since first described by taxonomists in 
Central America. Its high nitrogen content is exploited by fanners in coffee and cocoa 
plantations where the shade species is pruned and the foliage left on the ground to 
provide nitrogen to the cash crop.
An additional use of the nitrogen fixing capabilities of Erythrina has been proposed 
by researchers. The proposed new use of Erythrina is as a diet supplement for 
ruminants just as legumes are used as supplements in the temperate zones (Benavides, 
1983). Through microbial fermentation, ruminants have the capability of utilizing 
various types of organic matter as food. Microorganisms in the rumen of bovines, for 
example, obtain energy and protein from forage unusable by non-ruminants. 
Microorganisms in turn produce microbial protein, B vitamins and other valuable 
nutrients that can be utilized by the bovine (Hungate, 1966). Frequently, the limitation 
in the growth and quality of the animals is the amount and the availability of digestible 
nitrogen present in the feed. Many farmers supplement the pasture diet of ruminants 
with a high energy/high protein concentrate. However, for the small subsistence 
farmer, the cost of purchasing concentrate is prohibitive. As an alternative for the small 
farmer, other materials high in nitrogen, such as Erythrina, are readily available and may 
serve just as well as a concentrate in supplying high quality protein to ruminant animals. 
Erythrina contains 24.0 to 38.4% crude protein in the dry leaves, 70% of which is 
digestible by ruminants (Espinoza, 1984). When present in a coffee agroforestry
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system the Erythrina tree may produce up to 90 kg of dry leguminous foliage per year 
per hectare (Russo, 1984).
Other crops now in use as feeds for animals, such as alfalfa and canary grass, also 
contain undesirable compounds (Marten, 1981). With time and careful breeding 
strategies, these compounds have been essentially eliminated from domestic species 
greatly improving the forage quality of these types of pastures species and forestalling 
the possibility of milk or meat contamination. At the Centro Agrondmico Tropical de 
Investigacidn y Ensefianza (CATIE), Turrialba, Costa Rica, an arboretum of nitrogen 
fixing trees has been established (Viqu6z, Payne and Sanchez, 1985). The Latin 
American Nitrogen Fixing Tree Arboretum contains plots of individual clones of 
Erythrina species collected throughout Central America. Thirteen of these clones were 
selected as described in Chapter 3 for this preliminary study of the content and 
composition of Erythrina alkaloids in the foliage of three different Erythrina species, E. 
berteroana, E. poeppigiana and E. costarricensis, to determine if the expression of these 
alkaloids varies between genetic clones and to identify low alkaloid content clones of 
Erythrina to be used in the development of feeding programs for small family fanners of 
Central America.
This investigation represents the first attempt ever to investigate Erythrina alkaloid 
content variation on a clonal basis. It may be the first study of clonal evaluation of any 
nitrogen fixing tree species and the first study to examine E, costarricensis leaves.
4.2 Experimental
4.2.1 Clonal Selection and Sample Preparation 
The process of clonal selection and sample preparation prior to extraction was 
described in Chapter 3.
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4.2.2 Extraction of Dry and Lyophilized Plant Material
The lyophilized and dried samples were extracted using 95% ethanol in a Soxhlet 
apparatus. Typical alkaloid extraction procedures were used. Figure 4.1 illustrates the 
flow chart of an extraction of a representative sample.
4.2.5 Statistical Analysis
ANOVA and correlation tadstical analyses were performed using Statview 512+ 
(Abacus Concepts) software.
4.2.4 GC/MS Analysis
One microliter of the extract dissolved in chloroform was injected into a Hewlett 
Packard 5890 gas chromatograph and analyzed with an Hewlett Packard 5971 
quadrupole mass spectrometer. Gas chromatographic conditions were as follows: 40°C 
for 3 min., ramp of 20°C/min. to 250°C and held at 250°C for 25 minutes. A DB-5 
(J&W Scientific) 30 m capillary column was used (0.25 mm i.d., 0.25 |im film 
thickness). The flow rate of helium was 30 cm/sec. The scan rate was 0.5 scans/sec 
and the mass range scanned was 15-550 mass units. Electron impact at 70 eV was 
used. The data was acquired and analyzed using DOS based ChemStation (Hewlett 
Packard) software.
Quantitative analysis of six of the Erythrina alkaloids was accomplished using single 
ion areas of duplicate samples and calibration curves of authentic standards under the 
GC conditions described above except that the scan range was narrowed to 50-450 amu.
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Lyophilized or Oven Dried Plant Material (20 g) 
Soxlet Extraction with Hexane (400 mL)
24 hours
Soxhlet Extraction with Ethanol (400 mL)
24 hours Discard Plant Material
Rotoevaporate Solvent, Dissolve in 2% H2S04 (100 mL) 
Extract with 6 x 50 mL Chloroform
Discard Chloroform
Adjust to pH 10 with NaHC03 and 25% NH4OH 
Extract with 5 x 50 mL Chloroform
aqueous organic
Acidify to < pH 2 with 25% HC1 
Heat to 60C for 1 hour 
Leave overnight
Dry over Na2S04, Filter 
Remove Solvent 
Dissolve in Chloroform to 0.2-5 mg/mL
GC/MS Analysis
Figure 4.1 Extraction Procedure for a Representative Plant Material Sample
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Ten data points were used for B-erythroidine calibration: 4.134, 20.69, 41.38, 
103.4, 206.9, 413.8, 827.5, 2069, 8300, and 16,600 ppm. The calibration curve was 
linear over this range with an R2 value of 0.982 (Figure 4.2). Five data points between 
40 and 850 ppm were used for oxo-B-erythroidine calibration with an R2 of 1.000. 
Three data points were used for erysodine, erysopine, erythratine and erythraline over 
the range of 0 to 1000 ppm resulting in a R2s of 0.996, 0.925, 0.978 and 0.949 
respectively.
The molecular ion (M+) was used as the quantification ion and the M+-15 and M+- 
31 ions were used as the qualifier ions for all samples with a plus or minus 20% 
intensity tolerance. The duplicate samples were run over a three day period along with 
the standards using the same mass spec tune. If the qualifiers were satisfied on at least 
one of the duplicates then the alkaloid concentration was determined, however, if the 
molecular ion was detected in one or both duplicates but the qualifiers were not met for 
both runs then the compound was considered not to be present.
4.2.5 Identification of Erythrina Alkaloids
Alkaloid identification was accomplished by mass spectral interpretation and 
comparison to authentic standards in the case of B-erythroidine, oxo-erythroidine, 
erysodine, erysovine, erysopine, erythraline and erythratine, by mass spectral 
interpretation, literature references and computer library searches in the case of 
erysotrine and mass spectral interpretation and comparison to literature values in the case 
of erybidine and a compound of m/z = 254. Spectral data of Erythrina alkaloids taken 
from the literature are listed in Appendix A. The mass spectra and tabulated spectra of 
selected alkaloids detected in this study are listed in Appendix B.
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Figure 4.2a GC/MS Calibration Curve for B-Erythroidine from 0 to 20,000 PPM.
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Figure 4.2b. GC/MS Calibration Curve for B-Erythroidine from 0 to 250 PPM.
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4.3 Results and Discussion
Other researchers who have used GC/MS to investigate Erythrina alkaloids have 
utilized the trimethylsilyl (TMS) derivatization technique with OV-17 packed columns 
(Hargreaves et al., 1974, Barakat et al., 1979, Redha, 1983). We found, at least for the 
alkaloids examined in this study, that TMS derivatization was unnecessary. Alkaloids 
with or without hydroxy groups were well resolved on a DB-5 column under the 
chromatographic conditions described in the experimental section. Figure 4.3 
demonstrates this point. Erysodine, erysovine and their TMS derivatives are present in 
the same total ion chromatogram (TIC). The underivatized as well as the TMS 
derivatized compounds are easily detected using this technique. Other Erythrina 
alkaloids with free hydroxyl groups such as erytratine were also detected with adequate 
sensitivity without TMS derivatization.
The DB-5 cappillary column was easily overloaded with B-erythroidine, however 
quantitation was linear to 16,000 ppm. The calibration curves showed good linear 
correlation both at the high and the low ends (Figures 4.2a and 4.2b). However, the 
overloading problem can be seen in Figure 4.4 which shows the total ion 
chromatograms of several calibration points up to 8300 ppm. At 2069 ppm the fronting 
of the peaks can be discerned, therefore all samples for quantitation were run at or below 
2069 ppm and a calibration curve of 0 to 2069 ppm was used for calibration.
Alkaloid artefacts that oven-drying the leaf samples might introduce were also of 
concern. Bhukani et al. (1976) reported that some of the oxo Erythrina alkaloids may 
have been produced in the drying process. For this reason, all the samples in our study 
were divided into two groups, one which was lyophilized and one which was oven 
dried. However, there was no qualitative difference in the alkaloid profile between the 
oven dried or lyophilized samples (Figure 4.5). 8-Oxo-erythroidine (retention time =■ 
29.8 minutes) was present in samples processed by both methods. There was a
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difference, however, in the extraction efficiency between the two methods of sample 
preparation. Extraction of the oven dried material yielded slightly more alkaloid extract 
by weight per gram sample than did the extraction of the lyophilized samples. This may 
have occurred because the oven dried samples were milled whereas the lyophilized 
samples were crushed resulting in finer particles in the oven dried case.
Recovery of the alkaloids from the lyophilized plant samples was estimated by 
performing a series calculation based on two subsequent extractions of the same sample 
for each sample of one replicate. The amount extracted in the second extraction was 
taken to be a constant percentage that remained and would remain if extractions were 
performed indefinitely. This method worked well as the majority of the alkaloids were 
extracted during the first 24 hour extraction period and recoveries varied between 80 and 
100%. Most of the sample recoveries were above 90%.
There has been some controversy as to whether the expression of secondary plant 
products such as alkaloids is under genetic or environmental control. It is commonly 
observed that the alkaloid composition of a plant may vary with environmental 
conditions such as soil nutrient level, soil type, soil pH, elevation, drainage, sunlight 
and stress, but no conclusions have been demonstrated using these parameters (Bick et 
al., 1953a and 1953b; Keeler, 1971; Blua and Hanscom, 1986). On the other hand a 
correlation has been found between alkaloid content and the developmental stage of the 
plant (Krukoff and Bameby, 1974).
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In an effort to eliminate environmental variation in alkaloid composition in the present 
study, the clones utilized were grown under the same environmental conditions in the 
Nitrogen Fixing Tree Arboretum of Latin American in San Juan Sur, CATIE, Turrialba, 
Costa Rica. They were originally obtained from diverse regions of Costa Rica and 
therefore are genetically distinct. Any difference between the alkaloid content of the 
clones in this study should be primarily attributable to genetic differences and not 
environmental differences.
Taking a larger genetic view, there have been attempts to use the presence of a 
particular alkaloid to taxonomically classify ambiguous plant specimens or species. In 
some genera, such as Nicotiana, the alkaloid composition was an unreliable parameter of 
phylogenetic position (Cramner and Turner, 1967). On the other hand, Hargreaves et 
al. (1974) were able to distinguish between old and new world Erythrina species by 
their alkaloid profiles. Our studies revealed that E. poeppigiana, E. berteroana and £. 
costarricensis, which are all members of the new world Erythrina group, are more 
similar than distinct with respect to the specific Erythrina alkaloids encountered and it 
may be difficult to classify these species by their alkaloid profiles.
All three of the above species tested in our laboratory belong to the American species 
of Erythrina. E. poeppigiana belongs to the most modem Erythrina taxonomic section, 
Micropteryx, while E. berteroana and E. costarricensis belong to the section Erythrina, 
which is still evolving (Krukoff and Bameby, 1974). As a matter of fact, it is difficult 
to distinguish between E. berteroana and E. costarricensis and it is believed that these 
two species may interbreed (Folkers et al., 1941). As a case in point, three clones 
originally classified as E. costarricensis (2668, 2691 and 2703) were reclassified as E. 
berteroana during the course of this study by the Nitrogen Fixing Tree Project at CATIE 
where the arboretum is located.
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The total ion chromatograms of a representative lypophilized sample of each clone are 
presented in Figures 4.6, 4.7 and 4,8. The Erythrina alkaloids eluted between 20 and 
33 minutes, the range included in the figures. Figure 4.6 shows the five original E. 
berteroana clones, Figure 4.7 shows the three reclassified E. berteroana clones and the 
one E. costaricensis clone and Figure 4.8 shows the TICs of the E. poeppigiana clones. 
The most obvious peak in all the chromatograms is B-erythroidine at 21.6 minutes. 
Erysodinc eluted first at 20.8 minutes, and then erythaline at 21.2 minutes close to the B- 
erythroidine peak. a-Erythroidine elutes after B-erythroidine at 22.3 minutes. 
Erythratine elutes at 24.8 minutes; erybidine at 26.8 minutes and 8-oxo-B-erythroidine at
29.5 minutes.
The predominant Erythrina alkaloids detected in the clones of Erythrina berteroana, 
£. costarricensis and E. poeppigiana are presented in Table 4.1. The variation in 
alklaloid content of the clones will be discussed later in the chapter. All the clones 
contained B-erythroidine (ERTH) as the major alklaloidal constituent. The alkaloid 8- 
oxo-erythroidine (OXOE) was found in all but four clones with representatives lacking 
this alkaloid from each species. In other words, oxoerythroidine was not species 
specific in this study. Erysodine (EYSD) was detected principally in the E. berteroana 
clones at low levels, while erythraline (ERTL) was detected in three E. berteroana clones 
in relatively high levels. Erythraline was detected in only one E. poeppigiana clone at 
about 1 ppm. The one E. costarricensis clone did not contain oxoerythroidine, 
erysodine or erythraline, Erybidine (ERBD) was almost ubiquitous in this study.
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Figure 4.8 Total Ion Chromatograms (TIC) of E. poeppigiana Clones.
Tabic 4.1 Alkaloid Profiles of Selected Erythrina Clones.
CLONE# ERTR OXOEEYSD ERTL ERBD 247A 247B 245
E. berteroana
2652 3548 172 * *
2667 1039 21 0.2 * * *
2670 804 * * *
2674 266 6 * * * *
2689 1456 2 303 * * • *
2668x1 166 2 * * • *
2691x 745 3 4 234 * * * *
2703x 657 1 192 * * * *
E. costarricensis
2750 8 * *
E. poeppigiana
2661 477 10 * *
2687 196 4 * *
2700 131 1 1 *
2708 836 8 1 * * *
ERTR=B-erythroidine, OXOE = 8-oxo-B-erythroidine, ERSD -  erysodine, ERTL = 
erythraline, ERBD = erybidine, 247A, 247B, 245B, and 254 are unidentified 
compounds. All values arc averages of duplicate samples in |ig/g dry weight. See 
Table 4.3. for more details on quantitation. * indicates presence only. A space 
indicates that the alkaloid was not detected in either replicate.
1 These are clones that were orginally classified as E. costarricensis, but are now 
classified as E. berteroana.
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Alkaloids not detected in these clones for which standards were available were 
erysovine, erysopine and erythrine. Erythratine and erythratidine may have been present 
in a few clones but in very small amounts. No standard was available for comparison 
purposes in the case of erythratidine and the qualifiers were not satisified in the case of 
erythratine. The mass spectra of these compounds are depicted graphically and in 
tabular form in Appendix B.
Five compounds were detected in the clones that could not be identified. Several 
lower molecular weight compounds, two isomers with a molecular weight (MW) of 247 
and one compound with a molecular weight of 245, eluted before the other Erythrina 
alkaloids with retention times between 15.5 and 16.5 minutes (Figure 4.9). The 
unknown of MW of 245 was almost ubiquitous in the samples analyzed. The 247 
isomers were concentrated in E. berteroana and primarily accompanied by the unknown 
245. The 247 isomers may be dihydroderivatives of the 245 compound. From their 
mass spectra it is apparent that they contain a methoxy group (M-15 and M-31). 
Trimethylsilation revealed one hydroxy group in each of the unknowns. The 
fragmentation pattern and the presence of a peak at m/z of 130 suggests that these 
unknowns may be dienoid type Erythrina alkaloids as yet undescribed. Additional work 
is required in order to further elucidate the structures of these unknowns.
A compound of molecular weight 254 matches the description of a new type of 
Erythrina alkaloid reported by Redha (1983) which contains two nitrogens. The mass 
spectra are identical within experimental error, but an authentic standard of the alkaloid 
was unavailable for retention time matching via standard addition. The unknown of 
molecular weight 289 may be a dihydroderivative of a known Erythrina alkaloid.
Examination of the alkaloid profile reveals that two of the reclassified clones (2691 
and 2703) along with E. berteroana clone 2689 have similar alkaloidal characteristics. 
Clones 2689 and 2703 lack 8-oxo-erythroidine as does the one remaining E.
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costarricensis clone. However, clones 2691, 2703 and 2689 also contain the unknowns 
247A and 247B which are not present in E. costarricensis but are common in E, 
berteroana. Alternatively, only E. berteroana clones 2689, 2691, and 2703 contain 
erythraline, a dioxymethylene Erythrina alkaloid. It is possible that one or more of these 
three clones represents a hybrid between E. berteroana and E. costarricensis. They were 
certainly the most interesting in terms of alkaloid composition of all the clones studied. 
To fully assess the utility of alkaloid profiles for taxonomic classification of Erythrina 
species, additional genetic clones have to be analyzed for alkaloid content, especially of 
clones E. costarricensis which is poorly represented in this study.
By far the alkaloid present in the greatest quantity in all three species was fi­
ery throidine. B-Erythroidine represented 75% or more by weight of the predominant 
alkaloids detected. B-Erythroidine had been detected in the seed of E. poeppigiana, E. 
berteroana and E. costarricensis, and had been reported as a major alkaloid in the leaves 
of E. berteroana and E. poeppigiana (Table 4.2; Romeo and Bell, 1974; Jackson et al., 
1982). Usually when B-erythroidine occurs it is frequently the major alkaloid. This 
may be explained because B-erythroidine is the final biosynthetic product in Erythrina 
alkaloid biosynthesis. This subject is addressed later in this chapter. The alkaloid 
content of the leaves of E. costarricensis may have never been studied before this 
present study (Table 4.2), although erythroidine was reported in the seeds by Folkers in 
1945.
Jackson et al. (1982) detected 8-oxo-erythroidine in their samples of E. berteroana, 
but not in E. poeppigiana. In our study, 8-oxo-erythroidine was present in all E. 
poeppigiana clones. Erysodine was present in five of the clones, four E. berteroanas 
and one E. peoppigiana, however it wasn't as prominent as in other studies (Table 4.2). 
Erysovine and erysopine were not detected. Erythraline was reported by Barton et al. 
(1974b) in whole E. berteroana plants, but not in E. berteroana by Jackson et al. (1982).
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Erythraline was reported by Ito et al. (1975) in the leaves of E. poeppigiana, but it was 
not detected in E. poeppigiana leaves by Jackson et al. (1982). In our studies, the larger 
quantities of erythraline were found in E . berteroana, however, the presence of 
erythraline was highly variable between clones and this may explain the varied results 
among research labs concerning the presence of erythraline in these two species. 
Erybidine had been reported in E. poeppigiana by Ito and Jackson (Table 4.2), but has 
never been reported before in E. berteroana.
Of the unknowns, only MW 254 matches the description of an unknown compound 
in another work (Redha, 1983). This is the First time that a dinitrogen compound has 
been reported in any of these three species. The compounds with molecular weights of 
245 and 247 have not been mentioned by other groups. It seems that the MW 247 
compounds may be more species specific than the other Erythrina alkaloids detected. It 
would be interesting to pursue the presence of these compounds in other clones and 
other species of Erythrina to verify this theory.
Romeo et al. (1974) reported that there was no correlation between amino acid 
content and alkaloid content in the species he tested. This was corroborated in our 
studies where there was no correlation (r2»-0.014) between total nitrogen content and fl- 
ery throidine content (Table 4.3). The non-correlation of alkaloid content with nitrogen 
or protein content has been observed in other nitrogen fixing tree species such as 
Leucaena (Gonzales, 1967). This is fortunate from a genetic engineering standpoint 
because it suggests that alkaloid content end nitrogen content are not genetically linked. 
Moreover, there is great variability between clones of the same species in fi-erythroidine 
content (Table 4.3). There are low alkaloid content clones of each species which might 
be preferred for use in the development of alternative animal feeds. This variability also 
suggests a means of breeding low alkaloid, high protein Erythrina varieties for animal 
feed. Importantly, variation between individuals of the same genetic clone was very
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small both in total nitrogen (analyzed in triplicate) and B-erythroidine content (analyzed 
in duplicate).
Once it was determined that B-erythroidine was the major alkaloid in these three 
Erythrina species, it was not surprising to find very little variation in alkaloid 
composition between the species. B-Erythroidine is formed biosynthetically by diol type 
cleavage of the aromatic Erythrina alkaloids (Chapter 2). The cleavage is probably 
ex era-diol because of the occurrence of Erythrina alkaloids with a nitrogen at the C-16 
position. An example of a dinitrogen Erythrina alkaloid is melanacanthine reported by 
Redha (1983). Therefore, if B-erythroidine is the final product of the Erythrina alkaloid 
biosynthetic pathway in the Erythrina species examined, then it follows that all possible 
biosynthetic precursors, namely the aromatic types of Erythrina alkaloids, are shunted 
into this pathway and are convened principally to B-erythroidine, which is the major 
alkaloid detected. The aromatic Erythrina alkaloid precursors may not be present or 
detected in significant amounts because they may be rapidly converted to B-erythroidine.
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Tabic 4.2 Reports of Erythrina Alkaloids in the Species Studied by Other Investigators
Reference Plant Pan A lkaloids Identified
Erythrina berteroana
Folkers, 1940c seeds erysopine
erysovine
Folkers, 1942a seeds erysodine 
cry so nine
Folkers, 1945 seeds erythroidine
Barton, 1974b whole plants a, B-erythroidine 
erythraline
Hargreaves, 1974 seeds erysovine
erysodine
erysopine
erysonine
erysoline
a, B-erythroidine
Romeo, 1974 seeds a, B-erythroidine
Jackson, 1982 leaves a, B-erythroidine (major) 
8 -oxo-ery throidine 
(1 unknown)
Jackson, 1982 leaves/seeds erysodine
erysovine
erysopine
erysoline
erysonine
a, B-eiythroidine (major) 
8-oxo-ery throidine
Erythrina costarricensis
Folkers, 1941 seeds erysodine
erysovine
erysonine
etysopine
Folkers, 1945 seeds erythroidine
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Table 4.2 Reports of Erythrina Alkaloids in the Species Studied by Other Investigators
(continued)
Reference Plant Part Alkaloids Identified
Erythrina poeppigiana
Folkers, 1940c seed erysodine
erysovine
Folkers, 1944 seed erysothiovine
Folkers, 1945 seed erythroidine
Barton, 1973 leaves a, B-erythroidine
Romeo, 1974 seed a, B-erythroidine
Hargreaves, 1974 seed erysotrine
erysodine
erysovine
erysopine
erythratidine
a, B-erythroidine
Ito, 1975 leaves erysotrine
erysodine
1 l-hydroxyerysotrine 
erythraline 
erythrinine 
erybidine
Jackson, 1982 leaves erysodine
erysopine
erysotrine
erythratidine (major) 
erythratidinone 
11-hydroxyerythratidine 
11-hydroxyepierythratidine 
erybidine (major) 
a, B-erythroidine (major)
(3 unknowns)
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Table 4.3 B-Erythroidine and Nitrogen Content of Thirteen Erythrina Clones
mg/lOOg fresh wt. M-g/g dry wt. % dry w
Very High
2652 berteroana 61.58 al 3548 a 4.28
High
2689 berteroana 35.26 b 1456 b
Mid Range 
2667 berteroana 22.48 c 1039 be 4.92
2708 poeppigiana 18.92 cd 969 c 4.68
2691 berteroana 18.01 cd 745 cd 4.39
2670 berteroana 16.52 cde 804 cd 5.05
2703 berteroana 14.92 cde 657 cde 4.50
Moderately Low
2661 poeppigiana 8.44 def 477 df 5.43
2674 berteroana 6.33 ef 266 df 4.81
Lower
2668 berteroana 3.71 f 196 f 4.39
2687 poeppigiana 3.39 f 168 ef 5.86
2700 poeppigiana 2.77 f 131 f 5.08
Very Low
2750 costarricensis 0.17 f 8 f 4.48
1 Differing letters between clones indicates significant difference between the average 
values at the 90% confidence level using Fisher ANOVA analysis. For statistical 
analysis of total nitrogen content please see Chapter 3.
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4.4 Conclusions
GC/MS using a 5% phenyl/95% methyl column is a valuable technique for the 
analysis of Erythrina alkaloids. Clonal evaluation of E. poeppigiana, E. berteroana and 
E. costarricensis revealed that B-erythroidine, a drug previously used in surgery and 
electroshock treatments, was the major alkaloid in the leaves of these species. There 
was little statistical variation in the parameters measured between individual trees of the 
same genetic clone. There was wide variation in the concentration of B-erythroidine 
between Erythrina clones of the same species and between different Erythrina species, 
however there was little difference in the types of Erythrina alkaloids detected between 
clones or between species. Low alkaloid content clones of all three species were 
identified. Alkaloid content and nitrogen content were not correlated, which suggests 
that these important parameters are not genetically linked. Low alkaloid containing 
clones may be genetically engineered or bred to contain even lower amounts of alkaloids 
without affecting or even improving the total protein content. For the present, low 
alkaloids clones should be developed over high alkaloid content clones for alternative 
feeds.
CHAPTER FIVE:
POSSIBLE METABOLIC FATE OF ERYTH RINA  ALKALOIDS
80
81
5.1 Introduction
The use of nitrogen fixing crop species, such as alfalfa and clover, as a high protein 
animal feed is an established practice in U.S. agriculture. However, in many tropical 
countries nitrogen fixing pasture species are not commonly used. Temperate legumes 
do not grow well due to a combination of climate, competition and lack of traditional 
commercial inputs. On the other hand, nitrogen fixing tree species are abundant in the 
tropics. Many have been introduced or naturalized as a result of the coffee and cocoa 
industry where crops are managed below a prunable canopy of trees. Innovative uses of 
these trees have been developed by several international development organizations such 
as the Centro Agrondmico Tropical de Investigacidn y Ensefianza (CATIE) in Costa 
Rica.
Initial studies have demonstrated that Erythrina is a very versatile and easy to use 
nitrogen fixing tree (Russo, 1984). Erythrina has been used successfully in several 
agroforestry systems, for example as live fences, as shade for coffee plantations, as 
guides for climbing crops and more recently as a feed supplement for animals. Several 
studies by the Nitrogen Fixing Tree Projoect at CATIE have indicated that the foliage 
Erythrina poeppigiana and E. berteroana can substitute for all or a portion of the protein 
required by a ruminant with no detectable adverse effects (Samur Rivero, 1984; Vargas 
Fournier, 1983; Benavides, 1986). On the other hand, Erythrina is not a suitable feed 
for monogastric animals. Toxic symptoms developed during feeding studies with 
Erythrina in several non-ruminant species. Rats fed a diet consisting of 51% (w/w) E. 
berteroana lost weight over a 28 day experiment while the controls more than tripled 
their weight (De Leon, 1984) and pigs fed a diet containing less than 3% E. poeppigiana 
failed to gain weight and were removed from a study due to their poor physical 
condition (Vargas Fournier, 1983). Sterility and death resulted in a study involving 
rabbits fed Erythrina (Martin, 1984). Additional evidence that Erythrina may be toxic to
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non-ruminants animals lies in its use as a medicinal herb to combat insomnia in humans 
and its use by South American Indians as a fish poison (Dyke and Quessy, 1981).
One explanation of the toxicity differences between ruminant and monogastric 
animals with respect to Erythrina species is that some toxic compound(s) in the foliage 
of the Erythrina species may be detoxified by the microorganisms in the rumen and may 
not be detoxified by the gastrointestinal tract of the monogastric animals. Alternatively, 
some compound(s) may be metabolically activated in the monogastric animals and not in 
the rumen of the ruminants. The reductive neutral atmosphere of the rumen may 
generate very different metabolites than the acidic stomach of the monogastric animal.
As reviewed in Chapter 2, the genus Erythrina is known to contain curare like 
alkaloids (Dyke and Quessy, 1981). Clinically active alkaloids were isolated from the 
seeds of various Erythrina species in the 1930s and 1940s by Folkers and coworkers at 
Merck Pharmaceutical Company (Folkers and Major, 1937; Unna et al. 1944). These 
alkaloids were of interest because they retained neuromuscular transmission blocking 
activity even when administered orally. Further studies resulted in the isolation of 
several other "Erythrina-\ike" alkaloids from the seeds of various Erythrina species. 
The majority of new Erythrina alkaloids were less or as potent as the original drug, B- 
erythroidine (Figure 5.1). In the 1980s, B-erythroidine was isolated from the leaves of 
E. poeppigiana and E. berteroana (Jackson and Chawla, 1982). Work described in 
Chapter 4 confirmed that B-erythroidine was not only present in E. berteroana and E. 
poeppigiana, but was the major alkaloid present in these species (Payne and Foley, 
1992).
There is some circumstantial evidence that alkaloids of alkaloid containing plants may 
be transported to the milk of animals fed these plants. In the pioneering days of the 
United States, a disease known as milk sickness caused many fatalities. The disease 
was traced to the consumption of milk from cows that had eaten white snakeroot
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(Eupatorium rugasum) (Chccke and Shull, 1985), In a more recent case, anagyrine 
present in the milk of diary animals which consumed Lupinus latifolius, may have 
caused birth defects in California (Kilgore et al. 1981). There is additional evidence 
that other types of alkaloids, namely ergot, indolizidine and quinolizidine alkaloids also 
may contaminate the milk of dairy animals (Cheeke and Shull, 1985). Milk transfer of 
toxins can occur with mycotoxins and ketones as well as the alkaloids mentioned 
(Cheeke and Shull, 1985).
Much of the recent work demonstrating the milk transfer of naturally occurring toxins 
has centered on the species tanzy ragwort (Senecio jacobaea), a poisonous plant found 
in the Pacific Northwest known to contain hepatoxic pyirolizidine alkaloids. In one 
study (Johnson, 1976), histopathologic changes were not detected in the calves 
consuming milk of the cows eating 5. jacobaea, but clinical chemical tests showed 
hepatic biochemical lesions in calves. Rats fed goat's milk which contained 7.5 ng of 
pyrrolizidine alkaloids developed swollen hepatocytes of centrilobular distribution and 
biliary hyperplasia (Goeger et al. 1982). In another study in rats there was a high rate 
of transfer of the toxic substances through the milk as measured by lesions in the young. 
The dose given to the mother was not lethal but was lethal to the suckling young 
(Goeger et al., 1982). Additional studies by other investigators also indicate that 
Senecio alkaloids can be secreted into the milk of animals that consume Senecio spp. 
(Dickinson et al. 1976).
In many instances, these naturally occurring toxins in the milk of dairy animals pose 
no threat to the general public in countries with a developed dairy industry because the 
toxins are highly diluted with uncontaminated milk at processing centers before 
distribution. However, naturally occurring toxins are of concern to the small family 
farmer in developing countries who may use only one or two animals to provide milk 
for the entire family over a long period of time. In this case, any toxins consumed by
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the dairy animals may concentrate in the milk and pose a health threat to the family. 
Since Erythrina foliage is known to contain toxic alkaloids which cause muscle 
paralysis, it is imperative that the milk of the animals consuming Erythrina foliage be 
examined for alkaloid content and for the presence of toxic metabolites (Figure 5.2).
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Figure 5.1 8-Erythroidine
Figure 5.2 Schematic of the Milk Transfer of Toxins in Goats.
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5.2 Experimental
5.2.1 Feeding Study
Twenty dairy goats were preselected from the herd at the Animal Production 
Department, Centro Agrondmico Tropical de Investigacidn y Ensefianza (CATIE) in 
Costa Rica according to due date. The goats were crosses of Nubian, Totten berg, 
Saanen and Alpine and ranged in age from two to eight years. One month before 
expected parturition, the selected animals were fed a diet of 1 kg concentrate with grass 
and banana ad lib. This diet served as the control diet during the study. After 
parturition, the animals were separated into treatment groups. Treatment I was the 
control diet which was the same as the pre-experimental diet Treatment II consisted of 
a diet of 40% by weight E. poeppigiana foliage and 60% grass ad lib. with no 
concentrate. Treatment III consisted of a diet of 40% by weight E. berteroana foliage 
and 60% grass ad lib. The animals were conditioned on these diets for one month 
before milk samples were taken.
Data collection related to the feeding experiment occurred between October, 1989 and 
January 1990; feed consumption was recorded daily, body weights were recorded 
monthly, milk production was recorded weekly and milk samples were taken weekly for 
four weeks and then monthly for two months. For the milk analysis, a representative 
sample of 100 mL of milk was taken from the total daily milk production of each goat, 
immediately frozen and then lyophilized for storage until analyzed.
5.2.2 Milk Analysis
The lyophilized sample representing 100 mL of milk was placed in a Soxhlet 
apparatus and extracted with 400 mL of hexane for 24 hours. The solvent was 
evaporated and the residue dissolved in 20 mL of 2% H2SO4. The acid solution was
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adjusted to pH 10 with NaHCC>3 and 25% NH4OH and extracted with 3x10 mL 
chloroform and dried over Na2S0 4 . After solvent evaporation, the residue was 
dissolved in enough chloroform to provide a 1-5 mg/mL solution for GC/MS analysis.
The material remaining in the Soxhlet device after the hexane extraction was extracted 
with 400 mL ethanol. After rotoevaporation, the residue was dissolved in 50 mL 
H2SO4 and extracted with 4x10 mL chloroform which was discarded. The acidic 
solution was adjusted to pH 10 with NaHCC>3 and 25% NH4OH and extracted with 
3x10 mL chloroform and dried over Na2SC>4. After solvent evaporation, the residue 
was dissolved in enough chloroform to provide a 1-5 mg/mL solution for GC/MS 
analysis.
The basic solution remaining after chloroform extraction was readjusted to pH<2 
with 25% HC1, heated to 60°C over a water bath for 1 hour and left overnight to 
encourage hydrolysis. This fraction was worked up for GC/MS analysis as described in 
the preceding paragraph.
5.2.3 Rumen Incubations
Dried plant material (0.5 g) was incubated with 50 mL of a 20% rumen liquor/80% 
artificial saliva solution in sealed tubes flushed with CC>2 in an incubator at 40°C and 
under an atmosphere of CO2 for 48 hours. The rumen liquor was obtained by 
squeezing the rumen contents of a fistulated goat though cheese cloth. The artificial 
saliva was made from 9.8 g NaHC03, 7.0 g Na3P04, 5.7 g KC1,4.7 g NaCl and 1.2 g 
MgSC>4 in 10 L of distilled water. 1 mL of 5 3 g CaCl2 in 100 mL of water was added 
for each liter of mixed rumen liquor solution. The incubations were terminated by the 
addition of 5 drops of 25% HCI. The contents of the tubes were rinsed into 
lyophilization flasks, immediately frozen and then lyophilized for further analysis. The
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lyophilized rumen samples were extracted and analyzed according to the procedure 
described in the milk analysis section.
5.2.4 GC/MS Analysis
One microliter of the extract dissolved in chloroform was run on a Hewlett Packard 
5890 gas chromatograph and analyzed with an Hewlett Packard 5971 quadrupole mass 
spectrometer. Gas chromatographic conditions were as follows: 40°C for 3 min., ramp 
of 20°C/min. to 250°C and held at 250°C for 25 minutes. The column was a DB-5 
(J&W Scientific) 30 m capillary column with a film thickness of 0.25 pm and an i.d. of 
0.25 mm. The flow rate was 30 cm/sec of helium. The data was acquired and analyzed 
using DOS based ChemStation (Hewlett Packard) software at a scan rate of 0.5 
scans/sec from 15-550 amu. Ionization was electron impact at 70 eV. The mass spec 
was tuned according to the EPA semi-volatile method. The threshold was set at 1500.
5.2.5 Synthetic Hydrogenation
B-Erythroidine (15 to 30 mg) was dissolved in 1 mL of water to which 62 mg of 
solid NaOH and 1 g of raney nickel (Aldrich) was added. The solutions were either left 
stirring overnight or placed under 3 atm. of H2 for 90 min. The mixture was filtered 
through 0.45 pm nylon filter, rinsed, acidified and left overnight. The acidic solution 
was adjusted to pH 10 with 25% NH4OH and extracted with 5x5 mL chloroform, 
which was then evaporated and the resulting residue dissolved in enough chloroform to 
make a solution of 1-5 mg/mL for GC/MS analysis.
5.2.6 Statistical Analysis
Statistical analysis was performed using Statview 512+ (Abacus Concepts).
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5.3 Results
Through the use of mass spectral interpretation and comparison to the standard fi­
ery throidine, dihydroerythroidine isomers and tetrahydroerythroidine were identified. 
The dihydro- and tetrahydroerythroidines were detected in the milk of the experimental 
animals in the two treatment groups consuming E. poeppigiana and E. berteroana foliage 
and in the rumen incubation solutions. The tabulated mass spectra of these compounds 
and that of B-erythroidine are presented in Table 5.1. The various reduced compounds 
were well resolved on the DB-5 column and represented a very small portion of the total 
residue from the milk samples. The majority of the compounds in this fraction were 
long chain aliphatic compounds which were also well resolved. Three 
dihydroerythroidines (DHEI, DHEII and DHEIII) and one tetrahydroerythroidine (THE) 
were detected in the milk and rumen samples. The mass spectra of DHEI, DHEII and 
THE are depicted graphically in Figures 5.3, 5.4 and 5.5 respectively. DHEI 
constituted the major portion of the DHEs in the milk and rumen samples, DHE II was 
present in smaller amounts and DHEIII was present in trace quantities, if at all. Some 
unreduced fi-erythroidine was detected in two of the milk samples and in two of the 
rumen samples. No erythroidine, dihydroerythroidine or tetrahydroerythroidine 
compounds were detected in the milk collected from the goats in the control group 
consuming a diet free of Erythrina foliage.
Two dihydroerythroidine (DHEIV and DHEV) isomers were the only products of the 
synthetic hydrogenations over rancy nickel. DHEIV was the major isomer. No parent 
B-erythroidine or tetrahydro- compounds were detected. The mass spectra of major 
DHE isomer from the biological hydrogenation (DHEI) and the major isomer from the 
synthetic hydrogenation (DHEIV) are presented in Figure 5.6. The synthetic 
dihydroerythroidines were used to estimate the amount of dihydroerythroidines in the 
milk samples using the areas in the total ion chromatogram and background subtraction.
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Figure 5.7 and 5.8 display the results of the milk analysis over time on a per goat 
(Figure 5.7) basis and on a treatment averaged basis (Figure 5.8).
Statistical analysis (t-tests) revealed no difference between the two Erythrina 
treatment groups with respect to the concentration of DHEs even though the 
concentration of DHEs in the E. poeppigiana treatment group was approximately twice 
that of the E. berteroana group. The Erythrina treatment groups were significantly 
different from the control groups in the concentration of DHE in most instances, but not 
in all due to variation in the data. There was no correlation between DHE concentration 
in the milk and fat content of the milk (correlation coefficient = -0.192) or the amount of 
milk produced (correlation coefficient = -0.186). There was no significant difference at 
the 95% confidence level (c.l.) with respect to milk production between the treatment 
groups and the control group until the later part of the study (Figure 5.9).
There was a significant difference (95% c.l.) between all groups with respect to the 
amount of feed consumed (Figure 5.10). The diet containing £. poeppigiana was 
consumed n the greatest quantity, followed closely by the E. berteroana group. The 
control group ate significantly less foliage than either treatment group. The contribution 
of the concentrate was not included in the calculations of the total amount of foliage 
consumed for the control group.
Figure 5.11 presents the data on the body weights of the goats throughout the 
feeding experiment. Although the goats in the Erythrina treatment groups began to lose 
weight when compared to the control after three months on the treatment diets, the 
weight difference was not statistically significant.
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Table 5.1. Tabulated Mass Spectral Data as Percent of Base Peak of Biologically 
Hydrogenated Dihydroerythroidines (DHEI, DHEII and DHEIII), Catalytically 
Hydrogenated Dihdyroerythroidincs (DHEIV and DHEV), 
Tetrahydroerythroidine (THE) and B-Erythroidine (E).
 Percent of Base Peak
m/z DHEI DHEII DHEIII DHEIY DHEV
275 20 42 46 16 37
260 58 91 94 1 10
245 38 31 20 7 16
244 44 76 66 23 81
230 100 93 95 3 2
217 5 49 59 100 49
216 19 74 74 8 21
204 17 20 6 2 2
200 15 20 24 7 4
191 6 62 31 <1 1
186 21 38 25 2 4
178 13 24 50 <1 2
172 19 100 100 24 100
158 16 56 50 5 34
146 15 20 17 2 7
132 15 54 39 9 40
130 14 33 20 9 9
77 28 45 50 4 6
THE m/z 2 l E m/z 2t
277 9 273 55
262 18 258 26
247 14 242 100
232 17 240 27
218 6 214 14
206 8 198 17
178 29 184 14
164 10 182 21
148 100 170 21
146 16 156 15
132 18 130 34
130 5 91 20
77 14 77 25
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Figure 5.3 Mass Spectra of Dihydroerythroidine I (DHEI) from the Milk and
Rumen Samples
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Figure 5.6 Mass Spectra of the Principal Biological Dihydroerythroidine Isomer, 
DHEI, and the Prinicpal Synthetic Dihydroerythroidine Isomer, DHEIV.
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Figure 5.7 Amount of Dihydroerythroidines (DHEs) Present in the Milk of Goats 
which Consumed E. poeppigiana and E. berteroana Foliage per Goat.
Treatment goats only. Goat identification numbers shown in legend. All control 
goats where devoid of dihydroerythroidines.
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Figure 5.8 Average Amount of Dihydroerythroidines (DHEs) Present in the Milk of 
Goats which Consumed E. poeppigiana (•) and E. berteroana (A) and Foliage by 
Species.
Key: (a) pg per 100 mL of milk; (b) total pg DHE produced per goat per day. 
Vertical bars indicate plus or minus one standard deviation.
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Figure 5.9 The Amount of Milk Produced (kg) by Each Treatment Group, (x )
Control; (*) E. poeppigiana; (A) E. berteroana..
Vertical ban indicate plus or minus one standard deviation.
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Figure 5.10 The Amount of Feed Consumed (kg) by Each Treatment Group. (— )
Control. (------ ) E. poeppigiana; (....... ) E. berteroana..
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Figure 5.11 Body Weight of Goats (kg) by Each Treatment Group.
(x ) Control; (•) E. poeppigiana; (A) E. berteroana. Vertical bars indicate plus or 
minus one standard deviation.
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5.4 Discussion
The mass spectra of the dihydroerythroidines and tetrahydroerythroidine detected in 
the rumen samples exactly match the dihydro- and tetrahydroerythroidines detected in 
the milk samples of the treatment groups of each species. These compounds were not 
detected in the milk of the control group. The B-erythroidine present in the foliage of the 
E. poeppigiana and E. berteroana fed animals is evidently hydrogenated in the rumen of 
the dairy goats and transported to the milk of these animals.
In the rumen environment at a pH of 5.5 to 7.0, the absence of oxygen and the 
presence of microorganisms promotes reductive reactions (Dickinson et al. 1976). 
Hydrogenation is one of many reductive chemical reactions that takes place in the 
rumen. Most reports of hydrogenation focus on the rapid hydrogenation of unsaturated 
fatty acids by rumen bacteria for the construction of bacterial cells (Ward, 1964). 
During this type of hydrogenation, double bond migrations are known to occur (Wilde 
and Dawson, 1966).
The mass spectral data of the biologically formed DHEs and the synthetic DHEs 
indicate that the two hydrogenation processes produce different DHE isomers. The 
biologically hydrogenated DHEs have major molecular ion peaks as well as major peaks 
corresponding to (M-CH3)+, and (M-OCH3)+. The base peak of DHEI (m/z -  230) 
corresponds to a loss of an additional loss of CH2 as well as a loss of OCH3. These 
results are consistent with the fragmentation pattern of dienoid type of Erythrina 
alkaloids proposed by Boar and Widdowson (1970). If the conjugated diene is intact 
after hydrogenation, then the double bond present in the lactone ring of B-erythroidine 
(Figure 1) is hydrogenated in the rumen which may result in the formation of two 
diastereomers.
Inspection of the mass spectra of the major synthetic isomer, DHEIV, reveals that the 
molecular ion and (M-CH3)+ peaks are weak when compared to the mass spectra of the
101
biological DHEs and that the base peak of m/z =217 represents a loss of 58 mass units. 
This loss is typical of a alkenoid type Erythrina alkaloids (Boar and Widdowson, 1970). 
Hydrogenation of the double bond at the 2-3 position, probably the most facile position 
to synthetically hydrogenate, and subsequent double bond migration would result in a 
double bond at the 1-6 position. A retro-Diels Alder reaction would result in a loss of 
58 amu and the second mechanism of fragmentation proposed by Boar and Widdowson 
would also result in a loss of 58 units. These results support the hypothesis that 
although catalytic and bacterial hydrogenations are similar in many instances, conjugated 
double bonds are resistant to microbial hydrogenation (Garton, 1964). It should be 
noted that the pharmacological studies done by Unna (Unna et al. 1944) and others 
utilized DHE formed upon catalytic hydrogenation of 0-crythroidine. Therefore it is 
likely that the synthetic dihydroerythroidine investigated in the pharmacological and 
toxicological drug studies of the 1940s also contained a double bond at the 1-6 position 
and the 12-13 position.
The wide variability in the concentration of dihydroerythroidines in the milk of the 
treated animals was expected. Neither the experimental animals nor the foliage used as 
feed in the feeding study was genetically homogeneous. This variability may be 
environmental, genetic or biochemical in nature. The alkaloid content of the leaves may 
vary with environmental conditions thus causing variability in the amount of 0- 
erythroidine the animals were consuming. It is interesting that both Erythrina species 
varied similarly. The in concert variation of the DHE content of the milk in both 
treatment groups may be indicative of an environmental influence on the goats or on the 
trees which is superimposed on the other variables. The bacteria in the rumen of each 
animal may be slightly different resulting in different rates of hydrogenation of the 0- 
erythroidine and/or competing biochemical reactions in the rumen. Alternatively, each 
animal may metabolize the dihydroerythroidine produced differently or excrete them at
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different rates. Other contributions to the variability can be hypothesized. These results 
emphasize the importance of utilizing genetically homogeneous material in scientific 
investigations, particularly in feeding studies where biological variation may be great.
Only a small fraction of the B-erythroidine consumed may reach the milk in an 
unaltered or hydrogenated form. Studies described in Chapter 4 with Erythrina clones 
have shown that Erythrina foliage is approximately 0.1% by weight of B-erythroidine 
(Payne and Foley, 1992). If the goats eat on the average 2.2 kg of Erythrina foliage per 
day, then approximately 440 mg of B-erythroidine are consumed per day per goat 
assuming a dry weight of 20%. Estimates of the total amount of dihydroerythroidines in 
the milk are between 1 fj.g and 1 mg per day per goat. So the DHE found in the milk 
represents less than 0.2% of the total amount consumed if the above assumptions are 
used. It is possible that the foliage used in the feeding study was exceptionally low in 
alkaloid content, however there may be other explanations for the possibly low amount 
of DHEs detected in the milk of the experimental animals, such as environmental 
variation and differences in bacterial composition in the rumen of the experimental 
animals as previously discussed.
The results of the rumen incubations suggest that almost all the B-erythroidine found 
in the foliage is metabolized. Very little parent compound is detected in the rumen 
solutions after 48 hours, so it is unlikel) hat the pareant compound B-erythroidine is 
eliminated intact through the feces. Since the dihydro- compounds are probably 
transported via the circulatory system at a pH at which they are soluble and because they 
have no particular affinity for lipids, it is possible that DHE are eliminated through the 
urine as well as the milk. However, experiments with frog urine indicated that no 
pharmacologically active compounds were eliminated via the urine in frogs (Unna et al., 
1944). The parent compound, B-erythroidine, is known to be soluble in blood serum 
since intravenous injection was used in clinical administration of the drug. There have
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been no studies done on the degradative metabolism of B-erythroidine in humans or 
animals, however clinical use of the drug suggests that B-erythroidine is rapidly 
degraded or eliminated in human subjects (Unna, 1939). There was no correlation 
between the milk fat content and the amount of DUE detected suggesting that the DHEs 
are not preferentially sequestered in the fat of the animal. No Erythrina alkaloids were 
detected in the hexane fraction during extraction. In addition, most of the treatment 
animals maintained or lost weight, so fat deposition is an unlikely method of 
elimination.
The B-erythroidine may be degraded by rumen bacteria into compounds not present in 
the alkaloid fraction analyzed by GC/MS. Although several types of heterocyclic 
alkaloids, for example pyrrolizidine and indole alkaloids (Carlson and Breeze, 1984), 
are not substantially degraded by ring fission in the rumen, there are examples of 
heterocyclic fissions of other types of compounds such as coumarins where the lactone 
moiety is attacked (Gutenmann et al. 1972) or the example of diquat which is converted 
to a methyl urea derivative and CO2 (Williams, 1972). Thus it is possible that much of 
the drug is degraded and excreted before it reaches the milk.
It is possible that the hydrogenation of B-erythroidine or some other bacterial 
reactions is a detoxification mechanism. Even though adult goats do not develope toxic 
symptoms when fed Erythrina, several young animals that were given milk from goats 
on a diet containing Erythrina developed toxic symptoms (NFT project, CATIE, 
personal communication). It was unclear whether these symptoms resulted from a 
disease or a response to a toxin in the milk. It could be that the kids had not yet 
developed the bacterial population necessary to detoxify the possible toxins and 
therefore were susceptible to B-erythroidine or its metabolites.
It is difficult to assess the human health risk associated with the results presented in 
this paper. Dihydroerythroidine is one of the most potent forms of B-erythroidine with
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an effective dose for complete paralysis in mice of 80 |ig/kg (Robbins and Lundy, 
1947a and 1947b). This amount was exceeded in many milk samples on a total amount 
of DHEs produced per goat per day basis (Figure 5.8). However, mass spectral data 
presented here suggest that the DHEs formed in the rumen are different from the 
synthetic DHE tested in toxicological studies in the 1940s and 1950s (Boekelheide and 
Prelog, 1955) and therefore, the pharmacological data accumulated concerning the 
toxicity of DHE may not be pertinent to the isomers detected in the milk and rumen of 
the dairy goats in this study. From a review of the synthetic studies done on 
synthetically hydrogenated erythroidine derivatives, Snieckus concluded that in the case 
of B-erythroidine, the pharmacological properties of the drug were not dependent on the 
double bond configuration of the diene in the C and D rings (Snieckus, 1973). Several 
different optical isomers showed similar activities in biological assays. Therefore the 
dihydroerythroidines formed biologically may indeed possess biological activity. 
Furthermore, long term chronic exposure to these alkaloids, as well as other types 
alkaloids (Peterson, 1985), which may occur when a family consumes the contaminated 
milk regularly, is unknown.
5.5 Conclusion
B-Ery throidine, a paralyzing drug which is present in the foliage of Erythrina 
berteroana. and E. poeppigiana tree species, is rapidly hydrogenated in the rumen of 
dairy goats. Ery throidine, dihydroerythroidines and tetrahydroerythroidine were 
detected in the milk of the two treatment groups fed E. poeppigiana and E. berteroana 
foliage and were detected in rumen incubations which included dried plant material. The 
DHEs detected in the milk were not the same isomers formed upon catalytic 
hydrogenation of B-erythroidine and therefore the human health hazard associated with 
the consumption of milk which contains biologically hydrogenated DHEs is uncertain.
CHAPTER 6
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS
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6.1 Summary
After introducing the concept of agroforestry and describing the integration of 
animals in agricultural systems, the objectives of this research were presented. The 
objectives encompassed two main areas: the clonal evaluation of Erythrina clones and 
the identification of the metabolic fate of the major Erythrina alkaloids identified by gas 
chromatography and mass spectrometry analysis. Chapter 2 reviewed the scientific 
literature that pertained to Erythrina alkaloids. It was known that all Erythrina alkaloids 
possessed biological activity, however the exact mode of action has never been 
elucidated. Although the structure and stereochemistry of Erythrina alkaloids were 
determined, the exact structural requirements for biological activity were never revealed. 
Pharmacological studies focused on the duration of the drugs' effect and possible side 
effects.
Chapter 3 presented the basic experimental methodology for the plant collection, 
preparation and extraction. Additionally, liquid chromatographic techniques that could 
be used for Erythrina alkaloid analysis were investigated and discussed. These 
techniques included reversed phase liquid chromatography and LC/MS analysis. 
Chapter 4 detailed the GC/MS studies of the clone replicates. The potential importance 
of the alkaloid profiles in taxonomic classification was discussed as well as the 
implications of the large clonal variation in B-erythroidine content Clone 2652 was 
identified as the highest alkaloid containing clone, whereas, clone 2750 was very low in 
alkaloid content. There were low alkaloid content varieties of all three species evaluated.
The feeding study was described and discussed in Chapter 5. The milk of goats 
from three treatment groups were studied. Dihydroerythroidines and 
tetrahydroerythroidines were discovered in the milk of treated animals. Rumen 
incubations revealed that B-erythroidine was hydrogenated in the rumen. A discussion 
of the structural differences between synthetically hydrogenated and biologically
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hydrogenated dihydroerythroidines was included.
6.2 Conclusions
Statistical analysis of total nitrogen content and dry weight of the clones revealed that 
there are differences between clones of the same species with respect to these two 
parameters. As a species, E. poeppigiana in general was higher than either E. 
costarricensis and E. berteroana in nitrogen content, whereas E. berteroana was higher 
albeit more variable in dry matter content than E. poeppigiana. These differences 
suggest that Erythrina clones may vary in certain parameter due to genetic differences.
Studies presented here reveal that reversed phase HPLC can be useful in the analysis 
of Erythrina alkaloids. However, if trace amounts of alkaloids are present and need to 
be identified, gas chromatography /mass spectrometry is more sensitive. 8- Ery throidine 
eluted within 5 minutes in the reversed phase HPLC system developed. Peak 
asymmetry was minimized by using a polymeric column and a mobile phase of relatively 
high pH. If the compounds of interest are known and standards are available, then 
reversed phase HPLC can be very useful.
In an effort to develop a technique in which the alkaloids could be identified without 
the use of standards, LC/MS was investigated. An Extrel mass spectrometer, Waters 
HPLC system and a Thermabeam interface was utilized. Mass spectra of oxo-B- 
erythroidine and B-erythroidine were obtained but only when large injection volumes 
and high concentrations of alkaloids were used. Optimal HPLC conditions could not be 
used because of the drop in efficiency at the Thermabeam interface. Buffers could not 
be used in this system because of the high background which would have increased with 
the use of buffer. Highly aqueous mobile phases developed during the optimization 
stage of this research could not be used because of condensation at the interface and the 
high pressures generated at relatively low flow rates. Nevertheless, if samples are
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highly concentrated this method can be used to gri'e preliminary identification via mass 
spectra of the compounds of interest. This is the first time LC/MS has been used to 
investigate Erythrina alkaloids.
GC/MS using a 5% phenyl/95% methyl column is a valuable technique for the 
analysis of Erythrina alkaloids. Clonal evaluation of E. poeppigiana, E. berteroana and 
E. costarricensis revealed that B-erythroidine, a drug previously used in surgery and 
electroshock treatments, was the major alkaloid in the leaves of these species. There 
was little statistical variation in the parameters measured between individual trees of the 
same genetic clone. There was wide variation in the concentration of B-erythroidine 
between Erythrina clones of the same species and between different Erythrina species, 
however there was little difference in the types of Erythrina alkaloids detected between 
clones or between species. Low alkaloid content clones of all three species were 
identified. Alkaloid content and nitrogen content were not correlated, which suggests 
that these important parameters are not genetically linked. Low alkaloid containing 
clones may be genetically engineered or bred to contain even lower amounts of alkaloids 
without affecting or even improving the total protein content. For the present, low 
alkaloids clones should be developed over high alkaloid content clones for alternative 
feeds.
B-Ery throidine is rapidly hydrogenated in the rumen of dairy goats. Ery throidine, 
dihydroerythroidines and tetrahydroerythroidine were detected in the milk of the two 
treatment groups fed E. poeppigiana and E. berteroana foliage and were detected in 
rumen incubations which included dried plant material. The DHEs detected in the milk 
were not the same isomers formed upon catalytic hydrogenation of B-erythroidine. 
Since pharmacological studies have only included synthetically hydrogenated 
dihydroerythroidines, the human health hazard associated with the consumption of milk 
which contains biologically hydrogenated Ul lEs is unclear.
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5.6 Recommendations
Further studies should be performed in order to assess the toxicity of biologically 
formed dihydroerythroidines. As an example, goats could be dosed with a high level of 
B-erythroidine using a high alkaloid content clone identified in this study or by 
introducing seeds of high B-erythroidine content into the rumen of a fistulated goat. The 
milk collected from these animals could be freeze-dried and incorporated into the feed of 
mice in a controlled feeding study to determine toxic effects in mice. The results of this 
study could then be compared with the toxicity data accumulated using synthetically 
derived dihydroerythroidines.
Until the toxicity of the metabolites of B-erythroidine can be assessed, every effort 
should be made to utilize low alkaloid containing clones in feeding studies or in projects 
where Erythrina foliage will be used as a feed for animals.
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APPENDIX A
SELECTED SPECTROSCOPIC DATA ON ERYTHRINA  AND 
RELATED ALKALOIDS FROM LITERATURE SOURCES
127
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The units for the data listed below are as follows: optical rotation (degrees), UV 
(nanometers), IR (reciprocal centimeters), HPLC (mobile phase %volume), MS 
(m/z, % base peak), and NMR (6).
BOLDINE
Shamma, 1960 i
[aid (EtOH) +73
UV Oog e) 303 (4.2), 284 (4.2), 220 (4.6)
CRYSTAMIDINE
Chunchatprasert, 1982
MS m/z 309 (M+, 100), 294 (-15), 276 (-33)
HPLC Uchroprcp EtOH/CHCl3 10/90
NMR 400 MHz 6.32 (1), 6.90 (2), 3.67 (3a), 2.69 (4e), 1.40 (4a), 
6.06 (7), 6.88 (14), 6.72 (17), 3.26 (OCH3), 5.92 and 5.96 (O- 
CH2-O)
Ito, 1976
pale yellow oil
[aid +840 (c=0.5, CHCI3)
UV (log e, EtOH) 235 (4.13), 267 (4.15), 357 (3.31)
IR 1695 (C=0)
MS 309 (M+), 294, 278, 276 (100)
NMR (CDCI3) 6.73 (s), 6.70 (s), 6,93 (dd), 6.32 (br. d), 6.07 (m),
6.91 (d), 6.11 (d), 5.95 (q), 3.29 (s), 3.73 (m), 2.72 (dd), 1.40 (t) 
Mantle, 1984
MS 309 (M+, 85), 294 (-15, 28), 278 (-31. 60), 277 (65), 276 (100), 
266 (35), 250 (20) HRMS 309.0997 
NMR (CDCI3) 6.30 (dd, 1), 6.92 (dd, 2), 3.65 (dd, 3), 1.6 (4a), 2.70 
(ddd, 2.70), 6.05 (s, 7), 6.75 (d, lOe), 6.1 (d, lie ), 6.71 (s, 14), 
6.88 (s, 17), 3.28 (s, OCH3), 5.92 and 5.97 (OCH2O) 
DEMETHYLERYTHRALINE C 17H 17NO3 
Redha, 1983
MS 283 (M+), 268 (-15), 266 (-17, 100), 254 (-29), 266 (-57), 213 (- 
70)
NMR 90 MHz 5.94 (1), 6.42 (2), 4.34 (3a). 1.80 (4a), 2.40 (4), 5.70 
(7), 3.82 and 3.30 (8), 3.30 (lOe), 2.70 (10a), 2.55 (lie ), 2.72 
(11a), 6.74 (14), 6,60 (17), 5.85 (O-CH2-O)
DIHYDROERYSODINE C 18H23NO3 
Chunchatprasert, 1982 
MS m/z (TMS)
HPLC lichroprep EtOH/ CHCI3 (10/90)
NMR 400 MHz 5.58 (1), 2.51 (2), 2.70 (2), 3.80 (3a), 1.56 (4a), 
2.30 (4e), 2.23 and 2.43 (7). 270 and 296 (8), 3.13 (10a), 3.50 
(lOe), 2.51 (lie), 2.91 (11a), 6.64 (14), 6.55 (17), 3.26 (OCH3). 
3.80 (aryl OCH3)
Millington, 1974 (seeds)
MW. 301.1692 (HRMS)
NMR (100 MHz) 6.73 and 6.65 (s, aromatic); 5.67 (, =); 3.60 (m, 
next to OCH3); 3.89 and 3.34 (s, OCH3); 3.30-1.50 (c, -CH2-) 
Prelog, 1949 
[aid +239
UV Cog e, acid) 285 (3.7) 235 (4.0)
DIHYDROERYSOVINE C 18H 23NO3
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Ju-ichi, 1977 (Cocculus)
[a]d +223 oil
UV (log e, EtOH) 232 (3.83), 299 (3.55)
IR 3500 (OH)
MS 301 (M+), 243 (-58, 100), 242
NMR (C6D6) 6.99 and 6.30 (m, aryl), 5.37 (m, olefinic); 5.11(br, 
OH), 3.89 (m, CH3OCH), 3.27 and 2.98 (s, OCH3), 2.49 (q), 1.93 
(t)
DIHYDROXYDIMETHOXYTETRAHYDROBENZYLISOQUINOLINE
C 1 9 H 2 3 N O 4
Ghosal ctal. 1972 
brown oil
UV (log e, EtOH) 220-222 (infl, 4.24) 283-284 (3.81) min 255-257 
(2.95)
MS 329 (M+), 192 (100), 177 (48), 137 (52), 134 (26) 
DIMETHYLTRYPTOPHAN METHYL ESTER (N,N)
Ghosal et al., 1972
brown gum, m.p. methiodide 208-209 crystallized from EtOH as 
prisms
UV (log e) 222-224 (4.42), 282 (3.79), 292-295 (3.76)
[aid -59 (c 0.71, EtOH)
IR 3312 (NH), 2855 (NCH), 1722 (CO2CH3)
MS 246 (M+, 78), 183 (-CO2CH3), 130 (100, -CH(C0 2 CH3)- 
N(CH3)2), 116 (-CH2CH(C02CH3)-N(CH3)2)
NMR (60 MHz, CDCI3) 2.9 (s, N(CH3)2), 3.25 (dd), 3.32 (s, 
OCH3), 3.54 (dd), 4.45 (s), 7.0-8.2 (complex, 5H) 
EPIERYTHRATIDINE 
Chunchatprasert, 1982
MS m/z (TMS) 403, 388, 345, 257 (100)
NMR 400 MHz 5.61 (1), 4.35 (2), 3.65 (3a), 2.30 (4e), 1.68 (4a), 
3.04 and 2.74 (8), 2.43 amd 2.23 (7), 3.47 (lOe), 3.16 (10a), 2.57 
(lie), 3.04 (11a), 6.78 (14), 6.58 (17), 3.82 and 3.83 (aryl OCH3), 
3.27 (OCH3)
ERYBIDINE C20H25NO4 
Chunchatprasert, 1982
MS m/z (TMS) 413, 400, 372, 358 (100), 343......73
Crabb, 1975
NMR in CDCI3: 3.92, 3.87, and 3.87 (CH3O); 2.32 (NCH3)
Ito, 1971, 1973 and 1976 
m.p. 178-180 
[aid (EtOH) +0
UV (log e , EtOH) 216 (4.50), 284 (3.92)
IR (CHCI3) 3500 (OH)
MS 343 (M+), 328, 300, 286, 285, 256, 255 
NMR 60 MHz (CDCI3) 2.32 (s, NCH3), 2.42-2.78 (8H), 3.87 and
3.92 (OCH3), 6.78, 6.70, 6.68, and 6.67 (s, aromatic)
Jackson, Allertonia, 1982 (leaves of poeppigiana)
Redha, 1983 (leaves of poeppigiana)
130
ERYMELANTH1NE C 18H20N2O4 
Redha, 1983
MS 312, M-15, M-31 (100%)
IR 1730 cm-1 (ester carbonyl)
NMR 3.96 (methoxy carbonyl) 360 MHz spectra shown 
ERYSODIENE 
Barton, 1968
m.p. 226-230 MW 313.131868
IR vrnax in CHCI3 3545, 3300, 1675, 1655, 1625 cm-1
UV (e, EtOH,) 285 (3900) and 243 (20,700)
MS 313 (M+), 282 (100), 270,254
NMR CDCI3 at 100MHz 6.67 (s, 17); 3.37 (s, 14); 6.28 (t, 1); 5.99 (s, 
4); 3.70 (s, OCH3); 3.61 (s, OCH3); 3.65-2,10 (complex 8 
methylenes)
Ghosal, 1971
m.p. 222-224 stTaw colored needles 
IR vrnax 3525, 3305, 1672, 1648, 1620 
UV (log e) 238-242 (4.18) and 282-285 (3.05)
MS 313 (M+, 62); 298 (17), 282 (100)
ERYSODIENONE C 18H 19NO4 
Barton, 1968
m.p. 226-230 (EtOH)
UV (c, EtOH) 285 (3900), 243 (20,700)
IR (CHCI3) 3545, 3300, 1675, 1655, 1625 
MS 313, 282(100), 270, 254
NMR 6.64, (s, 17); 6.37 (s, 14); 6.28 (t, 1); 5.99 (s, 4); 3.7 (s, 
OCH3), 3.61 (s, OCH3), 3.65-2.1 (m, 8f methylene H)
Barton, 1970
m.p.226-229
UV (e) 243 (20,700) and 285 (3900)
IR 3545, 3300, 1675, 1655, and 1625
NMR 6.65 (s), 6.37 (s) 6.28 (t), 6.00 (s), 3.71 and 3.61 (s, OCH3), 
3.65-2.1 (complex 8H)
Gervay, 1966
UV 242, 283
IR 3500, 1692, 1665, 1630, 1595
NMR (CDCL3) 6.64 and 6.38 (s, aryl), 6.01 (s, olefinic), 3.28 (t, 
olefinic), 6.21 (OH), 3.72 and 3.62 (OCH3), 3.5-2.2 (br CH2 
muldplets)
Ghosal, 1971
straw coloured needles from EtOH m.p. 222-224 
UV flog e) 238-242 (4.18), 282-285 (3.50)
IR 3525, 3305, 1672, 1648, 1620 
MS 313 (M+, 62), 298 (17), 282 (100)
Ghosal, 1972
m.p. 222-225
UV (log e) 240-242 (4.32), 282 (3.55)
IR 3533, 3286, 1672, 1655, 1614 
MS 298 (35), 282 (100), 270 (18), 254 (22)
NMR (60 MHz, CDCI3) 6.66 (s), 6.28 (t), 5.98 (s), 3.72 (s, OCH3), 
3.63 (s, OCH3), 2.2-3.7 (complex, 8H)
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Mondon, 1966
UV (log e) 241 (4.12), 283 (3.47)
IR 1681, 1655, 1618 (conjugated diene)
MS 313 (M+), 282 (100)
ERYSODINE C 18H21NO3 
Boar, JCS, 1970
MS M+ (58%), M-CH3, M-CH3O (100%), M-CH50, M-C3H80, M- 
C4H70, M+ C5H80 
Boekelheide, 1960 
pKa 6.29
UV (log e) 285 (3.5); 235 (4.3)
Chawla, 1982 (seeds and leaves of berteroana)
MS of TMS deriv. 371 (M+, 58); 356 (M-CH3, 49); 340 (M-OCH3), 
100); 337 (15); 313 (10); 310(10); 287 (10); 73 (26)
Chawla, 1988
UV (log e, CH3OH) 228 (4.3); 283 (3.7);
MS m/z (%) 299 (M+, 72), 284 (47), 268 (100)
NMR (CDCI3) 6.78 (s, 14), 6.68 (s, 17), 6.57 (dd, 2), 5.99 (d, 1), 
5.72 (br. s, 7), 3.74 (s, aryl OCH3), 3.28 (s, CH-OCH3), 2.52 (dd, 
4e), 1.76 (t, 4a)
Chunchatprasert, 1982
MS m/z (TMS) 371, 356, 340 (100), ....73 
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 360 MHz 6.00 (1), 6.57 (2), 4.05 (3), 1.83 (4a), 2.52 (4e), 5.7 
(7), 3.75 (8), 3.55 (8), 3.49 (lOe). 2.92 (10a), 2.92 (11a), 2.61 
(lie), 3.77 (14), 6.68 (17), 3.78 (aryl OCH3), 3.34 (OCH3)
Crabb, 1975
NMR in C6D6: 6.65 and 6.76 (aromatic H)
El Olemy, 1972
m.p. 203-205, picrate 210-212, methiodide 229-30 
IR 3400 (OH)
Fokers, JACS, 71, 1949
crystallizes from EtOH containing excess HC1 
Folkers, JACS, 62, 1940
m.p. 204-205 yellowish, granules 
[aid +248 c~ 0.311 in EtOH 
Folkers, JACS, 63, 1941 (seeds of costarricensis) 
m.p. 200-201 
[aid +248 EtOH 
Folkers, JACS, 64, 1942
weak yellow-green fluorescence on alumina column where deposited w/ 
chloroform and eluted with EtOH 
Gentile, 1942
m.p. 204-205
[aid +250 (EtOH, c 0.3212, dm)
Ghosh, 1972 
m.p. 202
MS 299 (M+), 284, 268, 266 
Glasby, 1975
m.p. 204-205 colorless needles from EtOH 
[aid +248
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Hargreaves, 1974 (seeds of poeppigiana, costarricensis and berteroana, not in 
leaves)
Ito, 1973 and 1976 
m.p. 202-204 
[aid +231 (c 0.7, CHCI3)
UV (log e, EtOH) 228 (4.25), 284 (3.60)
IR (CHCI3 ) 3520 (OH)
MS 299 (M+), 284, 268 (100), 266, 241, 228, 215 
NMR 60 MHz (CDCI3) 1.82 (t, 4), 3.33 and 3.78 (s, OCH3), 5.75 
(br. s, 7), 6.02 (br.d, 1 \  6.60 (br. dd, 2), 6.72 and 6.83 (s, arom.) 
Jackson, Allertonia, 1982 (leaves of poeppigiana)
Marion, 1952 (seeds of berteroana, costarricensis and poeppigiana) 
m.p. 204-205 
[aid +248 
Millington, 1974
m.p. 205-205.5 
Prelog, 1949 
[aid +267
UV (log e, acidic) 287 (3.5); 238 (4.4)
Redha, 1983 (leaves of poeppigiana)
Sangster, 1965
UV (log e, EtOH/O.OlN H+) 235 (4.32), 285 (3.57); (EtOH/0.01 N 
OH-) 230-240 (sh, 4.28) and 297 (3.66)
Singh, 1969
m.p. 208-210 HC1 206-208 
ERYSOLINE C17H19NO3
Chawla, 1982 (seeds of berteroana)
MS of TMS deriv. 429 (M+, 100); 414 (M-CH3, 16); 398 (m-OCH3, 
3); 340 (51); 338 (42); 326 (12); 313 (21); 308 (12); 287 (10); 73 (60) 
Chunchatprasert, 1982
MS m/z (TMS) 429, 414, 340 (100), 338......73
NMR 220 MHz 5.96 (1), 6.53 (2), 4.48 (3a), 1.83 (4a), 2.54 (4e), 
5.74 (7). 3.68 (8), 2.94 (10a), 2.94 (11a), 2.54 (lie), 3.50 (lOe), 
6.87 (14), 6.65 (17), 3.87 (aryl OCH3)
Hargreaves, 1974 (seeds of berteroana)
Millington, 1974 (seeds)
MW 285.1362 (HRMS)
MS 285 (M+, 100) 268 M-OH, 89); 266 (M-OH, 21); 254 (M-CH3O, 
22)
NMR (60 Mhz) 6.69 and 6.46 (aromatic s); 6.34, 5.78 and 5.56 (m, -);
4.20 (m, next to OCH3); 3.79 (s, OCH3 ); 3.70-1.55 (complex-CH2 ‘) 
UV (c, EtOH) 225 (11,900) 283 (2950)
Redha, 1983
M S (T M S ) 429, 414, 398, 328 (100).... 73
ERYSONINE C 17H 19NO3 
Boekelheide, 1960 
pKa 6.50 
Chawla, 1982 (seeds of berteroana)
MS of TMS deriv. 429 (M+. 100); 340 (58); 338 (38); 326 (12); 313 
(24); 308 (10); 73 (58)
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Chunchatprasert, 1982
MS m/z (TMS) 429, 414, 340 (100), 338, ,...73 
Crabb, 1975
NMR in CftDfi: 6.65 and 6.76 (aromatic H)
Folkers, JACS, 63, 1941 (seeds of costarricensis)
chromatographed with chloroform and methanol on alumina, sparingly 
soluble in most solvents incl alcohols. Soluble in 5CV50 methanol and 
chloroform or in morpholine. 
m.p. 236-237 and 238-239, difficult to obtain clear m.p.
[aid +285-288 (0.5%HC1); +272 (morpholine)
Glasby, 1975
m.p. 236-237 colorless needles from EtOH 
[aid +289
Hargreaves, 1974 (seeds of costarricensis and berteroana)
Marion, 1952 (seeds of costarricensis)
no characteristic green color, phenolic 
m.p. 238-239 
[aid +285-288 
Millington, 1974 (seeds)
MS 285 (M+, 100) 268 M-OH, 89); 266 (M-OH, 21); 254 (M-CH3O, 
22)
ERYSOPINE C17H19NO3
Boar, JCS, 1970
MS M+ (83%), M-CH3, M-CH3O (100%), M-CH50, M-C3H8O, M- 
C4H7O, M+ C5H8O 
Boekelheide, 1960 
pKa 6.60
UV (log e) 292 (3.6); 240 (4.3)
Chawla, 1982 (seeds of berteroana)
MS of TMS deriv. 429 (M+, 62); 414 (M-CH3, 24); 398 (M-OCH3, 
100), 340 (12); 73 (45)
Chunchatprasert, 1982
MS m/z (TMS) 429, 414, 398 (100).......73
HPLC Lichroprep EtOH/ CHCI3 10/90 
Folkers, JACS, 62, 1940 (seeds of poeppigiana)
m.p. 240-241 white (green color with FeCl3 solution w/ 1 drop HC1) 
[aid +263.4 c= 0.291 in 60% absolute EtOH and 40% glycerol 
Folkers, JACS, 63, 1941 (seeds of costarricensis) 
m.p. 242-243
[aid +263 (40% glycerol and 60% EtOH); +276 (c=18.413 mg/2.023 
mL of 0.5% HC1); +225 (c=l3.860 mG/2.023mL morpholine) 
Gentile, 1942
m.p. 241-242, white prisms, with ferric chloride gives green color 
[aid +265 (EtOH-glycerol, c 0.0846, 2 dm)
Ghosh, 1972
m.p. 241-242
MS 285 (M+), 270, 254, 252 
Glasby, 1975
m.p. 241-242 colorless crystals from EtOH 
[aid +265.2
sparingly soluble in CHCI3, H2O and protic solvents
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Hargreaves, 1974 (seeds of poeppigiana, costarricensis and berteroana, not in 
leaves of poeppigiana)
Jackson, Allertonia, 1982 (leaves of poeppigiana)
Marion, 1952 (seeds of berteroana and poeppigiana)
less soluble in water, chloroform and alcohols, forms characteristic 
green color with ferric chloride in acid solution, base HC1 prisms 
m.p. 241-242 
[aid +265.2 
Millington, 1974 
m.p. 230-235 
Redha, 1983
MS (TMS) 429, 414, 398, 328 (100)....73 
ERYSOPITINE C 17H 21NO4 
Ghosal, 1972
m.p. 168-171
[aid +148 (c 0.52, EtOH)
UV (log c) 285-287 (loge 3 4.31
MS 303 (M+, 92), 288 (18), 271 (100), 245 (41, -CH2=CHOCH3) 
ERYSOSALVINE C 18H23NO4 
Glasby, 1975 
Millington, 1974 (seeds)
MS 317 (M, 8); 257 (a, 75); 258 (a, 23); 243 (b, 100); 242 (b, 26) 
NMR (60 MHz) 6.60 and 6.55 (s, aromatic); 4.45 and 5.87 (m, =);
3.60 (m, next to OCH3); 3.86 and 3.36 (s, OCH3); 3.30 and 1.75 (c, 
-CH2 -)
ERYSOSALVINONE 
Chunchatprasert, 1982
MS m/z (TMS) 461, 446, 430, 403 (100), 315......73
Millington, 1974 (seeds)
MS 317 M, 8); 257 (a, 75); 258 (a, 23); 243 (b, 100); 242 (b, 26) 
ERYSOTHIOPINE C 19H2IN O 7S
Folkers, JACS, 66, 1944 (seeds of poeppigiana) 
m.p. 168-169 
[aid +193 (c=0.183, EtOH)
Glasby 1975
m.p. 168-169 
[aid +194 
Marion, 1952 (seeds of berteroana) 
m.p. 168-9 
[aid 194 
CH3rck Index, 1968 
MW 407.44 
m.p. 168-169 
[aid +194 (c=0.103 in EtOH)
ERYSOTHIOVINE C 20H23NO7S
Folkers, JACS, 66, 1944 (seeds of poeppigiana) 
m.p. 187 short white crystals 
[aid +208 (c=0.359 in EtOH)
Glasby, 1975 
m.p. 187 
[aid +208
Marion, 1952 (seeds of berteroana and poeppigiana)
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m.p. 187 
[aid 208.5 
CH3rck Index, 1968 
MW 421.48 
m.p. 187
[aid +208 (c=0.359, EtOH)
ERYSOTINE
Chunchatprasert, 1982
MS m/z (TMS) 461, 446, 430, 703 (100), 315......73
Millington, 1974 (seeds)
MW 317.1930 (HRMS) 
m.p. 225-227 colorless crystals
MS 317 (M, 8); 257 (a, 75); 258 (a, 23); 243 (b, 100); 242 (b, 26) 
NMR (60 MHz) 6.68 and 6.48 (s, aromatic); 4.45 and 5.87 (m, =);
3.60 (m, next to OCH3); 3.8 and 3.36 (s, OCH3); 3.30 and 1.80 (c, - 
CH2 )
ERYSOTINONE C I8H21NO4
Boar, JCS, 1970
MS m/z 315 (M+, 20%), 272, 257 (100%), 229, 228, 201, 200 
Glasby, 1975 
Millington, 1974 (seeds)
MW 315.1467 (HRMS) 
m.p. 177-179 colorless needles 
[aid +342 (c 0.28 abs EtOH)
UV (e) 226 (17,600)
IR vrnax (CHCI3) 1675 cm-1 (C=0)
MS 315 (M+, 3); 257 (75); 256 (11); 229 (70); 228 (100); 242 (15);
272 (25)
NMR (100MHz) 6.80 and 6.58 (s, aromatic) 6.18 (m, =); 4.10 (q, next 
to OCH3); 3.84 and 3.56 (s, OCH3); 3.5-2.08 (c, -CH2-)
Mondon, 1970
m.p. 196-197 (racemic)
UV (log e ) 228 (4.5)
IR (KBr) 1680 cm -1 (C=0)
NMR 6.77 and 6.55 (s, aromatic); 6.12 (m, =); 4.07 (q, next to 
OCH3); , 3.80 and 3.51 (s, OCH3)
ERYSOTRAMIDINE C19H21NO4 
Chunchatprasert, 1982
MS m/z (TMS) 327 (M+, 100), 312 (-15), 294 (-33)
IR CHCL3 1665 CM-!
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 400 MHz 6.32 (1), 6.89 (2), 3.86 (3a), 1.70 (4a), 2.80 (4e),
6.02 (7), 3.99 (10c), 3.60 (10a), 3.08 (11a), 2.98 (lie ), 6.78 (14),
6.70 (17), 3.34 (OCH3), 3.76 (aryl OCH3), 3.86 (aiyl OCH3) 
Glasby, 1975 
ERYSOTRINE C 19H 23NO3 
Boar, JCS, 1970
MS M+ (40%), M-CH3, M-CH3O (100%), M-CH5O, M-C3H8O, M- 
C4H7O, M+ C5H8O
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Chawla, 1988
UV Gog e, CH3OH) 230 (4.3); 280 (3.8);
MS m/z (%) 313 (M+, 84), 298 (81), 282 (100)
NMR (CDCI3) 6.71 (s, 14), 6.48 (s, 17), 6.38 (dd, 2), 5.85 (d, 1), 
5.58 (br. s, 7), 3.95 (m, 3), 3.74 (s, aiyl OCH3), 3.64 (s, aryl 
OCH3), 3.22 (s, OCH3), 2.48 (dd, 4e), 1.76 (t, 4a)
Chunchatprasert, 1982
MS m/z (TMS) 313, 298, 282 (100),
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 220 NHz 6.05 (1), 6.69 (2), 4.10 (3a), 1.85 (4a), 2.55 (4c),
5.77 (7), 3.71 (8), 3.63 (8), 2.67 (lie), 3.55 (lOe), 2.90 (10a), 2.90 
(11a), 6.87 (14), 6.68 (17), 3.36 (OCH3), 3.78 (aryl OCH3), 3.88 
(aryl OCH3)
El Olemy, 1972
HC1 pale yellow needles m.p. 205-207 pricrate 160-162 
UV (log e, EtOH) 280(3.5),
IR 2250 (amine salt) 1615
MS 313 (M+), 298 (-15), 282 (-31), 281 (100), 280, 266 (-47)
NMR (CDOD) 3.85 and 3.75 (s, aryl OCH3), 3.35 (s, alkyl OCH3), 
6.9 and 6.7 (s, aryl), 6.55 (dd), 2.50 (ddO, 1.80 (t)
Ghosal, 1970
pale brown syrupy liquid, yellow picrate m.p. 161, picrolonate, 189- 
190
[aid (EtOH) +142
IR 1640, 1622, 1258, 1020, 805
UV (e) 235 (21,880) 282-285 (3262)
MS 313 (M+), 298 (-CH3), 282 (-OCH3), 179 
Ghosh, 1972
m.p. picrate 160 
MS 313 (M+), 298, 282, 280 
Glasby, 1975
m.p. 95-97 colorless crystals from light pet 
UV 228, 280 
Hargreaves, 1974 (seeds of poeppigiana)
Ito, 1976
oil, picrate 161-162 
[aid +140 (c 0.40, EtOH)
UV (EtOH) 229 and 280 
MS 313 (M+), 298, 282, 280
NMR in CDCI3 3.82 (s), 3.75 (s), 3.32 (s), 6.56 (dd), 5.98 (br. d/0,
5.70 (br. s), 6.83 (s), 6.63 (s), 4.05 (m), 2.53 (dd), 1.83 (t)
Jackson, Allertonia, 1982 (leaves of poeppigiana.)
Letcher, 1971
m.p. 95-96 from light pet. picrate 162-163 
[aid+142 (c 0.40, EtOH)
UV (log e , EtOH) 228 (4.17) and 280 (3.52)
MS 313, 298, 282(100)
NMR in C6D6 100MHz 5.93, 6.37, and 5.43 («, 1,2,7), 4.07 (next to 
OCH3), 2.11 (-CH2-.4), 6.97 and 6.46 (aromatic H), 3.46, 3.44 and
3.03 (OCH3)
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Miana, 1972
m.p. 94-98 colorless crystals picrate 164 HQ 205-206 
UV 232,284
NMR CDQ3 3.33, 3.78, 3.85 (s, OCH3)
MS 313 (M+), 298 (M-CH3) and 282 (M-OCH3, 100%)
Redha, 1983 (leaves of poeppigiana)
Sarragiotto, 1981
UV (c, EtOH) 230 (12100), 280 (3300),
IR 1610
MS 313 (M+, 65); 298 (41); 282 (100); 280 (12)
NMR (100 MHz, CDCI3) 6.86 (s, 14); 6.66 (s. 17); 6.56 (d, 2); 6.04 
(br d. 1); 5.76(br s, 7); 3.86 and 3.34 (s, OCH3); 1.89 (t. 4a)
Singh, 1969 (seeds) 
m.p. HQ 206-208 
UV (e) 232 (19,800) 284 (3,490)
MS 313 (M+, 33), 298 (M-CH3, 35), 282 (M-CH3O, 100) 
ERYSOTRINE-N-OXIDE C 19H 23NO4+
Sarragiotto, 1981
[aid+ 78.3 (ETOH, c 1)
UV (log e, EtOH) 231(14,000), 278 (2900 
IR 1610
MS 329 (M+, 5); 313 (10), 311 (10), 298 (12), 282 (20), 296 (90), 
254 (36), 239 (100), 224 (55), 165 (62), 152 (52)
NMR (100 MHz, CDQ3) 6.83 (s, 1), 6.76 (s, 14), 6.86 (d, 2), 4.06- 
4.12 (m, 4H), 3.95, 3.84 and 3.43 (s, OCH3), 3.36-3.08 (m, 3H), 
2.14 (dd, 4e)
ERYSOVINE C I8H21NO3 
Boar, JCS, 1970
MS M+ (46%), M-CH3, M-CH3O (100%), M-CH5O. M-C3H8O, M- 
C4H7O, M+ C5H8O 
Boekelheide, 1960 
pKa 6.45
UV (log e) 285 (3.5); 239 (3.8)
Chawla, 1982 (seeds and leaves of berteroana)
MS of TMS deriv. 371 (M+, 58); 356 (M-CH3, 49); 340 (M-OCH3, 
100); 338 (14); 313 (8); 310 (18); 73 (28)
Chawla, 1988
UV Gog e, CH3OH) 228 (4.3); 283 (3.6);
MS m/z (%) 299 (M+, 39), 284 (41), 268 (100)
NMR (CDCI3) 6.83 (s, 14), 6.59 (s, 17), 6.52 (2), 5.96 (1), 5.66 (br. 
s, 7), 3.84 (s, aryl OCH3), 3.28 (s, OCH3), 2.50 (dd, 4e), 1.78 (t, 
4a)
Chunchatprasert, 1982
MS m/z (TMS) 461, 446, 430, 403 (100), 315......73
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 400 MHz 5.98 (1), 6.51 (2), 4.03 (3a), 1.82 (4a), 2.50 (4e),
5.68 (7), 3.68 (8), 3.52 (8), 3.47 (lOe), 2,96 (10a), 2,90 (11a), 2.67 
(lie ), 6.85 (14), 6.60 (17), 3.86 (aryl OCH3), 3.32 (OCH3)
Crabb, 1975
NMR in C6D6: 6.65 and 6.76 (aromatic H)
Folkers, JACS, 62, 1940 (seeds of berteroana and poeppigiana) 
m.p. 178-179.5 large prisms
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[a](j +2232-234 
Gentile, 1942
m.p. 175-176 
Glasby, 1975
m.p. 178-179 colorless prisms from Et20 
[aid +252
readily soluble in CHCI3 and moderately so from EqO and EtOH 
Hargreaves, 1974 (seeds of poeppigiana and berteroana, not in costarircensis) 
Jackson, 1985
NMR 360 MHz spectra shown 
Marion, 1952 (seeds of berteroana, costarricensis and poeppigiana) 
m.p. 178-9.5 baseHCl needles 
taJd +252 
Millington, 1974 
m.p. 178-179 
Singh, 1970
m.p. 181-182
[aid +188 (c=0.47 ub /CHCI3)
MS m/z 299 (M+, 44%), 284 (-CH3, 47), 268 (-CH3O, 100)
UV (log e) 285 (3.6)
Singh, 1975
mp 169-170
TLC n-Bu0 H-Ac0 H-H20  (4:1:2)
UV (log e, EtOH) 284 (3.89)
MS m/z 299 (M+, 53), 284 (-CH3, 54), 268 (-OCH3, 100)
NMR 682(14-H), 6.58 (17-H) aromatic, 1, 2,and 7 H 5.95, 6.43,
5.64 (diffuse); 3.28, 3.82 (methoxy)
ERYSTEMINE C20H25NO4 
Glasby, 1975
m.p. 127-129 pale yellow prisms from light pet. pricrate m.p. 145-150 
[aid +189 
ERYTHAMIDE C 19H24NO3 
Ju-ichi, 1981 (Cocculus)
colorless cubes m.p. 87-89 
[aid +262 (EtOH)
IR (CHCI3) 3500, 3350, 1660 
MS 328 (M+), 270 (-58, 100),
NMR (acetone, d6) 4.87 and 3.99 (OCH3), 5.58 (m, olefinic H), 6.93 
and 7.91 (s, aromatic)
ERYTHLAURINE C20H25NO5 
Ju-ichi, 1981 (Cocculus) 
oil
[aid +232 (EtOH)
IR (CHCI3) 3500, 1710 
MS 273 (-58, 100)
NMR (CDCI3) 3.30 (s, OCH3), 3.91 and 3.93 (x. OCH3 and 
COOCH3), 5.63 (m, olefinic H), 7.18 (s, aromatic)
ERYTHRALINE C 18H 19NO3 
Boar, JCS, 1970
MS M+ (72%), M-CH3, M-CH3O (100%), M-CH5O, M-C3H8 0 , M- 
C4H7O, M+ C5H8O 
Boekelheide, 1960
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pKa 5.97
UV (log c) 292 (3.6); 238 (4.3)
Chunchatprasert, 1982
MS m/z 297, 282, 266 (100),
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 220 MHz 5.98 (1), 6.55 (2), 3.96 (3), 1.84 (4a), 2.48 (4e),
5.72 (7), 3.75 (8), 3.48 (3), 3.48 (lOe), 2.9 (10a), 2.85 (11a), 2.7 
(lie ), 6.78 (14), 6.52 (17), 5.9 (O-CH2-O), 3.32 (OCH3)
Dalton, 1979
m.p. 106-107 
[aid +212 (EtOH)
Deulofeu, 1947
HI m.p. 252-253 yellow needles 
[aid +176 (water, c=0.229)
Folkers, JACS, 1940
UV (e) 291 (14.5) off scale after 240 
Folkers, JACS, 1940 
m.p. 106-107
[aid +211.8 (c=0.944, abs. EtOH)
Ghosh, 1972
m.p. HBr 256 
297 (M+), 282, 266, 264 
Glasby, 1975
m.p. 106-107 
[aid +211
Hargreaves, 1974 (seeds of poeppigiana and berteroana, leaves of 
poeppigiana, not in seeds of costarricensis)
Ito, 1973 and 1976
oil HBr m.p. 245-248 
[aid +223 (c 0.6, H2O)
UV 232,290
MS 297 (M+), 288, 266 (100), 264, 226, 213 
NMR 60MHz (CHCI3) 1 .S3 (t, 4); 3.33 (OCH3); 5.73 (br. s, 7); 5.89 
(s, OCH2O); 5.90 (br. d, 1); 6.62 (br. dd, 2); 6.64 and 6.78 (s, 
aromatic)
Marion, 1952 
m.p. 106-7 
[aid +211.8 
Prelog, 1949 
[aid 228
UV (log e, acid) 290 (3.7); 238 (4.3) base 290 (3.6) 235 (4.2) 
Sangster, 1965
UV Gog e, EtOH/O.lN H+) 238 (4.29), 290 (3.66); (EtOH/O.OlN OH- 
) 225 (4.16), 273 (sh, 3.23), 290 and (3.59)
Singh, 1970
m.p. HBr 250-251 
UV (log e) HBr 291 (3.6)
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ERYTHRAMINE C 18H21NO3 (DIHYDROERYTHRALINE)
Barton, 1968
m.p. 120-121 
[a]d+168 (0.33)
MS 241 (-58, 100)
NMR in CDCI3 at 100MHz 5.55 (1); 2.34 (2,2) 3.73 (3); 1.67 (4a);
2.78 (4c); 6.60 (14); 6.60 (17); 5.85 (OCH2O); 3.26 (OCH3)
Boar, JCS, 1970
MS m/z 299 (M+, 20%), M-15, 268 (-31), 241 (-58,74%), 240 (100%) 
Crabb, 1974
NMR in CD Cl 3; 5.85 (bridged methylene); 6.6 and 6.6 (aromatic H), 
3.26 (CH3O); 3.73 (H next to CH3O); 2.34 (aliphatic next to =); 5.55 
(=); 1.57 and 2.78 (aliphatic next to spiro)
Folkers, JACS, 1939
m.p. HC1 249 free base unstable m.p. 104-105 
[a]d HC1 +220 
Folkers, JACS, 1940
UV (log e) 291 (4.2) and 238 
Ghosh, 1972
m.p. 120-121
MS 399 (M+) 268, 241,240 
Glasby, 1975
mp. 103-104
m.p. HI 249 orange-yellow needles form EtOH 
Marion, 1952
m.p. 103-4 small crystals 
Prelog, 1949 
[aid +223
UV (log c, acid and base) 292 (3.65); 241 (3.65)
Sangster, 1965
UV (log e, EtOH/O.lN H+) 241 (3.65), 291 (3.65); (EtOH/O.OlN 
OH-) 241 (3.65) and 291 (3.67)
ERYTHRARTINE C 19H23NO4 
El Olemy, 1972
yellow needles, m.p. 166-168 
UV (log e, EtOH) 230 (8.2), 280 (3.3)
IR 3200, 1620
MS 329 (M+), 314 (-15), 311 (-18), 298 (-31)297,(100), 296 (-18, 
15), 280 (-18, 31), 279 (-18, 32)
NMR (CDCI3) 3.80 and 3.90 (s, aryl OCH3), 3.4 (alkyl OCH3), 6.95 
and 7.05 (s, aryl), 6.6 (dd), 6.0 (br. d), 5.8 (br s), 4.70 (t), 4.15 (m) 
Sarragiotto, 1981
[aid + 256 (CHCI3 , c 1.4)
UV (e), EtOH) 227 (15,135), 275 (3630)
IR 1610
MS 329 (M+, 75); 314 (26), 298 (100), 296 (28), 280 (12)
NMR (100 MHz, CDCI3) 7.08 (s, 17), 6.92 (s, 14), 6,68 (dd, 2), 6.10 
(br d, 1), 5.82 (br s, 7), 4.80 (t, lie), 3.95, 3.83 and 3.37 (s, 
OCH3), 3.67 (dd, 10a), 3.14 (dd, lOe)
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ERYTHRARTINE-N-OXIDE C 19H23NO5
Sarragiotto, 1981
[a]d + 88.57 (ETOH, c 1.4)
UV (e, EtOH) 231(14,000), 278 (2900)
IR 1610
MS 345 (M+, 4) 329 (26); 326 (29), 298 (70), 239 (100), 224 (45), 
165 (47), 152 (39)
NMR (100 MHz, CDCI3) 7.08 (s, 1), 6.68 (s, 14), 6.74 (d, 2), 6.18 
(d, 1), 5.82 (br s, 7). 5.28 (br d, 11a), 4.4-4.0 (m, 4H), 3.92, 3.78 
and 3.38 (s, OCH3), 3.16 (t, 4a), 2.09 (dd, 4c)
ERYTHRASCINE 
Ghosal et al., 1972
cream colored needles m.p. 138-140 
[aid +152 (c 0.51, CHCI3)
UV (log c, EtOH) 210-212 (4.88), 233-235 (4.36), 284-288 (3.34)
MS 371 (<+, 42), 356 (22), 340 (100), 339 (27), 329 (31), 313 (24), 
311(17)
ERYTHRATIDINE C 19H25NO4
Barton, JCS, 1973 
m.p. 120-120.5 
[aid +258
IR vmax 3509 and 3387 cm-1
UV (e) 219 (22,500), 232infl (5700) and 284 (2600)
MS m/z 331 (M+), 300, 273, 257 (100%), 244 
NMR 6.58 (l,s), 5.81 (l,m), 4.43 (l,m), 3.6 (l,m), 3.74 (3,s), 3.3 
(3,s), 3.8-1.68 (11, complex aliphatics)
Chawla, 1988
UV (log e, CH3OH) 234 (3.75); 283 (3.49);
NMR (CDCI3) 6.64 (s, 14), 6.50 (s, 17), 5.93 (1), 4.50 (2), 3.87 (s, 
aryl OCH3), 3.82 (s, aryl OCH3), 3.68 (m, 3)
Chunchatprasert, 1982
MS m/z (TMS) 403, 388, 345 (100), 257..... 73
NMR 400 MHz 5.84 (10, 4.46 (2), 3.66 (3a), 1.83 (4a), 2.04 (4e), 
2.46 (7), 2.22 (7), 2.65 and 2.96 (8), 3.13 (10a), 3.49 (lOe), 3.00 
(1 la), 2.58 (1 le), 6.47 (14), 6.60 (17), 3.84 and 3.78 (aryl OCH3),
3.34 (OCH3)
Glasby, 1975
m.p. 120-121 colorless needles from EtOH as hemihydrate 
[a]d +222.5
Jackson, Allertonia, 1982 (leaves of poeppigiana and berteroana)
Millington, 1974 (seeds)
MW 331.1770 (HRMS) C19H25N04
m.p. 119-120
[aid +273 (c 0.3 abs EtOH)
UV (e, abs EtOH) 232 (7820) 287 (3550)
MS 331 (M+, 100), 300 (M-CH3O, 12) 273 (81), 272 (18), 257 (100), 
256 (20)
NMR (IOOMHz) 6.70 and 6.59 (s, aromatics); 4.56 and 5.93 (m, =);
3.70 (m, next to OCH3); 3.94, 3.89 and 3.44 (s, OCH3); 3.8-1.80 
(c, -CH2-)
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Redha, 1983 (leaves of poeppigiana)
HPLC EtOH/ CHCI3 10/90 
ERYTHRATIDINONE C 19H 23NO4 
Banon, JCS, 1973 
m.p. 119-120
[aid +358 (c = 1.121 in CHCI3)
IR vmax 1675 cm-1
UV (e, EtOH) 231 (19,600). 284 (3950)
MS m/z 329 (M+), 301, 298, 286, 272, 271 (100%), 243, 242, 228, 
215, 214,and 197 
NMR 6.68br (l,s), 3.57 (l,s), 6.13 (l,m), 4.05 (l,m), 3.88 (3,s).
3.78 (3,s), 3.5 (3,s) 3.32-2.28 (10, complex aliphatics) 
Chunchatprasen, 1982
NMR 400 MHz 6.02 (1), 3.96 (3a), 2.11 (4a), 2.52 (4e), 2.44 and 
2.61 (7), 2.71 and 2.94 (8), 3.12 (10a), 2.95 (11a), 2.58 (lie), 6.67 
(17), 6.48 (14), 5.86 and 5.86 (O-CH2-O), 3.46 (OCH3)
Glasby, 1975
m.p. 119-120 
Jackson, Allertonia, 1982 (leaves of poeppigiana)
Redha, 1983 (leaves of poeppigiana)
ERYTHRATINE C 18H21NO4/2H2O 
Banon, 1968
IR 3605 (intramolecular H-bond)
NMR in CDCI3 at 100MHz 5.56 (1); 4.28 (2); 3.60 (3); 1.63 (4a);
2.30 (4e); 6.73 (14);6.59 (17); 5.85 and 3.28 (OCH3)
Boar, JCS, 1970
MS m/z 315 (M+, 14%), 384, 257, 256, 241, 240 (100%), 228, 
Crabb, 1975
NMR in CDCI3: 5.85 (bridged methylene); 6.59 and 6.73 (aromatic 
H); 3.28 (CH3O); 3.60 (H next to CH3O); 4.28 (H next to OH); 5.56 
(double bond H) 1.63 and 2.30 (aliphatic next to spiro)
Deulofeu, 1947
m.p. 171-172 HI m.p. 240 HC1 (long prisms) m.p. 250 
[aid +138.6 (EtOH, c=0.39) HI +110 (water, c=0.209) HC1 +165.10 
water, c=0.333)
Folkers, JACS, 1940 
m.p. 170
[aid +145.5 c« 0.371, absolute EtOH)
Folkers, JACS, 1942
UV (e) 293 (4.3-4,8) increases past 240 
Glasby, 1975
m.p. 170-175 crystalizes as hemihydrate from Et20-pet ether 
Marion, 1952
m.p. 170-170.5 
[aid 145.5
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ERYTHRATINONE C18H19N04
Barton, 1968
m.p. 136-137 MW 313.130931 
[ald +409 (c 0.35)
IR vmax (CHCI3) 1675
UV (e) 297 (4800) and 230 (15,500)
MS 313 (M+), 270, 255 (100), 227, 226, 199, 198 
NMR CDCI3 at 100MHz 6.65 (s,17); 6.56 (s, 14); 5.9 (s, OCH2O);
3.98 (dd, 3); 3.51 (s. OCH3); 3.4-2.9 (complex 10 CH2s)
Boar, JCS, 1970
MS m/z 313 (M+, 20%), 270, 255 (100%), 227, 226, 199, 198 
Singh, 1972
m.p. 135-136
MS 313 (M+), 255, 227,226 
ERYTHRAVINE C 18H21NO3 
Chunchatprasen, 1982
MS m/z (TMS) 371, 356. 282 (100)......73
HPLC lichroprep EtOH/ CHCI3 40:60 
Glasby, 1975 
Millington, 1974 (seeds)
MW 299.1520 (HRMS) yeUow oil 
UV (e) 225 (14,000) and 282 (3070)
MS 299 (M+, 94), 282 (M-OH, 100); 280 (M-OH, 17); 266 (M-CH3O- 
H2 23
NMR (100 MHz) 6.88 and 6.68 (aromatic s); 6.57 (q =); 6.05 (d, =)
5.77 (s, =); 4.53 (m next to OCH3); 3.90 and 3.80 (s, OCH3, 1.75-
3.75 (complex -CH2- 8, 10, 11)
Redha, 1983
NMR 220 MHz 5.98 (1), 6.57 (2), 4.51 (3a), 1.83 (4a), 2.54 (4e),
5.75 (7), 3.63 (8), 3.70 (7), 2.66 (10a), 3.55 (10c), 2.97 (11a), 2.98 
(lie), 6.86 (14), 6.64 (17), 3.77 and 3.87 (aryl OCH3)
ERYTHRINADIENONE 
Crabb, 1975
NMR in CDCI3: 3.85 (aromatic CH3O); 6,63 and 6.36 (aromatic H); 
6.00 (H-OCH3)
ERYTHRININE C 18H 19NO4 
Crabb, 1975
NMR 5.94 (bridged methylene); 7.00 and 6.82 (aromatic H); 3.62 and
2.95 (ring C aliphatic), 3.32 (methoxy); 4.73 (H next to OH)
Ghosh, 1972
m.p. 197-198
MS 313 (M+), 298, 283, 282 
Glasby, 1975
m.p. 197-200 
[aid +204
UV 209, 230, and 289
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Ito, Chem Comm, 1970 
m.p. 197-200 
[a]d +204 (CHCI3)
MS m/z 313 (M+), 298, 283, 282, 280 
UV (log e) 209 (4.35), 230 (4.26) and 289(3.70)
IR vmax 3560 cm-1 (OH)
NMR 3.32 (3H, s, OCH3), 5.94 (2H,m, OCH2O), 6.82, 7.00 (2H, 
ss, para aromatic protons), 4.73 (1H, t, HOCH), 3.62, 2,95 (2H, 
pair of quartets), 6.00 (1H, broad doublet) and 6.60 (1H, broad 
double doublet)
Ito, 1973 and 1976 
m.p. 197-200 
[aid +204 (c 1.0, CHCI3)
IR (CHCI3) 3500 (OH)
UV (log e) 209 (4.35) 230(4.26), 289 (3.70)
NMR 60 MHz 3.32 (OCH3), 3.62 (q); 4.73 (t); 5.75 (br. s); 5.94 (m, 
OCH3O); 6.00 (br.d); 6.6 (br. dd); 6.82 and 7.00 (s, aromatics), 
ERYTHRISTEMINE C20H 25NO4 
Barton, 1970
m.p. 127-129
[aid+189 (c 0.4 in CHCI3)
MS MW 343.1789 m/z 343 (M+), 328, 312, 311 (100%), 310, 296, 
280
IR v max 1610 (no hydroxy or carbonyl)
UV (e, EtOH> 283 (3100) and 235 (20,000)
NMR in C6D0 7,09 and 6.93 (aromatic); 3.43, 3.43, 3.21, 3.02 (s, 
OCH3); 4.06 ( H at OCH3); 2.49 (q,4a); 2.08 (t, 4c); 6.32 (2); 5.88 
( 1)
Barton, JCS, 1973
m.p. 127-129, pale yellow prisms 
[aid +189 (0.4, CHCI3)
IR vmax 1610 cm-1
UV (log e, EtOH) 235 nm (4.3) and 283 (3.5)
MS m/z 343 (M+), 328, 312, 311 (100), 310, 296, 280 
NMR 7.09 (1H, s), 6.93 (1H, s), 6.32 (1H, dd). 5.88 (lH,d),5.38 
(lH,s), 4.06 (1H, X of ABMX), 3.94 (1H, dd), 3.97 (1H, A), 4.67 
(1H, B), 3.43 (6H,s)3.21 (3H, s), 3.02 (3H,s), 3.S-2.8 (2H, dd),
2.49 (lH.dd). 2.08 (lH.dd)
Chunchatprasert, 1982
MS m/z (TMS)
HPLC lichroprep EtOH/ CHCI3 10/90
NMR 400 MHz 6.01 (1), 6.58 (2), 4.09 (3), 1.79 (4a), 2.42 (4e), 5.71 
(7), 3.96 and 3.78 (8), 3.43 (lOe), 3.28 (lOe), 4.12 (lie ), 6.84 (14),
6.89 (17), 3.32 (OCH3), 3.56 (II-OCH3), 3.76 and 3.89 (aiyl 
OCH3)
Crabb, 1975
NMR in CfeDfi; 7.09 and 6.93 (aromatoc H); 6.32, 5.88, and 5.38 
(double bond Hs); 3.94 and 4.06 (H geminal with CH3OS); 2.08 and
2.49 (ring A aliphatic); 3.88 and 4.05 (aliphatic next to N); 3.43 
(CH3OS)
Glasby, 1975
m.p. 127-129 pricrate 145-150 
[aid +189 
UV 235 and 282 
Jackson, 1985
NMR spectra included in paper (w/o values)
Letcher, 1971
MS M+ (31), M-15 (20), M-30 (31), M-31 (96), M-32 (100), M-33 
(78)k, M-47 (31)
NMR 100MHz in C6D6 5.88, 6.32 and 5.38 (=, 1,2,7) 2.08 and 2.49 
(-CH2-, 4), 4.06 and 3.94 (next to OCH3), 6.93 and 7.08 (aromatic
H); 3.43, 3.43,3.21 and 3.02 (OCH3)
ERYTHROCARINE
Jackson, in Philipson, 1985
MS 283, 282 (M-H), 266 (M-OH), 264 (M-H2O-H)
NMR 5.85, 6.59 and 6.72 (aromatic H)
Jackson, Phytochem, 1985 
MW 283.121 
UV 235
MS 283 (M+), 282 (M-H), 266 (M-CH3), 264 (M-OH)
NMR 6.72 and 6.59 (aromatic) 2.99, 6.48, and 5.71 (diffuse, =, 1,2, 
7); 5.85 (methylene dioxy); 3.24 (m, 3); 1.78 (t, 4a); 2.46 (q, 4e) 
a-ERYTHROIDINE C I6H 19NO3
(berteroana, costarricensis, poeppigiana) 
mp 236
[aid +89 (water)
UV (log e) 233 (4.12); 254 (3.65) A233/254 = 2.95 
pKa (80%MCS) 5.42
IR 770, 810, 845, 860, 890, 902, 935, 943, 980, 990, 1010, 1022, 
1032, 1054. 1072. 1109. 1140, 1163. 1193. 1246, 1260, 1272, 
1295, 1321, 1342, 1640, 1715 
Aguilar, 1981 (flowers, americana)
UV (log e, EtOH) 226 (4.18)
[aid+123.85 (c 2.39, H2O)
IR film v max cm-1 2840, 1730, 1090, 890, 650,
NMR 60 MHz in CDCI3 6.43 (q, =, 2); 5.91 (d, =, 1); 5.80 (s, =, 14);
5.76 (m, =, 7); 4.46 and 4.03 (q, -CH2-, 17)3.5-3.96 (m, next to 
OCH3, 3); 3.65 (s, -CH2-, 8); 3.4 (s, OCH3); 2.33-3.23 (m, -CH2-, 
10, 11, 12); 1.66-1.93 (m, -CH2-,4)
Barton, JCS, 1973 (leaves of poeppigiana) 
m.p. 220-221 
Boar, JCS, 1970
MS M+ (83%), M-CH3, M-CH3O (100%), M-CH5O, M-C3H8O, M- 
C4H7O, M+ C5H8O 
Boekelheide, 1953
m.p. 58-60 beautiful white crystals HC1226-228 
told +136 (c 0.5% in water)
IR HC1 5.85 p (unsaturated lactone ring) and approx. 4.1, 7.0, 8.35, 
9.1, 9.5, 11.4, 11.6, 13.0 (spectrum shown)
UV (log e, EtOH) 224 (4.5)
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Boekelheide, JCS, 1953 (alpha HCL) (seeds of berteroana and poeppigiana) 
m.p. 58-60 HC1 m.p. 226-228 
IR approx v max 5.85, others 3.0, 4.1 9.1, 11.2, 11.9 
UV (log e) 224 nm (4.5)
(aid HC1 +118 (0.5% in water) base +136 
Chawla, 1982 (seeds and leaves of berteroana) 
glass
IR vmax 1720 (lactonic CO)
UV (log e) 227 (4.18)
MS 273 (M+, 72); 258 (M-CH3, 34); 242 (M-OCH3), 100)
NMR in CDCI3 5.88 (d. 1); 6.38 (dd. 2); 3.76 (m, 3); 1.69 (q. 4a); 
2.57 (q, 4c); 5.75 (br s. 7); 3.60 (s, 8); 2.83 (m, lOe); 1.75 (q, 11a); 
3.25 (m, 12); 5.75 (s, 14); 4.03 (q, 17a); 4.42 (q, 17e); 3.35 (OCH3) 
Glasby, 1975 
m.p. 94-95
Jackson, Allertonia, 1982 (leaves of poeppigiana and berteroana)
CH3rck Index, 1968 
m.p. 58-60
[aid +136 (c=0.5 in water)
Millington, 1974 (seeds of berteroana)
Mondon, 1970
m.p. 58-60, no color with sulfuric acid or ferric chloride, sensitive to 
air, stable as salt 
[a]d +136 (water)
UV (log e) 224 (4.5)
IR 5.78 (1730 cm-1)
Redha, 1983 (leaves of poeppigiana)
Sangster, 1965
UV lmax HC1 (EtOH) 229 (log e 4.54) and 232 (sh, 4.46)
Smith Kline and French Laboratories 
m.p. 236 
[aid +89 (H20)
IR vmax 1715 cm-1 others none 3200-3600 and 1193, 1109, 1054, 
980, 860, 770 
UV (log e) 233 (4.12) 
pK(80%mcs) 5.42 
fl-ERYTHROIDINE C 16H 19NO3 
Aguilar, 1981 (flowers, americana) 
m.p. 100 methiodide 219-220 
MS 273.1359 (M+)
IR vmax (KBr) in cm-1 2810, 1720, 1090, 810, 645 
IR vmax (KBr) in cm-1 2820, 1740, 1110, 840, 810 
NMR 60 MHz ir CDCI3 6.43 and 5.85 (q, «, 2, 1); 5.71 (m, =, 7);
4.63 (s, -CH2- next to ether); 4.1 (m, next to OCH3); 3.58 (m, - 
CH2- next to N); 3.38 (s, -OCH3); 2.35-3.23 (m, 14, 10, 11)
Barton, JCS, 1973 (leaves of poeppigiana) 
m.p. 222.5 
Boar, JCS, 1970
MS M+ (84%), M-CH3, M-CH3O (100%), M-CH5O, M-C3H8O, M- 
C4H7O, M+ C5H8O
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Boekelheide, JACS, 1953 (beta) (seeds of berteroana and poeppigiana) 
m.p. HC1 228-231 base 99-100 
fold +85 HC1+107
IR vmax 5.78 p. (carbonyl of d-lactone) and approx 3.3, 4.15, 9.1, 9.4, 
10.2, 12.2, 14.5 (spectrum shown)
UV (log e) 238 (4.4)
Chawla, 1982 (seeds and leaves of berteroana) 
glass
IR vmax 1720 (lactonic CO)
UV (log e) 230 (4.16)
MS 273 (M+, 63); 258 (M-CH3, 32); 242 (M-OCH3, 100)
MS of TMS deriv. 345 (M+, 40); 330 (M-CH3, 17); 314 (M-OCH3, 
40); 224 (65); 196 (75), 130 (100); 73 (64)
NMR 5.90 (d, 1); 6.44 (dd, 2); 4.11 (m, 3); 1.79 (q, 4e); 2.55 (q, 4e);
5.71 (s, 7); 3.63 (d, 8); 3,17 (q, 10a); 3,22 (q, lOe); 1.68 (m, 11a); 
2.40 (m, lie ); 2.98 (d, 14a); 3.07 (d, 14e); 4.57 (d, 17a); 4.77 (d, 
17e); 3.38 (OCH3)
Folkers, CA 37:5408 (seeds of berteroana and costarricensis) 
m.p. 228
Folkers, JACS, 1937 (americana seeds) 
m.p. HC1 228-229 base 94-96 
[a]d HC1 +109.7 (c=0.501 in H2O)
MW 273 
Glasby, 1975
m.p. 98.5-99.5 
[aid +88.8 
Jackson, 1985 (seeds of berteroana)
Jackson, AUertonia, 1982 (leaves of poeppigiana and berteroana)
Marion, 1952 (seeds of berteroana and costarricensis) 
m.p. 99.5-100 
[aid +88.8 
CH3rck Index, 1968 
m.p. 99.5-100 
[a]d +88-8
soluble in water, benzene, chloroform, methanol, EtOH 
Millington, 1974 (seeds of berteroana)
Mondon, 1970
m.p. 99-100 characteristic color with sulfuric acid or ferric chloride 
[a)d +89 (water)
UV (loge) 238 (4.4)
IR 5.78(1730 cm-1)
Redha, 1983 (leaves of poeppigiana)
Sangster, 1965
UV (log e, HCl-EtOH) 232 (4.4). 240 (4.4), 245 (sh, 4.27) and 264 
(sh, 3.28)
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HYDROXYERYSODINE (C ll)  C18H 21NO4 
Chunchatprasen, 1982 
IR 3600
UV (log c, EtOH) 280 (378) 230 (280) for beta OH 280 (3424) 230 
(11640) for alpha OH
MS m/z (TMS) 459, 444, 428 (100), 369, 338..... 73, 315 (M+), 300
(-15)k 284 (-31, 100), 266 (-49)
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 400 MHz (beta) 6.0 (KK 6.58 (20< 4.03 (3a), 1.79 (4a), 2.40 
(4e), 5.74 (7), 3.97 and 3.85 (8), 3.56 (lOe), 3.10 (10a), 4.66 (lie), 
6.82 (14), 7.0 (17), 3.31 (OCH3), 3.78 (aryl OCH3)
NMR 400 MHz (alpha) 6.02 (1), 6.55 (2), 4.22 (3a), 1.85 (4a), 2.70 
(4e), 5.70 (7), 3.66 and 3.70 (8), 3.45 (lOe), 3.18 (10a), 4.93 (1 la), 
6.85 (14), 7.09 (17), 3.35 (OCH3), 3.78 (aryl OCH3) 
HYPAPHORINE C 14H I8N2O 2 
Deulofeu, 1947 
m.p. 230-235 
Folkers, 1939, JACS
m.p. 231-232 free base 236-237 
[a]d +89.6 c=0.502 in H2O base +113.1 c=0.516, H2O 
Folkers, JACS, 63, 1943 (seeds of costarricensis) found in every species so 
far examined 
Langes Handbook
large monoclinic cyrstals/aqueous, very soluble in water and alcohol 
m.p. 255 (anhydrous)
Marion, 1952 (seeds of costarricensis)
Sarragiotto, 1981
m.p.247.8-248.8 HC1 233.1-234.4 
IR 3200, 1640
NMR (100 MHz, CF3COOH) 7.77-7.30 (6 aromatic protons), 4.53 (t,
1), 3.65 (d, 2), 3.47 (s, N(CH3)3)
ISOBOLDINE C 19H21NO4 
Barton, JCS, 1973
m.p. HC1 118-123 
Chan, 1966
amorphous white powder, m.p. 123-135 
UV (log e, EtOH) 280, 302 (4.03, 4.05)
IR (Nujol) 3300-3500, 1608, 1585, 1515s, 1415, 1335, 1315, 1280s.
1250s, 1110, 1080 
NMR 8.05, 6.85, 6.60 (s, aromatics)
Clezy, 1966
m.p. as pinkish needles or colourless plates 120-124 
[aid 41.3 (c, 0.7, EtOH)
UV (log e) 280 (4.11), 305 (4.15)
NMR 2.50 (NCH3), 3.85 (2xOCH3), 2.6-3.3 (m, complex aliphatics),
6.49 (3), 6.77 (8), 7.98 (11)
Jackson, Allertonia, 1982 (leaves of poeppigiana)
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ISOCOCCULIDINE 
Praskash 1988
NMR 400 MHz 6.03 (m, 1), 5.91 (m, 2), 3.53 (m, 3), 1.75 (m, 4a)
1.98 (m, 4e), 2.76 and 1.85 and 2.17 (m, 7), 2.79 and 3.20 (m, 8),
2.64 (m, 10a), 3.38 (m, lOe), 6.76 (m, 14), 6.73 (m, 16), 7.09 (m, 
17), 3.26 and 3.76 (OCH3)
MELANACANTH1NE C 18H20NO3 
Redha, 1983
m.p. 156-157 small needles crystalized from a mix of equal parts of 
EtOH/H20 
IR 1720 cm-1 (ester carbonyl)
UV (log e, EtOH) 230 (1870), 265 (infl, 562)
HPLC EtOH/CHCl3 5:95
MS (TMS) 312 (M+), 297 (-15), 282, 281 (-31, 100), 269, 221... 
NMR 400 MHz 6.08 (1), 6.59 (2), 3.97 (3a), 1.90 (4a). 5.75 (7), 3.54 
a d 3.74 (8), 3.54 (lOe), (3.07 (10a), 2.76 (lie ), 3.07 (11a), 8.00 
(14), 8.51 (17), 3.33 (OCH3), 3.96 (OCOCH3) 
METHOSYERYTHRATINE 
Chawla, 1987
MS (TMS) 417 (M+, 100); 329 (-88, 40); 328 (-89, 52) and 73 (94) 
NMR 360 MHz (CDCI3) 5.75 (d, 1); 4.31 (m, 2); 3.59 (m, 3); 1.77 (t, 
4e); 2.19 (dd, 4e); 2.95 and 2.6 (m, 8), 4.53 (t, 11), 6.47 and 6.64 
(s, 14/17); 3.40 and 3.36 (OCH3)
METHOXYERYSODINE (C ll)  C19H 23NO4 
Chunchatpraseit, 1982
UV (log £, EtOH) 230(1711), 280(658)
IR 3560 cm-1 (OH)
MS m/z (TMS) 401, 386, 370 (100),354, 339.... 73, 329 (M+), 314
(-15), 298 (-31), 297 (-32, 100). 282 (-47), 266 (-63)
HPLC Lichroprep EtOH/CHCl3 10/90
NMR 400 MHZ 6.0 (1), 6.58 (2), 4.05 (3a), 1,78 (4a), 2.43 (4e), 5.71 
(7), 3.96 and 3.77 (8), 3.3 (lOe), 4.08 (lie ), 6.81 (14), 6.96 (17),
3.32 (OCH3), 3.53 (11 OCH3), 3.77 (aryl OCH3)
Jackson, 1985
MS 329 (M+), M-15, M-31, M-32 (-CH3OH), M-47 (-CH3 and 
CH3OH), M-63 (M-OCH3 and CH3OH)
NMR spectra shown w/o values 
METHOXYERYSOPINE (C ll)
Chunchatprasert, 1982
MS m/z (TMS) 459, 444, 428 (100), 427..... 73
Redha, 1983
MS m/z (TMS) 459 (M+) , 428 (-31), 427, 396, 329, ....73 (100) 
METHOXYERYTHR ALINE 
Chunchatprasert, 1982
MS m/z (TMS) 327, 312, 296 (100), 294, 264 
HPLC Lichroprep EtOH/CHCl3 10/90 or PartisU CHCI3 
NMR 400 MHz 6.0 (1), 6.54 (2), 4.02 (3), 1.86 (4a), 5.72 (7), 3.81 
and 3.81 (8), 3.18 (10a), 3.46 (lOe), 4.15 (lie ), 6.78 (14), 6.91 
(17), 3.35 (OCH3), 3.56 (II-OCH3). 5.89 and 5,95 (O-CH2-O)
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Letcher, 1971
MW 327.1461 (HRMS) pale yellow gum 
ta]d +199
IR vmax (film) 1616 cm-1 
UV (log e) 227 (4.15) and 286 (3.5)
MS M+ (24), M-15 (16), M-30 (22), M-31 (90), M-32 (100), M-33 
(55), M-47 (32)
MS 327, 312, 297, 296, 295 (100), 294, 280
NMR in C6D6 100MHz 5.80, 6.32, and 5.37 (« 1,2,7); 4.95 and 3.94 
(next to methoxy, 3, 11); 2.1 amd 2.48 (CH2, 3); 3.99 and 7.04 
(aromatic); 3.17 and 3.01 (OCH3); 5.33 (O-CH2-O)
NMR in CDCI3 well resolved signals 4.08 (t) 
METHOXYERYTHRALINE-N-OXIDE 
Chawla, 1987
MS 343 (M+, 2), 327 (-16, 44), 312 (-31. 21), 296 (-47, 100), 295 (- 
48. 94), 294 (-49, 68), 280 (46)
NMR 360 MHz (CDCI3) 6.18 (d, 1); 6.65 (dd, 2); 4.19 (m, 3); 3.09 (t, 
4a); 2.08 (dd, 4e); 5.79 (br. s, 7); 5.09 (d, 8); 4.71 (m, 8); 4.71 (m, 
10a); 3.91 (dd, lOe); 4.50 (d, 11), 6.55 and 6.86 (s, 14/17), 6.03 and
5.97 (OCH2O); 3.63 and 3.41 (s, OCH3)
NORORIENTALINE C 18H 21NO4 OR C j8H 22N 04B r 
Barton, JCS, 1973 (leaves of poeppigiana isolated as HBr salt)
m.p. 257 from CH30H-Et20H (HBr salt) free base m.p. 145-147 
[aid +42 (c 0.18 in chloroform)
UV (e) 285 (8800) and 231 (16,500) in NaOH-EtOH 301 (10,500) and 
247 (19,500)
v max (nujol) 3300, 3200, 3100, 1605, and 1525 cm-1
NMR (TFA) 7.4 (2, NH2+), 7.87-7.63 (5, arotnatics), 4.72 (l.m),
3.89 (3, s), 34.34-3.12 (6, complex aliphatics)
MS m/z 315 (M+ -HBr), <78 (100%), 163, and 137 
Ito, 1973 and 1976
m.p. 104-106 HCL 158-160 
[aid -41.3 (c 0.46, CHCI3)
IR (CHCI3) 3550 (OH)
UV (log e, EtOH) 210 (4.60), 228 (4.12 ), 286 (3.83)
MS 315 (M+), 179 (100), 178, 177, 163
NMR 60MHz (CDClv) 3.82 and 3.83 (OCH3), 6.93-6.63 (4 aromatic 
H), 6.57 (s, aromatic)
NORPROTOSINOMENINE C18H21N04HCI 
Banon, 1968
m.p. HC1 241-242 colorless needles MW base 315.147048 
IR vmax 3350, 3100, 2720, 2660, 2620, 2555, 1605 cm-1 
UV (e, EtOH) 286 (7100) and 222 (infl 13,800)
MS 315 (M+), 178 (100), 163, 137
NMR CDCI3 at 100 MHz 9.99 (br s. NH/OH) 9.85 (s, NH/OH); 6.79 
(br s, 2, 4, 5); 6.63 (s, 8); 6.35 (s, 5) 4.49 (br m, 1); 3.77 (s,
OCH3); 3.57 (s, OCH3); 3.92-2.30 (complex methylene +20H/NH)
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Ghosal, 1971
m.p. 242-244 colorless needle::
[aid +28 (c 0.88 in water)
UV (log e) 222-225 (hump 4.13) and 284-285 (3.84)
IR v max (base) 3342, 3304, 1611
MS 315 (M+,<1%), 178 (100), 163 (32), 137 (16), 122 (9), 94 (6) 
NMR 8.98 (broad s, NH); 8.87 (s, OH); 6.76 (broad, s, 3H), 6.62 (s, 
1H), 6.36 (s, 1H); 4.50 (broad m, 1H); 3.72 (s, OCH3). 3.69 (s, 
OCH3), 2.5-4.1 (comeplex, 8H)
ORIENT ALINE C20H25NO4 
Barton, JCS, 1973
[a]d -35.5 (c=0.2 in CH32CO
UV (c, NaOH-EtOH) 310 (e 6900) and 252 (e 14,800)
NM R in D-acetone 6.83br (2, s), 6.61 (1H, d), 6.48 (1, dd), 6.02 (1, 
s), 5.1 (1, dd)) 3.78 (3, s), 3,72 (3, s), 3.07br (3,s) 3.33br (3,s) and 
3.9-3.1 (6, complex aliphatics)
MS m/z 343 (M+), 312, 206, 192 (100%), 177, 149, and 137.
MW 343.1775 
Ito, 1973
NMR 60 MHz 2.48 (s, NCH3), 3.79 and 3.85 (s, OCH3), 6.43 (s, 
aromatic)
OXOERYSOVINE at C8 C18H 19NO4
Chunchatprasert, 1982
UV (e, EtOH) 230 (2504) 284 (1052)
IR 1670 cm -1 or 1675
MS m/z 313 (M+, 100), 298 (-15), 282 (-31), 280 (-33)
HPLC Lichroprep EtOH/ CHCI3 10/90
NMR 400 MHz 6.29 (1), 6.84 (2), 3.82 (3), 1.63 (4a), 2.74 (4e),
5.97 (7), 3.94 (lOe), 3.57 (10a), 3.04 (11a), 2.93 (lie ), 6.80 (14),
6.69 (17), 3.29 (OCH3), 3.86 (aryl OCH3)
OXOERYTHRALINE at C8 C 18H 17NO4 
Chunchatprasert, 1982
IR (CHCI3) 1670 cm-1
MS m/z 311 (M+, 100), 296 (-CH3,41), 280 (-OCH3, 58),294 (-47) 
HPLC Partis il CHCI3 and Lichroprep EtOH/CHCl3 10/90 
NMR 220 MHz 6.34 (1), 6.91 (2), 3.80 (3), 1.70 (4a), 2.81 (4e), 6.06 
(7). 3.65 (10a), 3.91 (lOe), 3.02 (lie), 3.12 (11a), 6.88 (14), 6.85 
(17), 3.37 (OCH3), 5.92 and 5.96 (O-CH2-O)
Ito, 1976
IR (CHCI3) 1665 cm-1 (C=0)
MS m/z 311 (M+)
NMR (CHCI3) 6.91 (dd), 6.33 (br d), 6.78 (s), 6.75 (s), 5.93 (dd),
3.35 (s)
Jackson, 1985
MS 311 (M+), 295 (M-15), 280 (M-31), 278 (100%), 266, 258, 225, 
213, 189, 167, 149, 126, 105, 91, 71, 58
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Mantle, 1984
MS 311 (M+, 100), 296 (-15,50), 280 (-31, 65), 279 (33), 278 (76), 
268 (15), 250 (30) HRMS 311.1163 
NMR (CDCI3) 6.30 (dd, 1), 6.87 (ss, 2), 3.78 (Odd, 3), 1.67 
(ddd,4a), 2.80 (ddd. 4e), 6.0 (s, 7), 3.87 (ddd, 10a), 3.62 (ddd, 
lOe), 3.10 (ddd, 11a), 2.96 (ddd, lie ), 6.74 (s, 14), 6.72 (s, 17),
3.33 (s, OCH3), 5.91 and 5.92 (OCH2O) 
OXOERVTHRATINONE at C8 C I8H 17NO5 C18H17NOS 
Chunchatprasert, 1982
UV (e, EtOH) 230 (2780) 285 (1250)
MS m/z 327 (M+), 241 (-15, 100), 212 (-115)
HPLC Lichroprep EtOH/ CHCI3 10/90
NMR 400 MHz 7.30 (1), 3.49 (3a), 1.68 (4a), 2.59 (4e), 4.12 and
3.63 (7), 3.58 (10a), 3.72 (lOe), 3.09 (11a), 2.92 (lie ), 6.48 (14), 
6.66 (17), 3.40 (OCH3), 5.93 and 5.90 (O-CH2-O) 
OXOERYTHRININE C 18H 17NO5 
Dagne, 1984
m.p. crystals 200-201 MW 327.1111 (HRMS)
[aid +100 (CHCI3 c=0.35)
IR 3460 (OH), 3040, 2960, 1680 (C=0), 1505, 1485, 1250, 1100, 
1040, 930, 870 
UV (e, EtOH) 357 (1022), 272 (6740), 238 (12,600)
MS 327 (M+, 93); 312 (72); 296 (85); 295 (68), 294 (100), 282 (49), 
238 (64)
NMR (400 MHz, CDCI3) 1.67 (dd, 7a); 2.67 (br. dd, 4e); 3.66 (dd, 
lOe); 4.22 (dd, 10a); 4.84 (br t, 11); 5.92 and 5.96 (OCH2O); 6.03 
(s, 7); 6.34 (br d, 1); 6.83 (s, 14); 6.85 (br dd, 2); 7.02 (s, 17) 
OXO-a-ERYTHROIDINE
Chawla, 1982 (seeds and leaves of berteroana) 
m.p. 183 crystals from acetone 
[aid+137.9 (c 0.116, EtOH)
UV (log e) 222 (4.19) and 253 (4.16)
IR vmax 1700 cm-1 (CO); 1745 cm-1 (5 membered lactam CO)
MS 297 (M+, 100); 272 (M-CH3, 17); 256 (M-OCH3, 47)
NMR 6.25 (d, 1); 6.74 (dd, 2); 3.75 (m, 3); 1.62 (q, 4a); 2.57 (q, 
4e); 6.02 (s, 7); 3.11 (m, 10a); 4.35 (dq, lOe); 1.45 (dq, 11a); 1.93 
(m, lie); 3.03 (m, 12); 5.83 (d, 14); 3.97 (q, 17); 4.46 (q, 17e); 3.41 
(OCH3)
OXO-B-ERYTHROIDINE
Chawla, 1982 (seeds and leaves of berteroana) 
glass MW 287.1146 (HRMS)
[aid +32 (c 3.156, EtOH)
UV (log e) 254 (3.83)
IR vmax 1700 cm-1 (CO); 1745 cm-1 (5 membered lactam CO)
MS 287 (M+, 100), 272 (M-CH3, 27); 256 (M-OCH3, 46)
MS of TMS deriv. 359 (M+, 10); 344 (M-CH3, 16); 242 (62); 227 
(78); 73 (100)
NMR 6.25 (d, 1); 6.77 (dd, 2); 4.08 (m, 3); 1.72 (q, 4a); 2.82 (q, 4e); 
5.96 (s. 7); 3.22 (dq, 10a); 4.34 (dq, lOe); 2.02 (br dd, 11a); 2.40 
(m, 1 le); 3.10 (d, 14 a and e); 4.59 (d, 17); 4.73 (d, 17e); 3.42 
(OCH3)
Jackson, 1985 (seeds and leaves of berteroana)
OXOMELANACANTHINE at C8 C18H 18NO4
Redha, 1983
IR 1720 cm-1 (ester carbonyl), 1677 (carbonyl)
UV (e, EtOH) 232 (1478), 256 (1174)
MS 326 (M+), 311 (-CH3), 295 (-OCH3), 294 (-OCH3, H2), 283 (- 
C2H3O), 269 ....
NMR 400 MHz 6.42 (1), 6.93 (2), 3.77 (3a), 1.79 (4a), 2.75 (4e),
6.04 (7), 4.17 (lOe), 3.61 (10a), 3.15 (lie,a), 7.95 (14), 8.62 (17),
3.33 (OCH3). 3.96 (OCOCH3)
OXOMETHOXYERYTHRALINE <C8, C ll)
Chunchatprasert, 1982
MS m/z 341 (M+), 326 (-15), 310 (-31, 100), 294 (-47)
HPLC Lichroprep EtOH/ CHCI3 10/90
NMR 400 MHz 6.26 (10< 6.8 (2), 3.85 (3a), 1.62 (4a), 2.63 (4e),
5.95 (7), 4.15 (lOe), 3.55 (10a), 4.40 (lie ), 6.77 (14), 6.90 (17),
5.89 and 5.84 (O-CH2-O), 3.30 (OCH3), 3.45 (aryl OCH3) 
PROTOSINOMENINE 
Ghosal, 1971
pale brown gum
UV (log c) 220-222 (infl 4.22) and 282-286 (3.78)
MS 329 (M+, <2%); 192 (110), 177 (22), 137 (25) 
TETRAHYDROERYTHRAVINE 
Redha, 1983
MS (TMS) 375 (M+), 360 (-15), 386 (-89), 284 (-91). 272 (-103)... 
73 (100) MW 303 
UNKNOWNS 
Ghosal, 1971
I, UV 235-238, 282-285, 305-310 (sh)
II, UV 220-224, 230-235 (infl), 284-288, 300-305 (sh)
Redha, 1983
I, C I6H 17NO3 MW 271 3 OH groups MS (TMS) 478 (M+), 472, 
429, 398, 371...
II, C I6H I8N2O no OH 2 N conjug. diene MS 254 (M+),239 (- 
CH3), 223 (-OCH3, 100)
III, C6H9NO4 perhaps a.a. 231(M+) MS (TMS) 375 (M+), 360,
286, 272, 256, 242, 196,..... 73 (100) methylene glutamic acid or
pyrrolidinedicarboxylic acid
APPENDIX B
GAS CHROMATOGRAPHIC AND MASS SPECTRAL DATA 
OF SELECTED ERYTHRINA  ALKALOIDS DESCRIBED
IN THIS STUDY
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